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Abstract 
Piezo1 proteins are Na+ and Ca2+ permeable mechanosensitive ion channels. Expressed 
on endothelial cell membranes, where they sense the shear stress forces created by 
blood flow, Piezo1 channels are essential for vascular development. The functional 
significance of vascular Piezo1 channels in adult physiology and pathology, however, 
remains largely unexplored. Therefore, using an inducible, endothelial-specific Piezo1 
knock-out mouse line this study sought to identify and investigate the functional role of 
this channel in adult arterial vessels. Four morphologically and physiologically distinct 
arteries, the aorta, mesenteric, saphenous and carotid arteries, were selected and their 
responses to the vasoconstrictor phenylephrine (PE) and the vasorelaxant acetylcholine 
(ACh) were assessed using wire myography. While loss of endothelial Piezo1 did not 
alter or had only a small effect on the overall sensitivity or responsiveness of these 
vessels to either PE or ACh, further investigation revealed a significant increase in the 
endothelium-derived hyperpolarizing factor (EDHF) component of ACh-induced 
relaxation in mesenteric arteries. This anti-EDHF effect of Piezo1 was vascular bed 
specific, no difference between control or knock-out mice being observed in saphenous 
or carotid arteries. This finding led to the identification of a flow-stimulated 
vasoconstriction response in mesenteric vessels and furthermore provided an 
explanation for the reduced elevation in blood pressure detected in endothelial Piezo1 
knock-out mice during exercise. Mesenteric arteries contract during exercise, enabling 
blood to be directed to tissues actively involved in physical movement. The data support 
the hypothesis that Piezo1 channels have specific importance in whole body physical 
exercise, sensing increased blood flow at the endothelium to elevate tone in the 
underlying vascular smooth muscle cells of visceral arteries, thus redirecting blood to the 
muscles.  
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Chapter 1 Introduction 
1.1 The Mammalian Cardiovascular System 
1.1.1 Introduction  
The cardiovascular system is comprised of the heart and a complex network of blood 
vessels. Together they enable the transport of O2 and nutrients to tissues and CO2 and 
waste products away from tissues. The heart consists of four chambers, two atria and 
two ventricles. Oxygenated blood is distributed through the body via the strong muscular 
contraction of the left ventricle. Upon leaving the heart, blood enters elastic conduits 
named arteries. From there, arteries divide into smaller conduits named arterioles and 
ever smaller vessels until they contain only a single layer of cells: the capillaries, the 
major sites of nutrient and gaseous transfer. The deoxygenated blood is collected from 
the capillary bed by the venous circulation, composed of venuoles and veins, eventually 
returning blood towards the heart. Therefore the maintenance and regulation of the 
cardiovascular system is essential to life (Marieb and Hoehn, 2007).  
1.1.2 Structure of the cardiovascular system 
Most vessels, arterial and venous, are formed by three layers; the tunica intima, tunica 
media and tunica adventitia (Fig. 1.1). The thickness of these three layers depends upon 
the vessel size and type. 
The innermost tunica intima comprises a monolayer of endothelial cells (ECs), sealed to 
each other through tight junctions, supported by a basal lamina consisting of collagen 
and elastin fibres, smooth muscle cells (SMCs) and occasional fibroblasts. The internal 
elastic lamina delineates the border of the tunica intima. 
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The tunica media is the thickest layer of the three layers and, under normal 
circumstances, is composed solely of SMCs. These cells are orientated in spirals around 
the long axis of the vessel and linked to each other by gap junctions, thus their co-
ordinated contraction decreases the diameter of the vessel lumen. The SMCs can also 
synthesize and secrete all fundamental elements, including collagen and proteoglycans 
that are required for the extracellular matrix and for the formation of the external elastic 
lamellae. As a consequence they play an important role in the maintenance and 
remodelling of the medial architecture.  
The outermost tunica adventitia contains connective tissues, mostly comprising of 
collagen fibres, and functions to both support the vessel and to anchor it to adjacent 
tissues. It is mainly composed of fibroblasts, with some macrophages present.  
The adventitia and outer media are supplied by small penetrating blood vessels (the vasa 
vasorum), while the inner layer is supplied by pinocytic transport from the lumen. 
1.1.2.1 Arteries 
Receiving blood directly from the heart, elastic or conduit arteries are the thickest arteries 
(25 - 10 mm in diameter), Followed by the medium or muscular arteries (10 - 0.3 mm in 
diameter) and finally small arteries and arterioles (0.3 mm - 0.01 mm in diameter). All 
these vessels are connected with one another (Fig. 1.2). 
Elastic arteries, such as the aorta and its major branches (brachiocephalic, subclavian, 
pulmonary, the beginning of common carotid, and iliac), are characterized by their high 
elasticity, allowing them to absorb the pressure waves produced by contraction and then 
relaxation of the heart. They serve as an elastic reservoir, storing the stroke volume 
during systole and then recoiling elastically to force this volume to the downstream part 
of the vessels during diastole. This phenomenon is called the Windkessel effect, which 
enables a steady blood flow throughout the cardiac cycle and reduces the workload of 
the heart (Shadwick, 1999, Wagenseil and Mecham, 2009). The arterial wall 
components, which provide these elastic properties are collagen and elastin, deposited 
amongst SMCs in the intermediate layer of the artery (Wagenseil and Mecham, 2009).  
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The slightly smaller muscular arteries, including the mesenteric and renal arteries, 
function mainly to control the distribution of blood flow around the body. This is achieved 
through the presence of large numbers of SMCs in the tunica media, with constriction or 
relaxation of those cells helping to determine the volume of blood flow through a 
particular vessel.  
The small arteries (lumen <500 μm) and arterioles are positioned immediately prior to 
the capillaries and are responsible for ensuring that the volume and pressure of blood 
entering those vessels is correct. They are very similar in composition to muscular 
arteries, only smaller tunica layers and with loss of the elastic membranes. As with the 
muscular arteries they rely on SMCs to regulate their blood flow by altering the size of 
their lumen. In comparison with larger arteries they are much greater in number and 
consequently in total have a much greater cross sectional area. This makes them a 
primary determinant of vascular resistance.  
1.1.2.2 Veins 
Veins serve as a significant reservoir of blood, with around 64% of the circulating blood 
is located within them. Greater veins, which carry blood back to the heart, gradually 
merge into bigger muscular venules. The SMC-layer in these vessels is much thinner 
than that of the arterioles. This is because the lower blood pressure (BP) in venules 
offers less resistance to vessel contraction. The muscular venules drain blood from the 
post-capillary venules, which collect the deoxygenated blood from capillaries (Hall, 
2015).  
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Figure 1-1: Vessel wall cross-section 
(Günthner et al., 2009) 
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Figure 1-2: Diagram demonstrating how the structure of blood vessels differs 
throughout the cardiovascular system 
(Martini and Nath, 2012).  
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1.1.3 Blood pressure 
BP is the force that the circulating blood volume exerts on the walls of the vascular 
system. It is mainly determined by cardiac output (the product of heart rate and stroke 
volume) and peripheral vascular resistance (the resistance of blood vessels to blood flow 
which is determined by the blood vessels diameter). It is usually expressed as systolic 
and diastolic BP. Systolic BP is defined as the highest force during a heartbeat 
(contraction, ventricular systole), while diastolic BP is the lowest force between heart 
beats (relaxation, ventricular diastole)) (Barrett et al., 2010). After blood leaves the heart 
of a healthy human, its pressure is maintained at approximately 120/80 mmHg through 
the elastic and larger muscular arteries, however, as blood flows further from the heart 
BP progressively decreases in force and the difference between systolic and diastolic 
BP narrows. In veins the pressure is much lower, at about 5-10 mmHg. Thus, the forces 
experienced by an individual vessel will depend upon its sub-type and where it is located 
within the circulatory system (Fig. 1.3). 
1.1.3.1 Blood Pressure Control 
BP is regulated by a sophisticated system involving neural, hormonal and local 
mechanisms that can influence cardiac output and/or peripheral resistance. 
1.1.3.1.1 The autonomic nervous system 
The autonomic nervous system (ANS) has a significant role in BP control. The ANS 
branches include the sympathetic and parasympathetic systems which are regulated via 
the central nervous system through the medulla oblongata in the brain. They act in 
concert to control BP by modulating the contractility of the heart (cardiac output) and the 
vascular tone (peripheral vascular resistance). Sympathetic and parasympathetic 
innervation of the heart can efficiently change heart rate and cardiac output. Sympathetic 
stimulation leads to norepinephrine (NE) release and consequent increased heart rate 
and contractility, rising cardiac output and BP. Conversely, parasympathetic stimulation 
leads to acetylcholine (ACh) release to reduce heart rate and contractility and therefore 
also reducing cardiac output and BP (Gordan et al., 2015, Robertson et al., 1979) (Fig. 
1.3). For example, during a period of physical exercise, the activity of parasympathetic 
nerves is reduced and the activity of sympathetic nerve is raised, leading to a rise in 
7 
 
 
heart rate and contractility. However, after the cessation of exercise, autonomic tone and 
corresponding heart rate gradually return towards baseline levels, due to the combination 
of sympathetic withdrawal and reactivation of the parasympathetic system (Robinson et 
al., 1966, Lahiri et al., 2008). Furthermore, it is important to recognise that the influence 
and relative impacts of flow, blood pressure and vascular bed respond during physical 
exercise are different. In physical activity, while blood flow to the intestines reduces and 
subsequently increasing blood pressure (Qamar and Read, 1987), blood flow to skeletal 
muscle increases, therefore, in resistance arteries of skeletal muscle a vasodilator rather 
than vasoconstrictor mechanism must dominate. Comparably, during physical activity, 
blood flow to the brain is maintained or slightly raised to avoid syncope (Joyner and 
Casey, 2015). 
 
Sympathetic innervation of the peripheral circulation, targeting SMCs of blood vessels 
with efferent motor fibres, can modify peripheral resistance, and consequently BP. In 
small arteries and arterioles vasoconstriction in response to sympathetic nerve activity 
causes rises in the peripheral resistance to blood flow. These alterations in vessel 
diameter,  particularly of arterioles, contributes significantly to change BP and regional 
blood flow (Davis, 1993). 
1.1.3.1.2 The venous return of blood 
Since cardiac output is specified via stroke volume and heart rate, a rise in stroke volume 
can enhance the cardiac output or vice versa. Thus the venous return of blood to the 
heart is critical to determining cardiac output. An alteration in the venous capacitance 
can reduce venous return of blood to the heart and therefore, stroke volume. Additionally, 
when veins dilate they act as reservoirs for blood, efficiently decreasing the circulating 
blood volume and thus reducing BP.  
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1.1.3.1.3 Baroreceptors 
Central nervous system activity can be altered via inputs from baroreceptors to modify 
BP, one remarkable feature of the nervous system control of BP. The baroreceptor-
mediated variations in heart rate are the fastest-responding arterial pressure control 
mechanism. Baroreceptors located within the aortic arch and the carotid sinus 
recognizes alterations in the stretch of the vessel wall, secondary to the pressure of blood 
flow (Fig. 1.4). The baroreceptor is one of the most critical elements in BP regulation, as 
it ensures minimum BP variability throughout normal daily life (Berdeaux and Giudicelli, 
1987, Gordan et al., 2015, Hall, 2015).  
If a reduction in BP is identified, such as when shifting position from lying down to 
standing up, impulses are sent from the baroreceptors to the vasomotor centre as the 
first part of the reflex arc. Efferent signals are then sent out to the blood vessels, 
especially the arterioles, prompting them to constrict. This raises the peripheral vascular 
resistance, thus raising BP back to its average level. Impulses are also sent from the 
baroreceptors to the cardiac centres, stimulating the cardio acceleratory centre to raise 
sympathetic activity and reduce parasympathetic activity. This raises the heart rate and 
force of contraction, and consequently cardiac output, and continues until BP returns to 
its homeostatic level (Gordan et al., 2015). 
1.1.3.1.4 The renin-angiotensin-system 
The renin-angiotensin-system is a further key modulator of BP regulation. When arterial 
pressure drops, the kidneys secrete the enzyme renin. Renin then catalyses the 
formation and production of angiotensin I, which is further converted into angiotensin II 
(ANG II) by an angiotensin-converting enzyme. ANG II is a potent arteriolar 
vasoconstrictor and therefore raises BP via enhancing peripheral resistance (Fig. 1.5) 
(Gordan et al., 2015). 
Furthermore, ANG II stimulates aldosterone secretion from the adrenal gland, which 
leads to a reduction in salt and water excretion via the kidneys, raising blood volume and 
BP over the period of hours or days. The fluid intake and excretion balance is 
fundamental for BP homeostasis and maintenance. The mechanism is a feedback loop, 
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which identifies alterations in BP and changes salt and water excretion accordingly, 
hence modifying the volume of extracellular fluid and returning BP to its normal levels. 
As BP rises, the kidneys excrete higher volumes of urine, to decrease extracellular fluid 
volume and then BP. The excretion of sodium also rises concurrently. On the contrary, 
in the case of hypotension, renal tubular reabsorption of salt and water rises to increase 
extracellular fluid volume and raise BP (Fig. 1.5) (Guyton et al., 1972). 
In addition, hypotension leads to sympathetic activation of the adrenal glands, located 
superior to the kidneys, inducing release of epinephrine and norepinephrine release from 
the adrenal medulla. These hormones increase BP via raising heart rate and heart 
muscle contractility and also by mediating vasoconstriction of arterial and venous vessels 
(Guyton et al., 1972).  
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Figure 1-3: Systemic Blood Pressure  
The graph shows the components of blood pressure (BP) throughout the blood 
vessels, including systolic, diastolic, mean arterial, and pulse pressures (Klabunde, 
2011). 
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Figure 1-4: Explanation of how baroreceptor and the autonomic nervous system 
control blood pressure (BP). 
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Figure 1-5: Summary of the regulation of blood pressure by the renin-angiotensin 
system   
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1.1.4 Vascular smooth muscle cells  
Vascular SMCs, which are capable of contracting and relaxing in response to particular 
stimuli, underlie the principal mechanism of arterial lumen diameter regulation. Force can 
be generated in SMCs through an increase in the concentration of intracellular calcium 
([Ca2+]i). Ca2+ can bind to calmodulin (CaM) and then trigger the calmodulin-dependent 
activation of myosin light chain (MLC) kinase. MLC phosphorylation activates myosin 
ATPase, enhancing adenosine-5’-triphosphate (ATP) hydrolysis and so production of 
cross-bridges between the filaments of myosin and actin and force generation (Dillon et 
al., 1981, Hai and Murphy, 1989). MLC phosphatase dephosphorylates MLC, resulting 
in the relaxation of SMCs. Consequently, vascular tone control essentially occurs 
through modulation of the SMCs [Ca2+]i or via modifying the sensitivity of contractile 
filaments to Ca2+ through regulation of MLC kinase and phosphatase activity (Ratz et al., 
2005). Increases in [Ca2+]i concentration can occur as a consequence of release from 
intracellular stores, although this source of Ca2+ alone appears insufficient to sustain 
SMC contraction (Lagaud et al., 1999, Berridge, 1995), or influx across the cell 
membrane. Channels which can mediate this influx include voltage-gated Ca2+ channels 
(VGCCs), transient receptor potential channels (TRPs) and Orai1, along with the 
Na+/Ca2+ exchanger (NCX). The major vasoconstrictors exert their effects through 
activation of G-protein coupled receptors (GPCRs), whose downstream signalling 
cascades can influence the activity of one or more of these Ca2+ permeable channels. 
1.1.4.1 Gq/11 protein-coupled receptor signalling 
The major vasoconstrictors such as epinephrine (and the related synthetic phenylephrine 
(PE)) and NE exert their effects through activation of particular GPCRs; seven- 
transmembrane domain receptors coupled to heterotrimeric Gq/11 proteins. Upon 
stimulation, the receptors serve as a guanine nucleotide exchange factor, increasing 
exchange of guanosine diphosphate to guanosine triphosphate on the α subunit of the 
G protein, which results in separation of the α subunit from the βγ subunits (Clapham 
and Neer, 1997). Once separated, the α subunit stimulates phospholipase C (PLC) β1, 
which  catalyses the hydrolysis of phosphatidylinositol-4,5-biphosphate (PIP2)  into 
inositol-1,4,5-trisphosphate (IP3) and 1,2-diacylglycerol (DAG) (Berridge and Irvine, 
1989). IP3 stimulates IP3 receptors found on the sarcoplasmic reticulum, resulting in Ca2+ 
efflux from this intracellular store (Grayson et al., 2004) (Fig. 5). This first increase in 
[Ca2+]i elicits the additional Ca2+ release from the intracellular store following ryanodine 
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receptor activation (so-called Ca2+-induced Ca2+ release) (Boittin et al., 1999). This Ca2+ 
release from intracellular stores can activate Ca2+-sensitive chloride channels (Akata et 
al., 2003, Piper and Large, 2004), leading to efflux of negatively charged chloride ions 
from the cell and so membrane depolarisation (Leblanc et al., 2005). The increase in 
[Ca2+]i can also stimulate the sodium-calcium exchanger (NCX), which pumps one Ca2+ 
ion out of the cell  in exchange for three Na+ ions being pumped in (Fig. 1.6) (Berra-
Romani et al., 2010, Horiguchi et al., 2001, Weiss et al., 1993). The activity of this 
exchanger also acts to depolarise the membrane. 
DAG, another product of PLC activity, can also contribute to depolarisation and rise of 
[Ca2+]i via stimulation of non-selective cation currents through canonical TRPCs (Fig. 
1.6) (Gudermann et al., 2004, Hardie, 2007). TRPC2, TRPC3, TRPC6, and TRPC7 
subtypes all exhibit sensitivity to DAG (Gudermann et al., 2004, Hardie, 2007, Large et 
al., 2009), however, in rat mesenteric arteries it appears to be TRPC6 that is responsible 
for the effects of DAG on the SMCs (Clapham and Neer, 1997). 
1.1.4.2 Voltage-gated Ca2+ channels 
SMCs in small arteries and arterioles are richly endowed with  VGCCs, possessing 
around 1000 channels per cell. A specific feature of these channels is that their channel 
open state probability is a constant steep function of the membrane potential; a 10 % 
variation in membrane potential leads to a three-fold change in channel open state 
probability. 
Ca2+ can enter the SMCs through VGCCs upon cell membrane depolarisation. Since 
there is a large Ca2+ gradient across the cell membrane, opening of the VGCCs produces 
a large influx of extracellular Ca2+ resulting in constriction of the arterial vessel. Equally, 
cell membrane hyperpolarisation leads to VGCCs closure, resulting in decreased [Ca2+]i 
and relaxation of the cell, and so the vessel (Jaggar et al., 1998). Consequently, due to 
the large quantity of VGCCs, small artery tone heavily relies on membrane potential. 
This channel family contains ten members, two of which have been found in the 
vasculature, the L-type Ca2+ channels (LTCCs) (Fig. 1.6) and the T-type voltage-
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dependent Ca2+ channel. The LTCCs needs high depolarisation to be activated, to 
between -30 mV and -10 mV depending on LTCCs subtype, while the T-type channel is 
activated at lower membrane potentials, about -45 mV (Catterall et al., 2005, Smirnov 
and Aaronson, 1992). While T type channels play a critical role in a number of 
physiological processes, involving neuronal and cardiac pacemaker activity,  LTCCs play 
a significant role in maintaining BP: mean BP was reduced by a quarter in LTCCs knock-
out mice (Moosmang et al., 2003) and comparable changes have been seen in rats 
treated with a pharmacological blocker of LTCCs channels (Pinterova et al., 2010).  
1.1.4.3 Store-operated Ca2+ entry  
Store-operated Ca2+ entry (SOCE) is a cellular response to the depletion of [Ca2+]i store, 
coupling it to the activation of Ca2+ permeable channels in the cell membrane (Berridge, 
1995). Stimulation of cell surface receptors, such as those for various growth factors, 
hormones, and neurotransmitters, result in the formation of the IP3, stimulation of Ca2+ 
release from the endoplasm reticulum (ER) by the IP3 receptor (IP3R) and consequent 
store depletion (Smyth et al., 2010). TRPC1, TRPC4, and TRPC5 are suggested to 
particularly contribute to SOCE in  VSMCs (Beech et al., 2004, Xu and Beech, 2001, Xu 
et al., 2006). Additionally, SOCE in arterial myocytes, involves the transmembrane 
proteins stromal interacting molecule 1 (STIM1) and Orai1  (Baryshnikov et al., 2009). 
STIM1 acts as a Ca2+ sensor in the ER, which upon translocates Ca2+ depletion to the 
close proximity of the plasma membrane where it can interact with and activate the cell 
membrane Ca2+ permeable Orai1 channel (Fig. 1.6) (Zhang et al., 2005).  
Intracellular store depletion can also evoke further Ca2+ influx through stimulating NCX 
to operate in the opposite direction to normal, with Na+ ions extruded in exchange for 
entry of one Ca2+ ion. NCX is co-expressed with Orai1 in the plasma membrane of human 
arterial myocytes and shows a functional correlation with SOCE. A functional and spatial 
relationship between NCX and sarco/endoplasmic reticulum Ca2+ pump ATPase was 
also observed in SMCs of pig coronary arteries (Baryshnikov et al., 2009, Davis et al., 
2009). NCX in rat mesenteric arteries was shown to contribute to the Ca2+ entry after 
depletion of the stores (Lagaud et al., 1999). 
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1.1.4.4 Ca2+ sensitization mechanism 
In addition to increasing [Ca2+]i concentration, vasoconstrictors that activate GPCRs 
coupled to Gq/11 proteins also increase contractile Ca2+ sensitivity (Ca2+-sensitisation) 
(Bradley and Morgan, 1987, Mulvany et al., 1982). This mechanism involves stimulation 
of MLC kinase and/or block of MLC phosphatase activity leading to higher Ca2+ efficacy 
(Ratz et al., 2005, Somlyo and Somlyo, 2003). 
In rat mesenteric arteries, two important pathways have been recognised, involving 
either the serine-threonine kinases protein kinase C (PKC) or Rho-kinase respectively. 
Activation of Gq/11-coupled GPCRs stimulates PLC to cleave PIP2 into IP3 and DAG, 
the latter being an activator of PKC. A target of PKC is calponin, a thin filament-
associated protein that interferes with the coupling between actin and myosin by 
inhibiting the ATPase activity of myosin. When phosphorylated by PKC, calponin 
changes its structure and its inhibitory effect is lost, thus contraction is enhanced (Budzyn 
et al., 2006, Gokina et al., 1999, Pohl et al., 1997). α subunits of Gq/11 and G12/13 
proteins activate GEF (guanine nucleotide exchange factor) proteins for the small 
GTPase RhoA, an activator of Rho-kinase. Stimulation of this kinase can downregulate 
the activity of MLC phosphatase, leading to increased force for a given [Ca2+]i (Ratz et 
al., 2005, Somlyo and Somlyo, 2003). In rat mesenteric arteries and veins, Rho-kinase 
is involved in the tone creation in response to an elevation of intramural pressure (Enouri 
et al., 2011, VanBavel et al., 2001). It also contributes to contraction of big arteries, for 
example the aorta or superior mesenteric artery, in response to α-adrenergic or 
thromboxane receptor (TP) activation, or high potassium (K+). (Budzyn et al., 2006). 
1.1.4.5 Gs and Gi/o protein-coupled receptors 
Receptors coupled to Gs or Gi/o proteins respond to stimuli such as light, gustatory 
compounds, odorants, neurotransmitters, neuropeptides, hormones, and glycoproteins. 
All adrenergic and muscarinic receptors are coupled to these proteins (Hollmann et al., 
2005). Receptors coupled to Gs or Gi/o proteins, respectively activate or block adenylyl 
cyclase, which generates cyclic adenosine monophosphate (cAMP) from ATP.  cAMP in 
the vasculature directly opens cyclic nucleotide-gated ion channels (Leung et al., 2010, 
Shen et al., 2008), activates PKA (Simonds, 1999) and activates exchange protein 
activated by cAMP  (Epac) (Purves et al., 2009).  
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Cyclic nucleotide-gated channels are nonselective cation channels which can be opened 
by the direct binding of cyclic nucleotides cAMP and cGMP (Kaupp and Seifert, 2002). 
In cultured ECs from bovine aorta, cyclic nucleotide-gated channels are involved in 
adrenaline-mediated increase in [Ca2+]i  (Shen et al., 2008). These channels are 
expressed in rat mesenteric artery SMCs (Kruse et al., 2006), and they may participate 
in contraction evoked by the TP receptor agonist U46619 (a thromboxane A₂ receptor 
agonist) (Leung et al., 2010). 
PKA can influence smooth muscle contraction in several ways. This kinase can 
phosphorylate and so inactivate MLC kinase (Conti and Adelstein, 1981). In contrast 
phosphorylation by PKA activates multiple K+ channels, including ATP-sensitive K+ 
channels (Quinn et al., 2004, Shi et al., 2007), voltage-gated K+ channels (Aiello et al., 
1998, Waldron and Cole, 1999), and big conductance Ca2+-sensitive K+ channels 
(BKCa2+) (Tian et al., 2004), resulting in hyperpolarisation of the cell. Also, PKA can block 
store-operated Ca2+ channels (Liu et al., 2005) and LTCCs (Liu et al., 1997, Orlov et al., 
1996, Xiong et al., 1994), reducing and/or preventing an increase in [Ca2+]i concentration. 
All these effects lead to SMC relaxation and so vessel dilation. However, PKA can also 
activate PKC (Wooten et al., 1996), possibly resulting in Ca2+ sensitization in SMCs.  
Finally, cAMP signalling is involved in the activation of Epac, a guanine nucleotide 
exchange factor for the small G protein Rap (Bos, 2006, Bos, 2003, Gloerich and Bos, 
2010), which reduces the activity of ATP-sensitive potassium channels (K+) in rat aortic 
SMCs (Purves et al., 2009). In cultured human embryonic kidney cells, Epac is capable 
of activating PLC (Schmidt et al., 1996), however, this action has not yet been 
demonstrated in small resistance arteries. 
1.1.4.6 Potassium channels in smooth muscle cells 
The plasma membrane of SMCs comprises a huge number of K+ channels  (about 50000 
per cell). They mainly participate in the regulation of the membrane potential, thus 
influencing VGCC open probability. K+ channel opening leads to an outward flux of K+ 
ions, due to the electrochemical gradient for K+ that decreases the net negative charge. 
This hyperpolarisation of the cell results in closure of VGCCs. Therefore, K+ channels 
can affect vascular tone and resistance (Bonev et al., 1997).  
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One of the major K+ channels responsible for maintaining the SMC membrane potential 
is the delayed rectifier voltage-gated K+ channel, which can be activated when 
depolarisation reaches approximately -40 mV (Ko et al., 2008, Nelson and Quayle, 
1995). This channel  is regulated by PKA, PKC and PKG (Ko et al., 2010), and is 
sensitive to the magnesium intracellular concentration (Tammaro et al., 2005).  
Calcium-dependent K+ (K Ca2+) channels on SMCs are critical for the control of small 
artery tone and also the fine-tuning of agonist and pressure-induced constriction 
(myogenic) (López et al., 2009). KCa2+ channels are activated by [Ca2+]i and 
depolarisation. Since opening of KCa2+ channels leads to hyperpolarisation, countering 
the (agonist/pressure-induced) depolarisation that they were stimulated by, they can 
exert a stabilising, negative feedback on the membrane potential and can limit the 
contraction. Numerous studies have shown a role of smooth muscle KCa2+ channels in 
the myogenic response, describing that active closure of KCa2+ channels participates in 
the beginning of myogenic depolarisation and constriction (Kauser et al., 1991). 
Additionally, KCa2+ channels may not only have a role in modulating constriction 
responses but also can be required to mediate the dilation response by endothelial-
derived hyperpolarisation factor (EDHF). EDHF will be discussed in sections 1.2.1 and 
1.2.2. 
The BKCa2+ channels are abundant in blood vessel SMCs. They are activated by Ca2+ 
concentrations greater than 500 nM and are also activated by depolarisation (Ko et al., 
2008, Nelson and Quayle, 1995, Xia et al., 2002). The BKCa2+ channels are coupled to 
ryanodine receptors (RyRs), which are located in the ER membrane and are responsible 
for the release of Ca2+ from intracellular stores during excitation-contraction coupling in 
both cardiac and skeletal muscle (Lanner et al., 2010). They are also involved in Ca2+ 
spark-elicited membrane hyperpolarisation in arteries (Jaggar et al., 1998) where BKCa2+ 
channels are activated by Ca2+ release, in the form of Ca2+ sparks. Ca2+ sparks are 
transient local Ca2+-signaling events caused by the opening of ryanodine-sensitive Ca2+ 
release channels [referred to as RyRs] in the ER membrane (Herrera et al., 2001).  
Less abundant is an inward-rectifying K+ (Kir) channel, which is distinguished by its 
conduction of an inward current at membrane potentials negative to the equilibrium 
potential and smaller outward current at membrane potentials positive to equilibrium 
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potential (Nelson and Quayle, 1995). Consequently, the activity of Kir channels provides 
a pathway by which extracellular K+ can change the membrane potential of SMCs 
(Quayle et al., 1997). This mechanism plays a significant role in endothelium-derived 
hyperpolarisation (Dora et al., 2008, Edwards et al., 1998). The sarcoplasmic KATP 
channel is a hetero-octamer, comprising of four Kir and four sulphonylurea receptor 
subunits. In rat vascular SMCs, reduction of intracellular ATP levels enable the KATP 
channel to open with a conductance of 50-250 pS (Ko et al., 2008). The KATP channel is 
responsible for hyperpolarisation in response to β-adrenoceptor activation (Garland et 
al., 2011, White et al., 2001). PKC has also been reported to modulate the activity of the 
channel, blocking K+ current in response to ANG II (Kubo et al., 1997, Sampson et al., 
2007).  
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Figure 1-6: Schematic diagram showing contraction mechanisms in vascular 
smooth muscle cell.  
Membrane depolarisation triggers the opening of L-type Ca2+ channels (LTCCs), 
resulting in Ca2+ influx into the cells and leading to Ca2+/calmodulin dependent myosin 
light chain kinase (MLCK) activation. MLCK then phosphorylates myosin light chain 
(MLC), inducing the myocyte to contract. Ca2+ is removed from the cytosol by Ca2+ 
ATPase on the plasma membrane and sarcoplasmic reticulum (SR) and also by the 
Na+/Ca2+ exchanger (NCX) on the plasma membrane. The myosin light chain 
phosphatase (MLCP) dephosphorylates MLC, which initiates relaxation of the cells. 
However, the MLCP activity is blocked via certain agonists by RhoA and Rho-dependent 
kinase stimulation. The sympathetic nervous system can also increase contraction of 
myocyte by stimulating α1 adrenoceptors to release the second messengers inositol 
triphosphate (IP3) and diacylglycerol (DAG). IP3 activates IP3 receptors on the SR to 
cause Ca2+ release from the SR, an intracellular Ca2+ store. DAG can activate protein 
kinase C and so phosphorylation of other proteins. Both mechanisms cause myocyte 
contraction. Store-operated Orai1 channels are activated by stromal interaction molecule 
1 (STIM1) protein, a sensor of depletion of Ca2+ in the SR. Store-operate calcium entry 
(SOCE) is activated by the reduction of SR [Ca2+]. Transient receptor potential canonical 
(TRPC) channels mediated Ca2+ influx after the activation by DAG or calcium store 
depletion.  
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1.1.5 The endothelium 
The internal surface of blood vessels throughout the circulatory system is lined with a 
single layer of ECs. This layer of ECs is a specialised type of simple squamous 
endothelium isolated from a basal lamina of the surrounding outer layers (Günthner et 
al., 2009). ECs usually present a non-thrombogenic surface to which platelets and 
leukocytes in the circulating blood do not adhere, thus the coagulation system remains 
inactivated (Félétou, 2011). The endothelium serves as a particular barrier between the 
blood vessel lumen and surrounding tissue and regulates the entrance of materials such 
as amino acids and glucose and the transit of white blood cells into and out of the 
bloodstream. ECs control vessel tone and function by releasing trophic factors, 
vasodilators and vasoconstrictors that are involved in angiogenesis. These cells also 
mediate inflammatory responses through the surface expression of chemotactic and 
adhesion molecules and the release of chemokines and cytokines. Endothelial 
dysfunction could result in pathophysiological events that contribute to the development 
of vascular complications resulting from for example atherosclerosis and thrombosis 
(Cines et al., 1998, Chiu and Chien, 2011). 
Focusing on the control of vessel tone, ECs release mediators that influence the 
contractile state, both positively and negatively, of the neighbouring vascular SMCs 
(VSMCs). The first mediator to be identified, a vasodilator, was prostacyclin (Moncada 
et al., 1976). Subsequently, nitric oxide (NO) was identified as a key mediator in the 
vasorelaxation elicited by the muscarinic receptor agonist ACh (Furchgott and Zawadzki, 
1980). A further, incompletely defined, vasodilator is the EDHF, while vasoconstrictors 
identified include thromboxane and endothelin-1. One or more of these mediators can 
be released in response to activation of endothelial receptors by agonists such as ACh, 
bradykinin, ATP, serotonin and substance P, all vasodilators (Vallance and Chan, 2001). 
Additionally they can be released following activation of mechanoreceptors on ECs, 
which are able to sense shear stress resulting from blood flow over the cell surface, again 
inducing vasorelaxation. NO and EDHF, two of the most significant mediators of 
vasodilation will be discussed further in the following sections.  
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1.1.5.1 Nitric oxide  
Substances such as ACh, bradykinin, or substance P can trigger an increase in [Ca2+]i 
in ECs. This Ca2+ binds to CaM to create the Ca2+- CaM complex, which has been shown 
to convert nitric oxide synthase (NOS) into its active form (Busse and Mülsch, 1990). The 
active enzyme, in the presence of molecular oxygen and NADPH, converts L-arginine 
into citrulline and NO. The NO generated in the ECs then diffuses to the SMCs, where it 
activates soluble guanylate cyclase (sGC) leading to the conversion of GTP, guanosine 
triphosphate, into cGMP (Rapoport and Murad, 1983). Increasing cGMP in SMCs leads 
to the inhibition of Ca2+ entry into the cells, K+ channel activation, eliciting 
hyperpolarisation, and activation of the cGMP-dependent protein kinase PKG. 
Consequently, the decrease in [Ca2+]i and stimulation of MLC phosphatase reduces the 
contraction of SMCs (Carvajal et al., 2000) (Fig. 1.7). 
1.1.5.2 Endothelium-Derived Hyperpolarising Factor (EDHF) 
EDHF is so named because of its hyperpolarising influence on the membrane of ECs, 
which can be spread to the SMCs, resulting in relaxation (Chen et al., 1988, Taylor and 
Weston, 1988, Garland and McPherson, 1992).  
This factor was first observed in guinea pig mesenteric artery, where the action of the 
muscarinic agonist carbachol on the ECs resulted in SMC hyperpolarisation and 
consequently vessel relaxation. After ECs were removed, the inhibitory effect of 
carbachol was abolished, and the hyperpolarising response to carbachol was changed 
to a depolarisation, indicating that the hyperpolarisation observed must be derived from 
the endothelium (Bolton et al., 1984). Further evidence for another endothelium-
dependent relaxation factor emerged when it was found that the SMC hyperpolarisation, 
and relaxation induced by ACh or bradykinin after stimulating ECs, was not affected by 
pharmacological blocking of NO or prostacyclin (Félétou and Vanhoutte, 2006).  
1.1.5.2.1 EDHF relaxation mechanism  
It is well known that  administration of a muscarinic agonist causes an increase in the 
concentration of Ca2+ within ECs (Peach et al., 1987). Hyperpolarisation occurs as a 
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result of the ensuing opening of the small and intermediate-conductance calcium-
activated potassium channels (SKCa2+ and IKCa2+), triggering positively charged K+ to 
efflux (Edwards et al., 1998). EDHF can be inhibited by blockers of endothelial SKCa2+ 
and IKCa2+, such as apamin or charybdotoxin (Garland and McPherson, 1992). 
The mechanism underlying the transmission of the hyperpolarisation to the VSMCs has 
not been definitively determined (Busse et al., 2002), however, a couple of hypotheses 
have been put forward;  
i) Gap junctions, which allow the movement of small molecules, exist between ECs, 
between SMCs (both homocellular gap junctions), and between ECs and SMCs 
(myoendothelial gap junctions). Therefore, the electrical signal may simply be transferred 
freely between the cells. The coupling between cells will also help to regulate or 
synchronise a response within a section of the vessel. Ultrastructural evidence showed 
that ECs can extend cellular protrusions through perforations in the internal elastic 
lamina to come into close contact with SMCs (myoendothelial gap junctions) in rabbit 
carotid artery and rat mesenteric artery (Sokoya et al., 2006).  
ii) A substance released from the ECs may diffuse into the SMCs.  
The evidence supporting each of these pathways for relaxation varies throughout the 
vasculature.   
An in vivo study in the hamster cheek pouch microcirculation showed that a small number 
of ECs stimulated via microiontophoresis of ACh can cause the relaxation of the entire 
artery length (Duling and Berne, 1970). The rate at which the signal was spread, its 
spread along the entire length of the vessel far away from the site of ACh stimulation, 
and the fact that it could be stopped by cutting the vessel all argue against the 
involvement of a diffusible factor and in support of it being electrical in nature.  
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It has been suggested that endothelial EDHF-like substances such as the cytochrome 
P450-derived eicosanoid 11,12 epoxyeicosatrienoic acid (11,12 EET) can diffuse to the 
neighbouring SMCs, leading to KCa2+ channels opening in the SMCs membrane 
(Lamping et al., 2000, Fleming, 2001). There is an indication that this can account for 
the EDHF response in coronary and renal arteries of different species. A 
Having been transmitted to VSMCs the hyperpolarisation decreases the open probability 
of the VGCCs and consequently reduces the levels of cytoplasmic free Ca2+, which leads 
to SMC relaxation (Nelson et al., 1990).  
1.1.5.2.2 EDHF in small arteries  
Numerous discoveries have found that communication between cells through gap 
junctions is most efficient in vessels where the ratio of ECs to SMCs is very high (Berman 
et al., 2002, Shimokawa et al., 1996); for example, gap junction-mediated dilation is 
higher in small mesenteric arteries than in the aorta (Chaytor et al., 1998). Therefore, 
the role EDHF plays in the vasodilatation of small vessels is greater than in big vessels. 
Given the greater impact that smaller vessels have on BP, EDHF may be critical in BP 
maintenance. In support of this idea, SKCa2+ and IKCa2+ knockout mice developed 
hypertension (Taylor et al., 2003, Si et al., 2006) and loss of EDHF function has been 
observed in hypertensive rats, with the resistance arteries being the most important sites 
of loss (Goto et al., 2000). 
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Figure 1-7: (a). Diagram showing the endothelial cells and vascular smooth muscle 
cells in an artery. (b) Endothelium-mediated relaxation through nitric oxide 
(NO) and prostacyclin (PGI2)  
AC = adenylyl cyclase; cAMP = cyclic adenosine monophosphate; cGMP = cyclic 
guanosine monophosphate; COX = cyclooxygenase; eNOS = endothelial nitric oxide 
synthase; sGC = soluble guanylyl cyclase (Bryan et al., 2005).  
a b 
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1.1.5.3 Endothelium-Derived Contractile Factor (EDCF) 
The endothelium is able to exert a relaxation effect on the underlying SMCs by releasing 
NO and EDHF. Additionally, the endothelium also releases contracting factors in several 
vascular beds, including in response to thromboxane/endoperoxides, superoxide anions, 
and endothelin-1 (Vanhoutte and Tang, 2008). The first EDCF observation was made on 
isolated dog veins, where the ECs induced the surrounding SMCs to constrict in 
response to arachidonic acid and thrombin (De Mey and Vanhoutte, 1982). Another early 
observation of EDCF was in the aorta from adult spontaneously hypertensive rats 
(Lüscher and Vanhoutte, 1986), where ACh induced a concentration-dependent rise in 
tone. Subsequently the release of EDCF has been observed to be triggered in response 
to shear stress, muscarinic agonists and serotonin, and as a result of rises in [Ca2+]i.  
Although the exact composition of EDCF remains to be determined, it is known to be a 
result of arachadonic acid metabolism via the cyclooxygenase enzyme which is inhibited 
via indomethacin, and has been proposed to be mediated via the action of prostaglandin 
H2 and prostacyclin on the receptors of TP receptors on the VSMCs (Vanhoutte and 
Tang, 2008).The balance of EDCF and EDHF is important to endothelial function, as 
suggested by the hypertension related endothelial dysfunction resulting from their 
imbalance (rise in EDCF coupled with a decrease in EDHF) (Vanhoutte et al., 2005).  
1.1.5.4 Ca2+ in the endothelial cell  
Stimulation of the vascular endothelium by ACh, bradykinin and histamine is typically 
correlated with an increase in the EC [Ca2+]i, which occurs as a result of release from 
[Ca2+]i stores and/or entry from the extracellular space. The mechanisms that give rise 
to the changes in [Ca2+]i are similar to those described in VSMCs (1.1.4). A key difference 
is that ECs do not express VGCCs. Consequently, in contrast to VSMCs, little Ca2+ influx 
is triggered by increases in membrane potential. 
The EC membrane does express KCa2+ channels, which are stimulated by an increase in 
[Ca2+]i and depolarisation, however, the channel subtypes appear to be different from 
VSCM. KCa2+ channels on ECs seem to be lacking the ß1 subunit, and are consequently 
less Ca2+ sensitive than smooth muscle KCa2+ channels (Katakam et al., 2000). Agonists 
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such as ACh, which increase [Ca2+]i, can open endothelial KCa2+ channels resulting in K+ 
efflux and ECs hyperpolarisation.  
In rat mesenteric arteries, activation of Gq/11 protein-coupled receptors by ACh and 
carbachol increases ECs [Ca2+]i as a result of phospholipase C-mediated IP3 generation, 
IP3 receptor stimulation and consequently Ca2+ efflux from intracellular stores (Mumtaz 
et al., 2011, McSherry et al., 2005, Oishi et al., 2001, Rodríguez‐Rodríguez et al., 2009, 
Fukao et al., 1997). In human umbilical vein ECs, RyR have been reported to contribute 
to the rise in [Ca2+]i in response to ACh and histamine, and spontaneous [Ca2+]i events 
(Paltauf‐Doburzynska et al., 2000, Kansui et al., 2008). However, rises in [Ca2+]i in ECs 
from rat mesenteric arteries responding to muscarinic receptor activation are insensitive 
to ryanodine (Mumtaz et al., 2011).  
In mesenteric arteries, both the amplitude of the [Ca2+]i increase and the resulting cell 
hyperpolarisation were diminished by removal of extracellular Ca2+. Demonstrating the 
additional importance of Ca2+ influx (Dora et al., 2008, Fukao et al., 1997, McSherry et 
al., 2005, Mumtaz et al., 2011). 
Attenuation of the mesenteric artery hyperpolarisation was also observed after blocking 
the sarcoplasmic reticulum Ca2+-ATPase (Fukao et al., 1997). Consequently, it was 
proposed that store depletion in ECs stimulates SOCE Ca2+ entry, probably, through a 
channel from the TRP family (Mumtaz et al., 2011). All canonical, vanilloid, and 
melastatin TRP subfamilies are expressed in ECs, with the TRPC subfamily being the 
main candidate for SOCE (Hill et al., 2006a, Yao and Garland, 2005, Zholos et al., 2011, 
Tiruppathi et al., 2006). It was determined that the TRPC1 and TRPC4 channels can 
form a complex with IP3 receptors to optimize signalling of Ca2+ (Rath et al., 2009).  
Another critical pathway of Ca2+ entry can be myoendothelial gap junctions. It has been 
reported in rat mesenteric arteries that activation of SMCs, with a resulting increase in 
Ca2+, can lead to an enhanced [Ca2+]i in the adjacent ECs (Dora et al., 2000, Oishi et al., 
2001). This mechanism can function as a negative feedback to decrease vascular tone 
responding to the sharp rising of SMC [Ca2+]i by dilators or hyperpolarisation. 
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Finally, EC cyclic nucleotide-gated channels can play a role in endothelium-dependent 
vascular relaxation, their activation leading to an influx of Ca2+. These channels are 
activated following Gs protein – coupled receptor stimulation by neurotransmitters (e.g., 
noradrenaline, dopamine, serotonin) leading to cAMP production. Irrespective of the 
source, rises in [Ca2+]i can potentially activate endothelial NOS, resulting in release of 
NO,  cyclooxygenase (resulting in production of prostanoids), and/or the intermediate 
and small conductance Ca2+-sensitive K+ channels (IKCa2+ and SKCa2+, respectively), 
causing K+ efflux and ECs hyperpolarisation (Chen and Cheung, 1997, Edwards et al., 
1998, Zygmunt and Högestätt, 1996). The relative contribution of each differs between 
different activators in different arteries related to different expression levels.  
1.1.6  Mechanical modulation of arterial tone 
Mechanical forces correlated with blood flow play a major role in the control of vascular 
tone. Forces applied to the wall of the vasculature due to blood flow can be categorised 
into two classes. The first is parallel to the wall to produce shear stress, a frictional force 
on the ECs surface. The second acts perpendicular to the wall and represents BP 
(Davies, 1995). While transmural pressure is spread to all vascular layers of the wall 
(intima, media, and adventitia), shear stress is sensed only by the internal EC layer. 
1.1.6.1  Flow-induced responses 
Shear stress force is determined by three variables: blood velocity, blood viscosity and 
the diameter of vascular vessels. Therefore, as these variables alter the degree of shear 
stress experienced by the cells lining the blood vessels will alter. The major physiological 
response to shear stress, which was first identified by Schretenmayr in 1933, is 
vasodilation. This results from the release of NO and prostacyclin. Additionally, laminar 
shear stress has atheroprotective effects (Davies, 1995),  related to anti-thrombotic, anti-
inflammatory and anti-adhesive properties. For example, it blocks platelet aggregation 
(Kramer et al., 1989), leukocyte adhesion and proliferation of SMCs (Berk et al., 2001). 
The molecular mechanism underlying the flow-elicited relaxation remains still unclear but 
presently it is believed to be mediated by the endothelium, the sensor of the force. Shear 
stress causes mechanical distortion of ECs, initiating mechanotransduction, the 
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transduction of mechanical force into chemical signalling. Eventually the downstream 
biochemical signalling results in physiological responses (Li et al., 2005, Lehoux et al., 
2006, Davies, 2009).  
The role of endothelial-derived agents in flow-elicited responses was not discovered until 
50 years after the finding of flow-dependent vasoregulation (Hull Jr et al., 1986). 
Endothelium-derived NO plays a major role in the control of flow-mediated relaxation in 
healthy vessels (Joannides et al., 1995, Shiode et al., 1996). After shear stress is 
applied, NO is generated and sustained for the length of the stimulus (Fleming et al., 
2005). NOS, the enzyme responsible for the production of NO, is stimulated by shear-
stress in a biphasic manner. One phase is Ca2+ dependent, with CaM binding to Ca2+ 
and activating NOS by causing its fast separation from its negative regulator caveolin 
and its subsequent association with HSP-90. Then NOS is phosphorylated on serine 
residue (Ser 1177) by protein kinase A (Fleming, 2010), increasing its sensitivity to Ca2+. 
During the second phase, NOS is stimulated by resting Ca2+. This is named “calcium-
independent” NOS stimulation in response to shear stress, which leads to sustained NO 
production (Balligand et al., 2009). 
However, flow-elicited relaxation is not completely dependent upon NO, as responses 
are still observed in NOS knock-out mice (Huang et al., 2001). PGl2, cytochrome P450 
metabolites of AA and hydrogen peroxide (H2O2) are other mediators of this response 
(Miura et al., 2001, Sun et al., 2007, Drouin and Thorin, 2009, Kang et al., 2009, Koller 
et al., 1995). Furthermore, in mesenteric arteries of female rat, the power of EDHF-type 
control of flow-elicit relaxation has been found (Morton et al., 2011). Thus, flow-induced 
vasodilatation is a mixed response including the release of various endothelium-derived 
vasodilators.  
1.1.6.2  Pressure response  
Arteries continually experience BP and cyclic stretching. A myogenic response of arteries 
can develop in response to these forces. The myogenic response is an intrinsic 
constriction state of SMCs,  independent of  neurohumoral and endothelial influences 
(Davis and Hill, 1999, Khavandi et al., 2009). Myogenic constriction is a major element 
of basal vascular tone (Hill and Davis, 2007) from which the contractile machinery can 
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respond to stimuli, with either gain or loss of contractile force, giving local control of blood 
flow and pressure in a fast and efficient manner.  
A three-phase model of in vitro arterial myogenic behaviour has been proposed. The first 
one is identified as tone development (myogenic tone; 40–60 mmHg). The second one 
is myogenic reactivity (60 and 140 mmHg), revealing the response to change in 
transmural pressure. Increased transmural pressure results in myogenic constriction, 
while decreased pressure leads to myogenic dilatation. The third phase only happens 
when the vascular wall of the artery is unable to sustain the constriction against the 
transmural pressure (above 140 mmHg): a total loss of myogenic tone which is known 
as forced dilatation (Osol et al., 2002).  
Small arteries with internal diameter <300μm possess the ability to develop a strong 
myogenic response (Khavandi et al., 2009) while larger and very small arteries develop 
only a relatively weak myogenic response. Moreover, the myogenic response differs 
between species and vascular beds (Osol et al., 1991, Watanabe et al., 1993, Liao and 
Kuo, 1997, Miller et al., 1997).  
Bayliss was the first to report the myogenic response in the beginning of the last century. 
However, despite intensive investigation into its physiological and pathophysiological 
significance, so far the cellular mechanisms which translate pressure variations to VSMC 
contractions are not completely understood. The following series of events are believed 
to be involved in the myogenic response. Elevated intraluminal pressure is sensed by 
the ion channels, membrane lipids within the bilayer itself and/or by extracellular matrix-
integrin complexes. Stimulation of these pathways results in the opening of non-selective 
cation channels, membrane depolarisation and activation (opening) of LTCCs. The 
increased Ca2+ level leads to Ca2+/CaM-dependent stimulation of MLC kinase, then 
phosphorylation of the 20-kDa myosin regulatory light chains and contractile interaction 
of actin and myosin (Zou et al., 2001, Hill et al., 2006b, Hill et al., 2009).  
The consequence of pressure-elicit responses depends upon the duration of the vascular 
wall exposure to the increased intraluminal pressure. Sustained exposure ultimately 
leads to structural modifications within the vascular wall, termed ‘pressure associated 
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remodelling’ (Mulvany, 2012). For example, in response to increased BP there is a 
decrease in internal diameter with an increase in wall thickness despite no overall 
change in cross-sectional diameter of blood vessels, a phenomenon known as ‘eutrophic 
inward remodelling’.  
The physiological significance of myogenic constriction is likely to control target organs 
microcirculation, providing protection from pressure associated damage to exposed 
organs such as the brain, heart and kidneys. Consequently, the effect of abnormal 
myogenic responses in the pathogenesis of cardiovascular disease and protection 
against hypertension-elicit organ damage have been extensively discussed (Davis and 
Hill, 1999, Hughes and Bund, 2002). Flow and pressure, two mechanical stimuli, have a 
major role in the local regulation of vascular tone in small arteries. 
1.1.6.3   Pharmacological modulation of vascular tone  
The manipulation by pharmacological agents of both the myocardium and vasculature at 
the level of the autonomic nervous system (by α or β adrenoceptors), myocardium (such 
as Ca2+ sensitization by levosimendan), or locally (such as by sympathectomy) is 
generally accepted in anaesthesia to decrease the effects of critical illness and to control 
the end-organ perfusion, either by raising vascular tone or cardiac output (Hebbes, 
2016). 
The pharmacological agents are all vasodilators, targeting SMC and /or the neighbouring 
vascular EC to reduce vascular tone. The most effective vasodilators work through 
decreasing the actin-myosin complexes in VSMCs. Vasodilators can be classified into 
several types (Golan et al., 2011):  
i) NO donors, (for example organic nitrates and sodium nitroprusside), induce 
vasodilation via stimulating guanylyl cyclase and increasing MLC dephosphorylation.  
ii) Blockers of cGMP phosphodiesterase class V (PDE5) inhibit cGMP hydrolysis and 
thus enhance dephosphorylation of MLC.  
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iii) Ca2+ channel blockers induce vasodilation through decreasing the concentration of 
[Ca2+]i.  
iv) K+ channel openers cause vasodilation via opening ATP-sensitive K+ channels, thus 
hyperpolarising the cells and preventing opening of the VGCCs required for the influx of 
Ca2+ and contraction of the VSMCs.  
v) Antagonists of endothelin receptors inhibit endothelin-mediated vasoconstriction.  
vi) α1 adrenergic antagonists block the endogenous epinephrine and norepinephrine 
vasoconstrictive action.  
vii) Angiotensin converting enzyme blockers and ANG II receptor subtype 1 (AT1) 
antagonists block the vasoconstrictive effect of endogenous angiotensin II, either 
through blocking the formation of the ANG II (ACE inhibitors) or inhibiting its cognate 
receptor (AT1 antagonists) (Golan et al., 2011). 
viii) Hydralazine inhibits Ca2+ dependent ATPase and phosphorylation (Jacobs, 1984).  
ix) β-adrenergic antagonists competitively inhibit the binding of endogenous 
catecholamines to β1-adrenoceptors in the heart (O'Rourke, 2007). 
1.2 Arterial Remodelling and Hypertension  
The vascular wall is composed of ECs, SMCs, and fibroblasts which act in concert to 
form a complicated autocrine-paracrine set of interactions. The vascular wall can detect 
and sense alterations in the milieu, and integrates these signals via intercellular 
communication and by the local production of mediators, which affect vascular structure 
and function. Vascular remodelling is an active process of structural modifications that 
includes alteration in at least four cellular processes: cell growth, cell death, cell 
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migration, and the extracellular matrix degradation. Vascular remodelling relies on 
dynamic interactions among locally created growth factors, vasoactive substances, and 
hemodynamic stimuli. Furthermore, remodelling is an adaptive process that occurs in 
response to long-term alterations in hemodynamic conditions; however, it may therefore 
contribute to the pathophysiology of vascular diseases and circulatory disorders 
(Gibbons and Dzau, 1994). 
In response to raised arterial pressure, the structure of a vessel is changed such that the 
ratio of the wall width to the lumen width is elevated via either a rise in muscle mass or 
rearrangements of cellular and noncellular elements. These alterations heighten 
vascular reactivity, which potentiates the rise in peripheral resistance characteristic of 
hypertension. Another vascular remodelling form includes alterations primarily in the 
dimensions of the lumen (Gibbons and Dzau, 1994). Hypertension affects more than 
25% of adults in the UK yet, in the majority of cases, the exact mechanisms causing it 
remain unknown. Hypertension is a long term medical condition in which resting systolic 
and diastolic BP are persistently elevated greater than 140/90 mmHg, in adults. It is a 
major risk factor for severe diseases, such as heart attack, stroke, and arterial 
aneurysms, but can remain undiagnosed since very few symptoms accompany it. It is 
for this reason that hypertension is termed “a silent killer”. Primary, or idiopathic, 
hypertension is estimated to be accountable for 90-95% of hypertensive patients, with 
secondary hypertension, associated with for example kidney disease or an adrenal 
medulla tumour, only accounting for a small proportion of hypertensive patients.  
Although collagen and elastin are both extracellular matrix proteins (ECM), they have 
different elastic properties. Collagen is the most abundant fibrous protein within the ECM. 
Collagens, which constitute the main structural element of the ECM, provide tensile 
strength, regulate cell adhesion, support chemotaxis and migration, and direct tissue 
development. The bulk of interstitial collagen is transcribed and secreted by fibroblasts 
that either reside in the stroma or are recruited to it from neighbouring tissues. By 
exerting tension on the matrix, fibroblasts are able to organize collagen fibrils into sheets 
and cables and, thus, can dramatically influence the alignment of collagen fibres (Frantz 
et al., 2010).  
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Collagen associates with elastin, another major ECM fibre. Elastin fibres provide recoil 
tension to tissues that undergo repeated stretch due to their mechanical properties. 
Importantly, elastin stretch is crucially limited by tight association with collagen fibrils. 
Secreted tropoelastin (the precursor of elastin) molecules assemble into fibers and 
become highly crosslinked to one another via their lysine residues by members of the 
lysyl oxidase enzyme family. Elastin fibers are covered by glycoprotein microfibrils, 
mainly fibrillins, which are also essential for the integrity of the elastin fiber (Frantz et al., 
2010).  
At low pressure (110 / 70 mmHg in men), elastin is predominantly expressed in the artery 
wall with collagen contributing less than 10%. However, at higher pressures, collagen 
expression is enhanced and, as a result, the vessels gradually become stiffer. Thus, 
hemodynamic forces exert a regulatory effect on the vascular structure and stiffness 
(Zieman et al., 2005). Any alterations to blood vessel dimension, geometry and/or 
microstructure that result from changes in haemodynamic forces, such as a persistent 
rise in BP, are termed ‘remodelling’ (Humphrey et al., 2009).  
It has been proposed that remodelling could be an adaptive response of the arterial wall 
to control a homeostatic mechanical state (Humphrey, 2008). Stiffening could, for 
example, help to reduce aortic distension and prevent aortic aneurysm or rupture 
(Wagenseil and Mecham, 2009, Shadwick, 1999, Rachev et al., 1997, Roach and 
Burton, 1957). Remodelling, however, can also lead to a number of diseases, such as 
fibrosis, hyperplasia of the arterial intima and media, modifications in vascular collagen 
and elastin, endothelial dysfunction, and arterial calcification (Van Varik et al., 2012). 
Despite the molecular mechanisms underlying vascular remodelling not yet being clear, 
three types of cells, vascular ECs, VSMCs and adventitial fibroblasts are suggested to 
be involved in mediating the process, through modulating ECM proteins (Humphrey et 
al., 2009, Humphrey, 2008). 
Hypertension is linked with arterial stiffening and remodelling. Increased BP over time 
can result in vascular remodelling, hypertrophy, and hyperplasia; structural alterations 
that contribute to arterial stiffening. Untreated hypertension can lead to a vicious cycle of 
arterial stiffening, causing further hypertension, which promotes further arterial stiffening 
and so on (Franklin, 2005). A study by Benetos and colleagues in 2002 demonstrated 
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that high BP is the main determinant of aortic stiffness (Benetos et al., 2002). However, 
aortic stiffness in non-hypertensive people is linked with a higher risk of developing 
hypertension in the future (Dernellis and Panaretou, 2005, Liao et al., 1999, Kaess et al., 
2012). Thus, these studies suggest a bi-directional correlation between vascular stiffness 
and hypertension. 
The balance of collagen and elastin in the ECM is frequently controlled by the matrix 
metalloprotease (MMP) family. The ECM is degraded by MMPs, leading to fragmented 
and irregular elastin fibers and creating uncoiled, stiffer collagen fibres (Li et al., 1999, 
Zieman et al., 2005). Since arterial remodelling can be both beneficial and detrimental 
changes in MMP activity, either increases or decreases could affect cardiovascular 
function. Deoxycorticosterone acetate-salt hypertensive rats exhibit significantly 
increased MMP-2 expression and activity (Watts et al., 2007). However, there is a 
reduction in MMP-1 concentration and a rise in tissue-inhibitor of metalloproteinase-1 
(TIMP-1), a blocker of MMPs, in hypertensive patients serum with left ventricular 
hypertrophy (Laviades et al., 1998). 
Mature collagen and elastin contain crosslinks, which can be formed via enzymatic and 
non-enzymatic pathways. Lysyl oxidase deaminates the side chain of lysine and 
hydroxylysine residues, leaving highly reactive aldehyde groups that react with each 
other, or with unmodified lysines (van der Slot et al., 2005, van der Slot et al., 2004, 
Kagan and Sullivan, 1982). In the non-enzymatic pathway, oxidative reactions between 
glucose and collagen lead to the formation of so-called advanced glycation end-products 
(Snedeker and Gautieri, 2014). The crosslinks are essential to the structural integrity of 
collagen and elastin, however, excess crosslinking can increase their stiffness and 
reduce their sensitivity to degradation. The numbers of mature crosslinks is increased 
with hypertension (Hayashi and Naiki, 2009) and lysyl oxidase is upregulated in the 
vessels of hypertensive rats. Additionally, a study about heart failure in humans revealed 
that increased lysyl oxidase expression is associated with high collagen crosslinking and 
possibly collagen-mediated left ventricular stiffness (López et al., 2009). 
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1.2.1 Pharmacological treatment 
The pharmacological treatment of primary hypertension is not very specific, given that 
so far its main cause remains unclear. Several different therapeutic approaches currently 
exist. The most commonly used agent is a diuretic (thiazide class), which inhibits renal 
sodium absorption in the early part of the distal tubule and consequently increases water 
excretion. This results in a decrease in total blood volume and so BP. Also used are 
inhibitors of beta-adrenergic receptors; ‘beta-blockers’. These inhibit postsynaptic 
receptors of the noradrenaline system leading to decrease arterial blood pressure by 
reducing cardiac output (slow down the heart rate) and decrease the force at which blood 
is pumped round the body. Angiotensin-converting enzyme blockers can lower ANG II 
levels and aldosterone levels by inhibiting the activity of angiotensin converting enzyme. 
Angiotensin receptor inhibitors can cause vasodilatation and decrease peripheral 
resistance by blocking the ANG II receptor. Ca2+ channel blockers (dihydropyridine class) 
can induce vasodilation by inhibiting LTCC activity in vascular cells (Chobanian et al., 
2003).  
1.2.2  Non-pharmacological treatment 
Non-pharmacological interventions have also played an important role in lowering BP. 
These interventions include low salt consumption, weight reducing diet, regular exercise 
and moderate alcohol consumption (Ohta et al., 2011). A decrease in salt intake lowers 
BP persistently. An earlier study (He and MacGregor, 2004) demonstrated that a 
reduction of 4.6 g in salt intake was associated with a 4.6 mmHg decrease in systolic 
BP. Losing weight has also been correlated with declines in the levels of BP. Despite 
following the same exercise recommendation, individuals who lost weight had a bigger 
reduction in BP than those who did not (Blumenthal et al., 2000). Besides weight loss, 
exercise itself has the potential to decrease the levels of BP. A study by Cornilesen and 
colleagues, 2013, showed that any physical activity was linked with a decline of between 
1.8 mmHg and 10.9 mmHg in systolic BP, an effect reported in both hypertensive and 
non-hypertensive individuals (Cornelissen and Smart, 2013). A decline in the alcohol 
consumption could also lead to decreases in BP. A reduction of 67% in alcohol 
consumption is correlated with a mean drop of -3.31 mmHg (-2.52 to -4.1 mm Hg) and -
2.04 mm Hg (-1.49 to -2.58 mm Hg) in systolic BP and diastolic BP respectively (Xin et 
al., 2001). 
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1.3  Piezo1 channels and their vascular roles 
Biological mechanosensation forms the basis of many essential physiological functions, 
such as touch perception, proprioception, organ development, osmotic homeostasis, 
hearing and equilibrioception, as well as control of BP and arterial remodelling, as 
discussed earlier. However, very little is known about the mechanosensitive cellular 
components and their molecular identities. 
Ion channels located in the membrane of cells can sense mechanical stimuli, the 
mechanical force can be transduced via the bilayer tension or the cytoskeleton. 
Numerous channels have been reported to respond to mechanical stimuli. Two of the 
best studied are the bacterial mechanosensitive MscS and MscL channels, which seem 
to be stimulated directly through bilayer tension (Kung et al., 2010). However, in 
metazoans (animals) homologues of these channels are not present. Other examples 
include the Shaker K+ channels and certain two-pore domain K+ channels, though the 
physiological role of these channels in mechanotransduction is not yet fully clear. 
Significant roles for members of the DEG/ENac and TRP channel families have been 
established in Caenorhabditis elegans and Drosophila melanogaster. However, the 
function of these channels as mechanotransducers in mammals is not clearly 
determined.  
A significant breakthrough was made in 2010, with the identification of Piezo1 and its 
homologues, Piezo2 (Coste et al., 2010). Piezo1 was shown to underlie the currents 
elicited by mechanical activation of the Neuro2A mouse neuroblastoma cell line and 
Piezo2 was shown to contribute to mechanically activated currents in dorsal root 
ganglion neurons. Their heterologous expression induced two kinetically distinct 
mechanically activated currents. 
Piezo proteins appear to correspond to an evolutionarily conserved family of ion 
channels, with homologues identified in species such as the slime mould D. discoideum 
and the rice plant O. sativa (Coste et al., 2010). While it remains to be determined 
whether the homologues form mechanosensitive ion channels in these species the 
Drosophila melanogaster Piezo (DmPiezo, also named CG8486) does mediate 
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mechanically-stimulated currents, although with distinct pore properties compared with 
the mammalian channels (Coste et al., 2012).  
Characterisation of Piezo1 and Piezo2 as the primary mammalian mechanosensitive ion 
channels has resulted in a series of studies on their role in physiology and 
pathophysiology. Although, given the short time since their discovery the roles identified 
so far likely represent only a small fraction of those that will be found in the future.  
Piezo2 has been shown to be required for touch sensing. It is expressed in Merkel cells 
of mammalian skins and forms the main sensor of mechanical forces in these cells. 
Furthermore, Piezo2 is expressed in outer hair cells, ECs in the brain, enterochromaffin 
cells of the gut. It also mediates mechanical transduction in dental primary afferent 
neurons, particularly in medium- to large-sized neurons that contain nociceptive 
neuropeptides such as CGRP. Piezo2 has also been shown to sense airway stretch and 
mediates lung inflation-induced apnoea (Won et al., 2017, Wu et al., 2017b, Wu et al., 
2017a, Wang et al., 2017, Ikeda et al., 2014, Maksimovic et al., 2014, Ranade et al., 
2014, Nonomura et al., 2017, Beurg and Fettiplace, 2017). 
Heterozygous mutations in the PIEZO2 gene affects the function of skeletal muscle and 
are described to be causative for three phenotypically overlapping conditions termed 
distal arthrogryposis type 5 (E2727del and I802F), Gordon Syndrome and Marden–
Walker Syndrome. These conditions are characterised by cleft palate and congenital 
contractures of the hands and feet. They are caused by altered amino acids in the highly 
conserved intracellular C-terminal domain of Piezo2 (Coste et al., 2013, McMillin et al., 
2014). Piezo1 is a pore-forming subunit, as confirmed by functional reconstitution into 
artificial bilayers (Coste et al., 2012). It is permeable to  Na+, K+, Ca2+, and Mg2+, with a 
slight preference for Ca2+ (Coste et al., 2010). The pressure sensitivity of Piezo1 is in the 
range of ~−15 to −40 mmHg (Coste et al., 2010, Li et al., 2014). 
In 2017, Guo and MacKinnon published a cryo-electron microscopy structure of the 
mouse Piezo1 channel, revealing that it forms a triskelion with arms consisting of 
repeated arrays of 4-TM (24 helices arranged as six repeated 4-TM)  structural units 
surrounding a pore. Its shape deforms the membrane locally into a dome (Fig 1.8). It has 
39 
 
 
been suggested that these structures act as sensors of mechanical force exerted on the 
channel, thus contributing to mechanical gating of Piezo1 (Guo and MacKinnon, 2017). 
Multiple gain- or loss- of function single nucleotide polymorphisms have been linked to 
human diseases, providing insight into the function of the channels. Piezo1 gain-of-
function mutations in humans are associated with a hereditary red blood cell condition 
termed dehydrated hereditary stomatocytosis. For example R2456H and R2488Q 
mutations in Piezo1 alter mechanosensitive regulation, leading to increased cation 
transportation in erythroid cells, which shows a novel role in mechanotransduction in red 
blood cell biology and pathophysiology (Albuisson et al., 2013, Andolfo et al., 2013, Bae 
et al., 2013). Piezo1 loss of function mutations cause an autosomal recessive congenital 
lymphatic dysplasia (Lukacs et al., 2015).  
Given the critical role of Piezo1 in mechanotransduction in both red blood cells and 
bladder urothelium (Miyamoto et al., 2012, Karaki et al., 1997, Zarychanski et al., 2012, 
Demolombe et al., 2013), it is perhaps not unsurprising that Piezo1 also plays a 
significant role in ECs. Piezo1 can be activated by shear stress, a frictional force 
experienced by ECs due to blood flow. This activation is required for the characteristic 
alignment of ECs with the direction of flow. This phenomenon is also important in 
vascular development. Global or endothelial-specific disruption of mouse Piezo1 
profoundly disturbed the developing vasculature and the remodelling and was embryonic 
lethal within days of the heart beating. Haplo-insufficiency was not lethal but endothelial 
abnormalities were detected in mature vessels (Li et al., 2014, Ranade et al., 2014). 
Piezo1 is also highly expressed in the myocytes of small diameter arteries. Smooth-
muscle-specific deletion of Piezo1 in the mouse fully impairs stretch-activated ion 
channel activity. Piezo1 is dispensable for the myogenic tone of arterial vessels, but is 
involved in the remodelling of small arteries in hypertensive conditions ((Retailleau et al., 
2015). 
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1.4 Yoda1 
A screen of ∼3.25 million compounds identified a synthetic small molecule that can both 
influence the activation of Piezo1 by mechanical stimuli and activate the channel in the 
absence of mechanical stimulation (Fig. 1.9) (Syeda et al., 2015). This molecule was 
named ‘Yoda-1’. Yoda-1 was able to activate Piezo1 reconstituted into an artificial cell 
membrane that did not include any other cellular components, thus suggesting that 
Yoda-1 interacts with Piezo1 in a manner that does not require any cellular elements or 
additional signalling apparatus other than a cell membrane. The study also demonstrated 
the specificity of Yoda-1  for Piezo1 over Piezo2 (Syeda et al., 2015). Yoda1 was 
successfully used to replicate the effects of mechanical activation of Piezo1 in red blood 
cells, namely their dehydration (Cahalan et al., 2015), demonstrating that it is a useful 
tool compound for the investigation of Piezo1 expression and function in vitro.  
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Figure 1-8: A representative Cryo-EM structure of Piezo1 
Side view of Piezo1 shows fine features of the trimeric complex with the transmembrane 
region indicated (Guo and MacKinnon, 2017).   
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Figure 1-9: Chemical structure of Yoda1 
 Used as an agonist of Piezo1. (Syeda et al., 2015)  
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1.5  Aims and Objectives 
Endothelial Piezo1 has been shown to be important for vascular development, however, 
the role of Piezo1 in the maintenance, function and remodelling of mature vessels 
remains to be determined. The main aims of this thesis relate, therefore, to investigating 
the relative contribution of Piezo1 channels in the regulation of vascular tone, excitability 
and contractility. To facilitate this, mice with conditional Cre-Lox-mediated disruption of 
Piezo1 in the endothelium (Piezo1EC mice) and the Piezo1 channel agonist Yoda1 were 
utilised.  
The objectives of this thesis were: 
To increase our understanding of physiological functions of Piezo1 channels in adult 
mice and to reveal the specific contribution of Piezo1 to vascular function. 
To study the role, and underlying mechanisms, of Piezo1 in vasoconstriction and 
vasorelaxation in intact arteries.  
To compare the contractile and vasodilatory responses in intact arteries of control and 
Piezo1 ∆EC mice.  
To determine if Yoda1 has vasoactive effects on resistance or conduit arteries and to 
characterise any effects of Yoda1 in this context.  
To identify whether Piezo1 can represent a novel therapeutic target for the treatment of 
arterial dysfunction. 
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Chapter 2 General Methods 
2.1 Materials and Solutions 
The experimental bath solutions, compounds and the solvents in which they were 
dissolved are shown in Tables 2.1, 2.2 and 2.3. Compounds were diluted in their 
respective solvent to 1000x the desired working concentration prior to addition to the 
bath solution. This minimised the solvent concentration that the vessels were exposed 
to during the experiments.  
Yoda1, the recently discovered activator of Piezo1 (Syeda et al., 2015) becomes 
insoluble in aqueous solutions at concentrations greater than 10 μM, restricting is usage 
in experiments to this concentration.   
Dooku1, a chemical analogue and competitive antagonist of Yoda1, was synthesised by 
Kevin Cuthbertson within the School of Chemistry at the University of Leeds (Evans et 
al., 2018). A scaffold (the scaffold is an approach to generate new chemical structures 
with similar biological activity to the original by changing components of the molecule) 
was used as starting material and a one-step reaction resulted in production of the 
compound (Fig. 2.1). Other analogues of Yoda1 were  synthesised using three general 
synthetic approaches: 2e and 2g were synthesised using a one-step procedure (Scheme 
S1), compounds 7b using a four-step procedure  (Scheme  S2),  and  compound  11  
using  a  separate  four-step  procedure  (Scheme  S3).  All synthesised chemicals were 
purified by column chromatography and characterised by four methods: 1H NMR (proton 
nuclear magnetic resonance), 13C-NMR (carbon-13 nuclear magnetic resonance), IR 
(infrared spectroscopy) and high-resolution mass spectrometry. Chemical structures of 
other Yoda1 analogues are shown in Fig 2.2. 
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Solution Chemicals 
Concentration 
(mM) 
Krebs 
Sodium chloride (NaCl) 125 
Potassium chloride (KCl) 3.8 
Magnesium chloride (MgSO4.7H2O) 1.5 
Sodium bicarbonate (NaHCO3) 25 
Potassium dihydrogen phosphate (KH2PO4) 1.2 
Ethylenediaminetetraacetic acid (C10H16N2O8) 0.02 
Glucose (C6H12O6) 8 
Calcium chloride  (CaCl2.2H2O) 1.2 
High 
potassium 
Krebs 
As with Krebs solution with the following changes  
Reduced NaCl 68.8 
Increased KCl, 60 
Table 2-1: Composition of solutions used in this study  
Solutions were made as required. All chemicals listed were supplied by Sigma.  
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Drug/Compound Supplier 
Solvent for 
stock 
Stock 
concentration 
Storage 
Bath 
concentration 
Phenylephrine 
hydrochloride 
Sigma 
Distilled 
water 
10 mM -20°C 0.01-1 µM 
Acetylcholine 
chloride 
Sigma 
Distilled 
water 
10 mM -20°C 0.01-1 µM 
L-NAME 
(N-nitro-L-
arginine 
methylester) 
Sigma 
Distilled 
water 
100 mM -20°C 100 µM 
Linsidomine 
(SIN-1) 
Sigma DMSO 20 mM  -20°C 0.1-10 µM 
Charybdotoxin Sigma 
Distilled 
water 
10 mM -20°C 100 nM 
Apamin Tocris 
Distilled 
water 
10 mM -20°C 500 nM 
Yoda1 Tocris DMSO 10 mM -20°C 0.1-10 µM 
Nifedibine Sigma DMSO 1 mM R.T. 1 µM 
Gadolinium 
(Gd3+) 
Sigma 
Distilled 
water 
10 mM R.T. 10 μM 
Ruthenium 
(RR) 
Sigma 
Distilled 
water 
30 mM -20°C 30 μM 
Table 2-2: Drugs/compounds  
Suppliers and solvents used to dissolve with stock concentration, storage and further 
dilution from stock (R.T.; room temperature).  
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Chemical Source 
Stock 
concentration 
Working 
concentration 
Additional information 
Dooku1 ____ 
10 mM in 
DMSO 
10 μM 
30 minutes pre-
incubation 
7b ____ 
10 mM in 
DMSO 
10 μM 
30 minutes pre-
incubation 
2g ____ 
10 mM in 
DMSO 
10 μM 
30 minutes pre-
incubation 
11 ____ 
10 mM in 
DMSO 
10 μM 
30 minutes pre-
incubation 
2e ____ 
10 mM in 
DMSO 
10 μM 
30 minutes pre-
incubation 
Table 2 3: Inhibitors applied to thoracic aortic segments. 
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Figure 2-1: Synthesis and chemical structure of Dooku1  
Synthesis pathway showing the starting scaffold (on the left-hand side), reagents used 
(middle arrow) and final compound structure (right-hand side). Product produced via an 
SN2 (nucleophilic substitution) reaction. Dooku1 used as an antagonist of Yoda1.  
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Figure 2-2: Chemical structures of 2e, 7b, 11 and 2g Yoda1 analogues 
 Structural variation to Yoda1 is highlighted by the box outline.  
2e 2g 
7b 11 
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2.2 Mouse 
Mouse models are progressively used in essential scientific research due to their 
advantages regarding small size, relative inexpensiveness and the capability to 
manipulate specific genes either via modification, addition or deletion. 
2.2.1 Mouse housing conditions and diet 
All work with mice was performed by Dr B Rode and Dr S Futers (University of Leeds) 
and approved by the University of Leeds Animal Welfare Ethics Research Board and by 
The Home Office, UK (Project Refs: 40/3557 and P606320FB)..  
Mice were maintained in GM500 individually ventilated cages (Animal Care Systems), at 
21°C, 50–70% humidity, light/dark cycle 12/12 hr, on RM1 diet (Special Diet Services, 
Witham, UK) ad libitum and Pure‘o Cell bedding (Datesand, Manchester, UK). Mice were 
housed in a Home Office-licensed animal facility (University of Leeds) and humanely 
euthanised by cervical dislocation as specified by Schedule 1 of the Animal Scientific 
Procedures Act (1986). All procedures and the transgenic mouse production were 
authorised by both the University of Leeds Animal Ethics Committee and the UK Home 
Office. 
2.2.2 Genetic disruption of the Piezo1 gene  
To characterize the physiological function of Piezo1 in ECs an inducible, endothelial-
specific Piezo1 knock-out mouse line was created (Rode et al., 2017). Mice with 
C57Bl/6J genetic background were used in this study. 
2.2.2.1 Genetic disruption of the Piezo1 strategy 
Firstly, flanking loxP sites were inserted between introns 17 and 18 and introns 21 and 
22 of the Piezo1 gene (Piezo1flox) (Li et al., 2014) (Fig 2.3). These C57BL/6 Piezo1flox 
mice (heterozygous for the floxed allele) were then crossed with mice expressing Cre 
recombinase under the tamoxifen inducible vascular endothelial specific Cadherin5 
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promoter (Tg(Cdh5-cre/ERT2)1Rha) and subsequently inbred to yield C57BL/6 
Piezo1flox/flox/Cdh5-cre mice (homozygous for the floxed allele) (Fig. 2.4)  (Rode et al., 
2017). Cre recombination resulted in deletion of exons 18–21 encoding amino acids 770 
to 2546. Loss of functional protein was confirmed by absence of Yoda1 response in 
isolated ECs (as shown in supplementary Figure 2 of the Rode et al. paper) (Rode et al., 
2017). 
Cre-ERT2 is a chimeric protein of Cre fused to the mutated ligand-binding domain of the 
human estrogen receptor (ERT2). The mutations render the receptor insensitive to 
physiological concentrations of its natural ligand, 17β-estradiol, but sensitive to 4-
hydroxytamoxifen (4-OHT), a metabolite of tamoxifen (TAM). Thus, the fusion with ERT2 
allows temporal control of the activity of Cre. In the absence of TAM the Cre-ERT2 is 
retained in the cytoplasm, however, in the presence of TAM the chimeric protein is able 
to translocate into the nucleus, where it can initiate loxP-specific recombination events 
(Relaix and Zammit, 2012, Monvoisin et al., 2006). 
2.2.2.2 Tamoxifen administration 
TAM (Sigma-Aldrich) was dissolved in corn oil (Sigma-Aldrich) at 20 mg/mL. All TAM 
injections were performed by Dr B Rode and Dr S Futers (University of Leeds). Adult 
male mice (10 to 16 weeks) were injected intra-peritoneally with 75 mg/kg TAM for 5 
consecutive days and analysed 10 to 14 days following the last TAM injection.  
Piezo1flox/flox/Cdh5-cre mice that received TAM injections are referred to as Piezo1ΔEC. 
Piezo1flox/flox littermates (lacking Cdh5-cre) that received TAM injections were the controls 
(control genotype). 
2.2.2.3 Genotyping 
Ear notches were collected for genotyping at two weeks of age. All genotyping was 
outsourced to Transnetyx Company (Cordova, TN, USA). They isolated genomic DNA 
from ear notches taken from mice at two weeks of age and performed real-time PCR 
analysis with specific probes designed for each gene of interest. This service probed the 
sample for the presence of a floxed gene, the wild-type Piezo1 gene and the Cre gene 
under the control of the Cadherin5 promoter. Primers in table 2.3 were used in our 
52 
 
 
laboratory by Dr B Rode to confirm the genotype and probe for Piezo1 deletion. Piezo1flox 
primers probed for the presence or absence of LoxP sites. Piezo1D primers probed for 
deletion of exons 18-21. The product appears only if deletion happened. 18S and Piezo1 
probes (the last 2 lines of the table) are for qRT-PCR which is used to analyse mRNA 
expression. In the Piezo1flox, the PCR primers targeted the endogenous Piezo1 
sequence either side of the 3’ terminal loxP site (expected products: 155 bp without the 
loxP site; 189 bp with the loxP site). In Piezo1D, The forward primer was 5’ of the 5’ FRT 
site and the reverse primer was 3’ of the 3’ loxP site.  
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Figure 2-3: Diagram showing insertion of loxP sequences into the mouse Piezo1 
gene in the introns between exons 17 and 18 and 21 and 22 
Cre recombination around these two loxP sites results in deletion of exons 18 to 21 from 
the gene.  
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Figure 2-4: Endothelial-specific Piezo1 modification 
Transgenic mice containing loxP sites flanking exons 18-21 of the Piezo1 gene (floxed) 
were crossed with transgenic mice expressing the bacterial Cre enzyme fused to a 
mutant transgenic mice ligand-binding domain of the human oestrogen receptor (ER) 
under the control of the endothelial specific Cdh5 promoter. Resulting offspring that were 
hemizygous for Cdh5CreER and heterozygous for the floxed Piezo1 gene were further 
crossed with homozygous floxed Piezo1 mice yielding the desired homozygous floxed 
Piezo1 mice that were hemizygous for Cdh5CreER. The Piezo1 gene in ECs of these 
mice, when exposed to tamoxifen, undergoes Cre-dependent recombination.  
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Gene Analysis 
Forward primer sequence 
(5’-3’) 
Reverse primer sequence 
(5’-3’) 
Product 
size 
(base 
pairs) 
Cdh5-cre 
Genomic 
DNA 
GCATTACCGGTCGATGC
AA 
AGTGAACGAACCTGGTC
GA 
408 
Piezo1flox 
Genomic 
DNA 
GGAGGGTTGCTTGTTGG
ATA 
ACTCATCTGGGTGAGGT
TGC 
155, 189 
Piezo1 D 
(Deletion) 
Genomic 
DNA 
ACCACCTGAGAAGTTGT
CCC 
ACTCATCTGGGTGAGGT
TGC 
379 
18s cDNA 
GATGCTCTTAGCTGAGT
GT 
GCTCTGGTCCGTCTTG 233 
Piezo1 cDNA CACAAAGTACCGGGCG 
AAAGTAAATGCACTTGA
CG 
370 
 Table 2-3: PCR primer sequences.  
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2.2.3 Patch-clamp electrophysiology 
Membrane potential was measured using the perforated whole-cell configuration of the 
patch-clamp technique in current clamp mode with an Axopatch-200A amplifier (Axon 
Instruments, Inc.) equipped with Digidata 1440 A and pCLAMP 10.6 software (Molecular 
Devices, Sunnyvale, CA, USA) at room temperature. Outside-out membrane patch 
recordings were made using the same equipment but in voltage-clamp mode. ECs and 
endothelium were bathed in a solution consisting of 135 mM NaCl, 4 mM KCl, 2 mM 
CaCl2, 1 mM MgCl2, 10 mM glucose and 10 mM HEPES (pH 7.4). Heat-polished patch 
pipettes with tip resistances between 3 and 5 MΩ were used. For membrane potential 
recordings, amphotericin B (Sigma-Aldrich) was used as the perforating agent, added in 
the pipette solution composed of 145 mM KCl, 1 mM MgCl2, 0.5 mM EGTA and 10 mM 
HEPES (pH 7.2). For application of fluid flow, endothelium or membrane patches were 
manoeuvred to the exit of a capillary tube with tip diameter of 350 μm, out of which ionic 
(bath) solution flowed at rates specified in the main text and figure legends. Calculation 
of shear stress (τω) was achieved using the Hagen-Poiseuille formula (τω = 4μQ/πR3) 
where μ is dynamic viscosity, Q is flow rate and R is radius of the capillary tube. 
2.2.4 Monitoring mouse activity / Running wheel analysis  
All mice were individually housed with free access to a running wheel. Detailed 
characteristics of running activity were recorded for each animal using custom-built 
hardware and software. A mouse was categorised as active when there were ≥2 
revolutions of the running wheel in each 1 min recording period. This equates to ≈ 10% 
of the mean dark cycle velocity of running for control animals (0.34 m/s). Continuous 
activity periods (bouts) were determined as activity showed in 2 or more consecutive 
minutes. One Piezo1∆EC mouse exhibiting complete inactivity for the first 3 days was 
excluded from the analysis along with its control genotype pair. 
2.2.5 Tissue staining 
Epididymal fat pad and liver tissues were fixed for 48 h in 4% PFA at 4 °C prior to 
processing on a Leica ASP 200 and embedding in CellWax (Cellpath) on a Leica 
EG1150H embedding station. Sections of 4 μm were cut on a Leica RM2235 microtome 
onto Plus Frost slides (Solmedia) and allowed to dry at 37 °C overnight prior to staining. 
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Slides were de-waxed in xylene and rehydrated in ethanol. H&E was performed by 
staining in Mayer’s Haematoxylin for 2 min and eosin for 2 min. Slides were imaged on 
an Aperio AT2 (Leica Biosystems) high definition digital pathology slide scanner with a 
maximal magnification of ×20. Tissue processing and imaging were performed at the 
Section of Pathology and Tumour Biology, Leeds Institute of Cancer and Pathology. 
2.2.6 Echocardiography 
Animals were maintained under steady-state isofluorane anaesthesia and placed on a 
heated platform with ECG and respiration monitoring. Core temperature was measured 
using a rectal probe (Indus Instruments) and maintained at 37.5 °C throughout recording. 
Echocardiography was performed using a Vevo2100 high resolution, pre-clinical in vivo 
ultrasound system (VisualSonics) with the MS-550D transducer at 40 MHz frequency 
and 100% power. Imaging was performed on a layer of aquasonic gel after the pre-
cordial skin had been clipped and de-epliated with cream (Veet). Parasternal long-axis 
view (PLAX) images were obtained in EKV mode (set at 1000 Hz for recording) over the 
entire cardiac cycle. The left ventricular area was traced in end-diastole (LVAd) and end-
systole (LVAs) and used to derive the ejection fraction (EF) with the Vevo LAB cardiac 
package software. The investigator performing sonography was blinded to the genotype 
of the animals. Transverse EKV recordings were also obtained over the abdominal aorta 
just below the diaphragm using the same settings as described for the heart. These 
images were evaluated in the VevoVasc software package to determine vessel 
distensibility. Maximal anteroposterior aortic diameter (from inner wall to inner wall) was 
measured in the same images in systole and diastole using Vevo LAB general imaging 
package software. 
2.3 Dissection of blood vessels 
Animals were killed by CO2 asphyxiation followed by cervical dislocation. The blood 
vessels were isolated and rapidly transferred to cold Krebs solution to avoid contact with 
air. All the dissection was performed by the experimenter (N. Endesh). They were then 
carefully pinned onto a dissecting dish, coated with a layer of silicone plastic (Sylgard), 
and placed under a light microscope. During the dissection, surrounding tissue/fat was 
carefully removed by hand dissection without damaging the blood vessels or stretching 
the artery. Extreme care was taken to avoid direct contact with the artery by pulling gently 
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with forceps and cutting through the membrane of the connective tissue because the 
endothelium is easy to damage by excessive mechanical stretch during the process of 
isolation, mounting wire, or cannulation. Arteries were stored for a maximum of 30 
minutes at 4°C in physiological salt solution, pH 7.4 prior to experiments. 
2.3.1 Thoracic aorta 
The descending thoracic aorta, which extends from the aortic arch to the diaphragm (Fig 
2.5), was accessed by removing the heart and lungs then excised into a Petri dish 
containing ice-cold oxygenated Krebs solution. It was cleaned off from the surrounding 
tissue and cut into 1 mm transverse segments. These segments were handled carefully 
to avoid unintentional damage to the surface of the intima. 
2.3.2 Mesenteric artery  
The mesenteric arcade (loops of small intestine) was removed after incision of the 
abdominal cavity to expose and open the overlying peritoneum. Then the mesentery was 
pinned out on a Petri dish in ice-cold oxygenated Krebs solution as shown in Fig 2.6. 
The first order arteries were located under a dissection microscope and classified as 
those branching straight from the superior mesenteric artery. The second-order 
mesenteric vessels (those that branch from the first order vessels) were carefully 
dissected from surrounding fat using small scissors and fine forceps (World Precision 
Instruments, Hertfordshire, England). Second order mesenteric artery was chosen as 
they are the smallest order branch of the aorta that it was practicable to handle for the 
experiments. An artery with a small lumen was desirable as they are the most important 
contributor to the control of vascular tone. Arteries were distinguished from veins due to 
their thicker muscular walls and an acute angle at the branching site. Arteries were cut 
into 1 mm segments. 
2.3.3 Saphenous artery 
The saphenous artery was distinguished as extending distally from the femoral vessels 
branching towards the knee (Fig 2.7). Arteries were carefully cleaned of all connective 
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and adipose tissue then the middle part of the saphenous artery was cut into two equal 
parts (1 mm segments). 
2.3.4 Carotid artery 
The common carotid artery is a large elastic artery. One carotid artery is positioned on 
each side of the neck. The right common carotid artery branches from the 
brachiocephalic artery and extends up the right side of the neck while the left common 
carotid artery branches from the aorta. These arteries present the main blood supply to 
the head, neck, and brain.  
Beneath a dissecting microscope, the chest was opened to reveal the right and left 
carotid arteries using dissecting small scissors and fine forceps (Fig 2.8). Both the left 
and right arteries were used for experimentation. Carefully they were cleaned of fat and 
surrounding tissue until the full length of both carotids from the aorta to the common 
carotid bifurcation could be seen (indicated by red lines in Fig 2.8). Once excised the 
arteries were kept in ice-cold oxygenated Krebs solution. For experimentation the 
arteries were cut into 1 mm segments.  
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Figure 2-5: Diagram of the aorta dissection  
Orange lines indicate the locations at which incisions were made to excise the 
descending thoracic aorta (Agmon et al., 2003).  
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Figure 2-6: Schematic diagram of the organisation of the mesenteric vascular bed 
Branching from the main mesenteric artery towards the gut wall are 1st, 2nd, 3rd and 4th 
order mesenteric arteries sequentially. Second order arteries were excised for use in 
wire myography experiments. Adapted from DMT website www.dmt.dk.  
Main 1st 3rd 4th 
 
2nd 
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Figure 2-7: Location of the saphenous artery in the rodent hind limb 
Green lines indicate the locations at which incisions were made to excise the saphenous 
artery (Zimmermann et al., 2009).  
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Figure 2-8: Diagram depicting the location of the left and right common carotid 
arteries in relation to the heart and aorta  
The red lines indicate the incision points when dissecting out these vessels. (Monvoisin 
et al., 2006).  
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2.4 Vascular myography 
Vascular myography is a technique regularly used to evaluate vasomotor responses of 
isolated blood vessels to vasoactive agents in the context of a controlled environment; 
for example in the absence of multiple vasoactive influences experienced in vivo such 
as mechanical forces or neural input. This method allows clear dissection of the 
vasomotor pathways and the mechanisms by which pharmacological agents manipulate 
the signalling systems of interest. Furthermore, it affords the possibility to perform 
experiments where the endothelium has been removed from the lining of the vessel 
lumen, and thus the ability to identify between responses originating from the 
endothelium versus those mediated via the smooth muscle cell (endothelium-
independent).  
2.4.1 Wire Myography  
Wire myography was first introduced by Mulvany & Halpern in 1976. The wire myograph 
is a kind of organ bath that is made of a horizontal stainless steel chamber comprising 
two opposing stainless steel ‘jaws’ (Fig 2.9). Each jaw has a pair of teeth between which 
the arterial segments are placed with the support of two pieces of wire. The jaw on the 
right side is joined to a micrometer for adjusting the distance between the two jaws. The 
jaw on the left is joined to a force transducer through a steel rod which passes through 
a hole in the side of the chamber, enabling the experimenter to assess alterations in 
isometric tension as the vascular segments dilate or constrict. The hole that the rod 
passes through is sealed with vacuum grease (Danish Myotechnology, Aarhus, 
Denmark). In this study, the contractility of four different vessels (mouse thoracic aorta, 
mesenteric arteries, saphenous and carotid arteries) was studied with the DMT wire 
myograph (DMT 620 myograph system, Aarhus, Denmark) (Fig 2.9). The chambers were 
connected to a vacuum pump, enabling wash out and so exchange of the bath solution. 
A gas inflow ensures the preparations in all four chambers are maintained under 
physiological conditions (37°C, and bubbled with a gas mixture of 95% O2:5% CO2 - this 
gas mixture was preferred to provide a more physiological oxygen tension than obtained 
when applying oxygen only). Myographs were washed daily and calibrated on a bi-
monthly basis as per the manufacturers’ guidelines. 
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2.4.1.1 Vessel mounting  
Following dissection of the vessel, but prior to beginning the mounting procedure, the 
myograph chamber(s) were filled with 5 ml Krebs solution at room temperature; chamber 
and solutions were continuously gassed with 95% O2/5% CO2 mixture and, to minimize 
vessel variability, for control and Piezo1 deletion arteries, two branches of the same 
artery were used in parallel. Pieces of 40 μm stainless steel wires were used for aorta 
and carotid arteries and 15 μm tungsten wires for mesenteric and saphenous arteries 
that fit the lumina of small arteries. Segments were freshly cut ready to be used for 
mounting the vessel. The first wire was secured under a mounting screw with the 
unsecured end clamped in position by the myograph jaws. Artery segments of 
approximately 1 mm in length were carefully positioned at the end of the wire and, with 
great care to prevent any damage to the lumen wall, the artery was pulled over the wire 
and into the gap between the myograph jaws (Fig 2.10a and b). The remaining free end 
of the wire was secured under the second screw as shown in Fig 2.10c. Once the first 
wire was secured the jaws were opened and a second piece of wire was passed through 
the artery (Fig 2.10d). Once the second wire had been passed through the artery ring 
such that the artery sat roughly in the middle of it, the jaws were re-closed in order to 
clamp onto the second wire and render it immobile. Then the two ends of the second 
wire were secured under the two screws of the second jaw (Fig 2.10e). The first end was 
secured with the jaw closed; tightening the screw over the wire such that the wire was 
pulled tight as the screw was tightened. The jaws were then re-opened just enough to 
loosen the hold over the second wire, and as with the first wire, the free end was held 
tightly with forceps and pulled taut to take up all slack as it was passed under the 
remaining screw and as the screw was tightened. Initially the jaws were set slightly apart 
to prevent the two wires from touching, but not enough to begin stretching the arterial 
ring. The mount was assessed to ensure the wires were tight, parallel and that the artery 
sat in the middle of the jaws free of tension or obstruction. All of the above procedures 
were carried out using a microscope (Nikon). Warm and oxygenated Krebs solution was 
provided to maintain the physiological properties of the vessels.  
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Figure 2-9: The wire myograph  
(a) DMT multi-chamber 620M Wire Myograph where the wire myograph interface 
contains four myograph units. (b) Each myograph unit holds a force transducer (left) and 
a micrometre (right), and both of them attached to corresponding jaws to maintain the 
vessel within the chamber. (c) The chamber with the jaws and a mounted vessel 
segment. Both the upper and lower jaws are attached to the micrometre screw and to 
the force transducer, respectively. (d) The jaws, wires, screws and a mounted vessel 
segment. Adapted from DMT website www.dmt.dk.  
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Figure 2-10: The mounting procedure 
(a and b) artery segments of 1 mm length were carefully positioned at the end of the wire 
with great care to avoid any damage to the lumen wall, the artery was pulled over the 
wire and into the gap between the myograph jaws. (c) The wire was wrapped clockwise 
around the screws of the jaw and clamped by closing the screws. (d) The jaws were 
separated and carefully insert another 2-cm-long wire through the lumen of the artery 
minimising contact with the wall and the second wire was clamped by moving jaws 
together again. (e) The second wire was wrapped clockwise and clamped to the screws 
of the second jaw and the wires were moved away so that they were as close to each 
other as possible without touching. Adapted from DMT website www.dmt.dk.  
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2.4.1.2 Normalization of the vessels  
Artery drug sensitivity and active force are both at their maximum when the artery internal 
circumference is 90% of that in vivo (Moyes et al., 2016). Thus, the normalisation process 
aims to standardise the tension of the mounted arteries by stretching their internal 
diameter to 90% of that the vessel would have if relaxed and under a transmural pressure 
of l00 mmHg/13.3 kPa. After mounting, the artery segments were stabilised in Krebs 
solution with continuous bubbling with a gas mixture of 95% O2 and 5% CO2. During this 
time, the chambers were heated and twenty minutes after reaching 37°C the 
normalisation protocol was started. The first step involved determining the length of the 
vessel segments (in mm) by using an eyepiece reticule. This was the position at which 
the artery had the smallest diameter, i.e. it had not yet developed any tension, the ‘zero’ 
position. It was obtained by adjusting the jaws slowly until the wires touched without 
pushing against each other. Then, the tension in the arteries was increased in a stepwise 
manner using the micrometre screw to increase the distance between the two myograph 
jaws, leaving enough time after every stretch for the artery to reach a steady state tension 
(5 minutes at least). The wall force and micrometre reading were recorded at each step. 
The level of stretch was re-adjusted by small increments to the diameter at which the 
segments contractile response to 60 mM KCl and 0.3 µM PE were maximal. By this the 
internal diameter was then set to 90% of that value. 
2.4.1.3 Wire Myography Protocols  
During the functional measurements, the distance between the two wires was kept 
constant, with changes in vessel contractility being measured through the force 
transducer (Fig 2.9).  
Following the normalisation procedure, arteries were equilibrated under tension for 30 
minutes. After this period had elapsed the arteries were initially contracted twice with 60 
mM high K+, which causes membrane depolarisation and consequently calcium influx 
through voltage-operated calcium channels (Karaki et al., 1997). This allowed the 
maximal contraction of the artery to be determined and confirmed that the contractile 
ability in the arterial smooth muscle was intact. Each high potassium stimulus was 
maintained for 10 minutes, after which new Krebs solution was added to the bath and 
the vessels allowed to relax. Any artery segments that were unresponsive to high 
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potassium were rejected, unresponsiveness being indicative of compromised vascular 
smooth muscle integrity (Fig 2.11).  
Arterial SMCs contain α1-adrenergic receptors that, when activated, lead to release of 
calcium from intracellular stores and consequently contraction (Hall et al., 2006). The 
resting or baseline tension set at the beginning of the protocol is passive and theoretically 
does not contain any active vessel tone. Therefore, in order to observe vasodilatory 
responses, vessels must first be pre-contracted to generate a state of active tone from 
which the vessels can relax. Within this study, PE, an α1 receptor agonist, was used as 
a vasoconstrictor for this purpose; arteries were treated with 0.3 μM final concentrations 
PE to obtain 60-80% of the maximal reference contraction to high K+ prior to application 
of known/potential vasodilators (Fig 2.11).  
Activation of ACh receptors present on ECs leads to NO production and consequently 
vaso-relaxation (Chadha et al., 2011). Therefore, pre-contracted arteries were stimulated 
with ACh to test for the presence and the functional integrity of the endothelium (Fig 
2.11).  
Cumulative concentration-response curves of PE (0.01–1 microMolar final 
concentrations in distilled water) (μM) (Sigma-Aldrich) were then constructed and the PE 
concentration that produced 80% of the maximal response (EC80) was determined (0.3 
μM). This concentration was then used to constrict the arteries, followed by ACh 
concentration-response curves (0.01–1 μM final concentrations in distilled water; Sigma-
Aldrich). (The endothelium was considered intact if ACh caused more than 60% 
relaxation of arteries pre-constricted with PE). Cumulative dose-response curves were 
achieved for PE, ACh and Yoda1 by adding concentrations of agonist to the bath in half-
log molar increments. This was used to evaluate the response to an agonist as a maximal 
response can be obtained from these data. It was also possible to calculate the EC50, 
which indicates the tissue sensitivity to the agonist, from these data. 
L-NAME is a competitive inhibitor of NOS, an enzyme involved in the formation of NO.  
It was used to determine the contribution of NO to endothelium-dependent vasodilatation 
by incubating artery segments with 100 μM L-NAME (final concentration)  for 20 minutes 
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prior to contracting the arteries with PE and applying the test vasodilator, this 
concentration is commonly found in similar studies in published literature (Leo et al., 
2014, Cooke and Davidge, 2003) or a combination of apamin (0.5 μM; final concentration 
in distilled water) and charybdotoxin (0.1 μM; final concentration in distilledwater) 
inhibitors of IKCa2+ and SKCa2+; (Tocris) these concentrations have previously been 
shown to inhibit IKCa2+ and SKCa2+ in rat mesenteric arteries (Stankevičius et al., 2006, 
O'Sullivan et al., 2004). 
To investigate the contribution of Piezo1 to Yoda1-induced relaxation, 10 µM Gd3+ or 30 
µM RR, inhibitors of mechanosensitive channels was applied 20 minutes prior to the pre-
constriction with PE. 10 µM Dooku1, a competitive antagonist of Yoda1, and other Yoda1 
analogues also were applied 30 minutes before the pre-constriction with PE 
Artery baths were washed at least three times with fresh, warm, and oxygenated Krebs 
solution between the different functional experiments. 
In some experiments, the endothelium was removed by gently rubbing the intimal surface 
with a wire. Care was taken not to over-stretch the segments during rubbing in order to 
avoid damaging their muscular layer. Endothelial denudation was considered successful 
if the endothelium-dependent vasodilator, ACh (1 μM), failed to produce relaxation. 
The relaxation response of SIN-1 (Sigma-Aldrich), an NO donor (0.01-1 μM in 100% 
DMSO), and after pre-constriction with 0.3 µM PE, was carried out to test the function of 
the VSMCs. 
2.4.1.4 Data analysis 
The experimenter was blind to the genotype of the animals. The individual 
measurements from each chamber were combined to calculate the mean and standard 
error of the mean (SEM) for each data set, where n indicates the number of mice. Results 
were expressed either in milliNewton tension (mN), which is the value of the myograph 
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response after the baseline tension subtraction, or as a percentage of a control response; 
high K+ or PE pre-constriction.  
In order to normalise for the difference in PE contraction, tension changes to ACh and 
Yoda1 are expressed as a percentage of the maximal vasoconstriction induced by PE in 
mN, rather than as a percentage of its own maximum relaxation in mN. This is more 
informative than just expressing the points on the curve as a percentage of the maximal 
ACh induced relaxation in mN, (all values subscribed by the smallest number that started 
with then divided by the biggest number and then multiplied by 100) Tension changes to 
PE are expressed as a percentage of the maximal constriction to 60 mM K+. Data were 
generated in pairs (control mice and Piezo1∆EC mice) and data sets compared statistically 
by paired or unpaired t-test. It was paired where both data sets were collected from the 
same mouse. The data were also analysed using paired or unpaired Student t-tests of 
area under the curve (AUC) to detect overall alterations in concentration response 
curves. The AUC was defined as the area between the mean response value and the 
baseline value of 0% relaxation (100% of contractile tone). Concentration–response 
curves were fitted by sigmoid curves with the Hill equation using Origin Pro software. 
The minimum level of statistical significance considered in the study was probability (p) 
<0.05 (*<0.05, **<0.01, ***<0.001). Where data comparisons lack an asterisk, they were 
not significantly different. The number of independent experiments of mice is indicated 
by n (one mouse each experiment). Origin Pro software was used for data analysis and 
presentation. 
2.4.2 Pressure Myography 
Pressure myography enables the study of artery responses under isobaric conditions, 
which may be more physiological than the wire myograph. This method was first 
developed in 1967 to study arterioles as small as 50 μm in diameter, superfused and 
pressurised by a single cannula (Uchida et al., 1967). Subsequently the technique was 
optimised to study microvessels up to 12 μm (Duling et al., 1981). Additional 
improvements have involved constant vessel imaging and using a second cannula to 
enable the changing of the luminal solution independently of the abluminal solution 
(Vanbavel et al., 1990). The importance of longitudinal stretching was emphasised to 
provide optimal experimental conditions for pharmacological studies (Coats and Hillier, 
1999).  
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2.4.2.1 Pressure myograph vessel mounting 
The mesenteric bed was dissected out of the abdomen and placed in a dissection dish 
that contained Krebs solution at 4˚C. Second order mesenteric arteries were carefully 
dissected out of the bed and the surrounding adipose tissue removed under a dissection 
microscope (Nikon) using fine forceps and scissors, always ensuring that the vessels 
were not stretched or damaged. The length of the vessels was usually between 3 and 4 
mm. The tissue was kept in Krebs solution at 4˚C until vessels were set up in the pressure 
myograph chamber (MODEL 110p, Danish Myo Technology) (Fig. 2.12). Prior to vessel 
mounting the pressure lines were filled with 37˚C temperature Krebs solution to ensure 
there were no air bubbles in the tubing. Under a dissection microscope, a small artery 
segment was transferred into a single vessel chamber containing 10 ml Krebs solution. 
The vessel was then manoeuvred over the tip of the inflow glass cannula using fine 
forceps and tied on securely with single strands of fine nylon suture. A flow was applied 
briefly to the vessel to clear the lumen of any blood before the vessel was tied onto the 
outflow cannula. One of the cannulae was attached to a micrometer that allowed 
manipulation of the length of the vessel segment. The chamber was placed onto the 
microscope (Axiover 40 CFL), which was connected to a CCD camera (DMX41 AU02, 
Imaging Source Europe, Bremen, Germany), to allow monitoring of vessel diameter (Fig. 
2.13). Data were recorded through a Pico-log (AD Instruments, UK) and PC computer, 
using Data Logger software (AD Instruments, UK). The tissue was perfused with Krebs 
solution, gassed with 95% air: 5% CO2 and maintained at a temperature of 37 ˚C. When 
the vessel was securely tied at both ends flow was passed through the system, with the 
tap at the outflow end open to allow the escape of fluid. The tap at the outflow end was 
then closed to allow pressure to be applied to the system. Pressure was started at 10 
mmHg and was stepped up in 10 mmHg intervals over a period of 20 minutes to 60 
mmHg. To avoid buckling with increased pressure, the vessel length was adjusted using 
the micromanipulators if necessary without any additional stretching. The constant 
pressure in the system confirmed the absence of arterial leakage; any arteries exhibiting 
leakage were discarded. Each artery was equilibrated at 60 mmHg, which approximates 
the mean arterial BP of mouse in vivo, for at least 45 minutes. After this equilibration 
period the vessel was ready for use in the protocol.  
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2.4.2.2 Pressure myography protocol  
Following the mounting procedure, the cannulated artery dimensions (outer diameter) 
were continuously monitored by a video dimension analyser. Furthermore, the chamber 
was perfused with 37°C Krebs solution gassed with 5% CO2 in O2. Viability testing of the 
artery segments included examining the vasoconstrictive and endothelium-dependent 
vasodilatory responses to 1 μM PE, and 10 μM ACh respectively. Each agonist 
concentration was applied extraluminally, while the alterations in the diameter were 
continually recorded. For studies of luminal flow in second-order mesenteric artery, 
vessel segments were mounted on glass cannulae as in a pressure myograph (Model 
110p, Danish Myo Technology A/S, Denmark). The intraluminal pressure of the artery 
was always kept at 60 mmHg. Flow was then generated by increasing the pressure 
difference (∆P) between inflow and outflow without changing the absolute intraluminal 
pressure. The pressure difference comes from the increase of inflow and simultaneous 
decrease of outflow. The outer diameter was monitored using a CCD camera (DMX41 
AU02, Imaging Source Europe, Bremen, Germany) and recorded with MyoView ll 
software. All vessels were equilibrated for at least 30 mins to reach a stable baseline. 
100 µM L-NAME was used to pre-treat tissue before the pressure difference was 
produced. Nicardipine was added to inhibit the activity of VGCCs. These experiments 
were performed together with Dr J Shi (University of Leeds).  
2.4.2.3 Data analysis 
Due to a dark internal lumen of the artery during stimulation, the two lines which measure 
the luminal diameter are unstable and make the measurement difficult to obtain. Thus, 
external artery diameter was measured. For normalisation of external diameter, the 
constriction to incremental increases in luminal pressure difference (∆P) (20, 40, 60, 70, 
80, 90 and 100 mmHg) was expressed as a percentage of the PE response. The data 
are expressed as mean ± SEM (n = the number of animals). Also the data sets of two 
groups are compared by unpaired t-test. All statistical analyses were performed using 
Origin software (Version 9). Statistical significance is indicated by *P<0.05, **P<0.01and 
***P<0.001.   
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Figure 2-11: Standard start protocol was carried out to validate artery segments  
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Figure 2-12: Schematic of the mechanical test system with optional accessories 
Adapted from DMT website www.dmt.dk.  
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Figure 2-13: Artery from a mouse mounted in a pressure myograph 
(a) Pressure myograph chamber showing that the inflow and outflow 3-way valves as 
well as the silicone tube in between the pressure transducer and the mounting pipette. 
(b) Mouse second-order mesenteric vessel mounted on glass tips of pressure myograph, 
pressurised at 60mmHg. Bars show outer diameter and inner diameter (lumen diameter). 
Adapted from DMT website www.dmt.dk.   
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Chapter 3 Vasoactive properties of the Piezo1 channel agonist 
Yoda1 on the mouse thoracic aorta 
3.1 Abstract 
3.1.1 Rationale 
Recently, Piezo1 has been identified as a protein that integrates vascular architecture 
with physiological force. Piezo1 has been found to form a critical, mechanical force 
sensor located to the endothelium which lines the inner walls of blood vessels. Piezo1 
can be activated by Yoda1, a synthetic small-molecule activator of Piezo1. Therefore, it 
is hypothesized that Piezo1 channels are determinants of vascular tone that were 
previously unrecognised and that chemical modulation of Piezo1 might be an important, 
novel approach for treating hypertension.  
3.1.2 Aim 
To investigate whether Piezo1 activation by Yoda1 has vasoactive effects on conduit 
arteries. 
3.1.3 Method 
Thoracic aorta segments of adult male mice were prepared and mounted on a wire 
myograph. Yoda1 effects and the mechanisms of EC-dependent relaxation and role of 
NO were elucidated by removing the endothelium or using L-NAME, a NOS inhibitor. 
Furthermore, the Piezo1 channel blocker Gd3+ and the Yoda1 competitive antagonist 
Dooku1 (and other Yoda1 analogues) were used to test dependency on Piezo1. 
 
78 
 
 
3.1.4 Results 
Yoda1 induced relaxation of mouse thoracic aorta which had been pre-constricted with 
PE. The relaxation induced by Yoda1 was suppressed by removing the ECs or by the 
presence of L-NAME. Gd3+ or Dooku1 (and other Yoda1 analogues) suppressed the 
Yoda1 response. 
3.1.5 Conclusions 
Yoda1 (an activator of Piezo1 channels), relaxed mouse thoracic aorta via an 
endothelium- and NO-dependent mechanism and this effect is potently reversed by 
Dooku1. 
3.2 Introduction 
Piezo1 channels act as mechanical sensors for ECs (Li et al., 2014). They sense shear 
stress, a frictional force generated by blood flow. Piezo1 is important for alignment of 
ECs in response to shear stress (Li et al., 2014). EC Piezo1 is required for embryonic 
development, suggesting a critical role for sensing shear stress in the vascular 
remodelling required for embryonic growth (Li et al., 2014).  While Piezo1 channels open 
in response to mechanical stimulation, such as shear stress or stretching, they can  also 
be activated in the absence of mechanical stimulation by a synthetic small-molecule 
activator called Yoda1 (Syeda et al., 2015). Yoda1 was discovered in a screen of 3.25 
million compounds in 2015. It lacks activity against the closely related Piezo2 channels 
and its effect on erythrocytes, in which Piezo1 is functional, was lost upon disruption of 
the Piezo1 gene (Syeda et al., 2015).  
Conduit arteries such as the aorta provide a useful model for studying NO-dependent 
effects. Vasodilation in these vessels is essentially NO-mediated, in contrast to many 
resistance arteries where the NO contribution to relaxation is less and other mechanisms 
often perform a greater role (Chataigneau et al., 1999). The aorta originates from the 
heart and is the greatest elastic artery in the body and the major trunk of the systemic 
arterial system. The aortic root originates from the left ventricle and terminates at the 
aortic bifurcation at the umbilicus, splitting into left and right iliac arteries. The aortic trunk 
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includes innominate, common carotid and subclavian arteries in the aortic arch of the 
thoracic aorta, and celiac, mesenteric, renal, and common iliac arteries of the abdominal 
aorta, and is classified anatomically into the thoracic aorta (superior to the diaphragm) 
and the abdominal aorta (Mohanta et al., 2016, Dingemans et al., 2000). The mouse 
thoracic aorta is depicted in Fig. 3. 1. 
In this chapter, the role of Piezo1 in the aorta was investigated since it provides a larger 
vessel on which to perform biochemical investigations compared with small arteries and 
the mounting procedure is relatively simple. Additionally, dysfunction of large conduit 
arteries has indications for vascular pathologies like atherosclerosis and coronary artery 
disease in animals and humans ((Deanfield et al., 2005, Felmeden and Lip, 2005, Heitzer 
et al., 2001). In the current study, a four chamber wire-myograph was used to investigate 
whether activation of Piezo1 has any effect on vessel tone in mouse thoracic aorta.  
In this study, the SMCs were constricted in vitro in two ways: firstly, through membrane 
depolarization, and secondly, through receptor activation. For the former, increases in 
cell surface membrane potential to trigger Ca2+ influx via VGCCs leading to constriction, 
while receptor activation stimulates contraction through a complex signalling pathway of 
second messengers. Stimulation of receptors through agonists at the cell surface leads 
to Ca2+ rise, either via release from intracellular stores or by signalling mechanisms that 
raise the Ca2+ sensitivity of the contractile machinery. In addition, the rise in [Ca2+]i can 
also occur through Ca2+ entry from receptor-operated Ca2+ channels on plasma 
membrane, facilitating raised cytosolic Ca2+ levels from the extracellular space (Murtada 
et al., 2012). Ca2+ attaches to the protein CaM leading to stimulation of MLC kinase, 
which phosphorylates the regulatory light chain of myosin. Once myosin has been 
phosphorylated it is able to form cross bridges with actin, which is required for initiation 
of SMC contraction as can be seen in Fig. 3.2 (Murtada et al., 2012, Webb, 2003). 
Therefore, the aim of this chapter was to determine if Yoda1, a Piezo1 activator, has 
vaso-active effects on murine thoracic aorta, to characterise any effects of Yoda1 and to 
investigate the mechanisms involved.  
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Figure 3-1: Picture of mouse thoracic aorta and associated blood vessels.  
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Figure 3-2:  Regulation of the contractile mechanism in smooth muscle cells.  
Smooth muscle activation via receptor agonists or electrical depolarization typically leads 
to a rapid rise in [Ca2+]i due to the influx of extracellular Ca2+ through voltage-gated Ca2+ 
channels and release from the sarcoplasmic reticulum (SR). Agonists bind to specific 
receptors leading to phospholipase C activity through coupling by a G protein. 
Phospholipase C produces potent second messengers such as inositol 1, 4, 5-
trisphosphate (IP3) which binds to specific receptors on the sarcoplasmic reticulum. Ca2+ 
binds to calmodulin and stimulates myosin light chain kinase (MLCK), resulting in myosin 
light chain (MLC) phosphorylation and association with actin. Cross-bridge cycling 
happens, starting contraction.   
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3.3 Results 
3.3.1 Yoda1-induced relaxation in isolated mouse thoracic aorta 
segments 
To ascertain whether or not Piezo1 has a role in the contractility of the aorta, the Piezo1 
activator (Syeda et al., 2015), was applied to segments of mouse thoracic aorta and 
constriction or relaxation of the vessel measured using wire myography. To ensure 
contractile integrity, all segments were first challenged with two consecutive exposures 
to 60 mM K+, resulting in vessel contraction as seen in Fig. 3.3a. Application of Yoda-1 
alone, tested at concentrations ranging from 0.1 to 10 μM, was without effect (Fig. 3.3b). 
In contrast, following pre-constriction of the aorta with PE, 5 μM Yoda-1 did cause a 
change in tension. Comparable to the positive control ACh, it induced relaxation (Fig. 
3.3c). In summary, the data reveal that Yoda-1 is able to alter the contractility of the aorta 
(i.e. cause relaxation) but that the presence of a vasoconstrictor is required to reveal 
these effects. 
3.3.2 Cumulative concentration-response of Yoda1  
To determine if the Yoda-1-induced relaxation in thoracic aorta was concentration-
dependent, cumulative concentration-effect curves were constructed. In these 
experiments, aortic segments were pre-contracted using PE (0.3 µM). After stabilisation 
of PE-induced tone, increasing concentrations of Yoda1 (0.1, 0.3, 1, 3 and 10 µM) were 
added to the segments without washing out after each concentration. Each successive 
concentration of Yoda1 was added after relaxation to the preceding concentration had 
maximised (Fig. 3.4a). The half maximal relaxant effect (EC50) occurred at a Yoda-1 
concentration of about 2.3 μM (Fig. 3.4b), lower than the value of 17.1 μM determined 
for mouse Piezo1 expressed exogenously in human embryonic kidney 293 (HEK293) 
cell line (Syeda et al., 2015). It should be noted that it was not possible to determine the 
concentration of Yoda1 required for maximum effect because of solubility limitations of 
Yoda1 in physiological solution. Therefore the EC50 obtained can only be considered as 
an estimation.  
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Figure 3-3: Yoda1-induced relaxation in mouse thoracic aorta segments. 
Typical tracing obtained from mouse thoracic aorta showing (a) Vasoconstriction in 
response to high potassium (60 mM K+) solution, which validated arterial viability (the 
control) prior to experimentation. (b) The application of Yoda1 at increasing 
concentrations as indicated by the dots (0.1, 0.3, 1, 3 and 10 μM) without the addition of 
phenylephrine (PE). (c) Responses to Yoda1 (5 μM) compared with control acetylcholine 
(ACh) (1 μM) following PE addition.  
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Figure 3-4: Cumulative concentration response curves of Yoda1 in mouse thoracic 
aorta.  
(a) Typical wire myography tracing showing a concentration-dependent relaxation 
response to Yoda1 as indicated by the dots (0.1, 0.3, 1, 3 and 10 μM) after pre-
constriction with 0.3 μM phenylephrine (PE). (b) Concentration response curve indicating 
the 50 % effective concentration (EC50) (n = 5). Curve was fitted using the Hill1 equation. 
Data are shown as mean ± SEM.  
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3.3.3 EC involvement 
To ascertain if the Yoda-1-induced relaxation was dependent upon EC, the endothelium 
was removed from the aortic segments by gently rubbing the intimal surface with a 
tungsten wire. Care was taken not to over-stretch the rings during rubbing in order to 
avoid damaging their muscular layer. Endothelial denudation was considered successful 
if the endothelium-dependent vasodilator ACh (1 μM) failed to produce relaxation (less 
than 10%) (Fig. 3.5a).   
Similar to ACh, removal of the endothelium resulted in total loss of Yoda1-induced 
relaxation following pre-constriction with 0.3 μM PE (Fig. 3.5a and b). These results 
indicate that the vasorelaxation to Yoda1 was EC-dependent. The contractile response 
to PE in thoracic aorta following mechanical removal of the endothelium was analysed 
to investigate the role of basal NO on contraction. No change was observed in PE 
responses before and after removing the EC (Fig. 3.5c). 
3.3.4 Effects of nitric oxide synthase inhibitor (L-NAME) on Yoda1-
induced relaxation 
ACh-induced relaxation in the aorta is dependent upon NO (Chataigneau et al., 1999). 
This gaseous molecule is synthesised in ECs by NOS, then NO induces vasorelaxation 
in VSMCs through inducing activation of the enzyme sGC, resulting in formation of the 
second messenger cGMP (Rapoport and Murad, 1983). To determine if Yoda-1 induced 
relaxation is also dependent on NO signalling, aortic segments were pre-incubated for 
20 minutes with 100 μM L-NAME, an inhibitor of NOS. The treated tissues were pre-
contracted with 0.3 µM PE and after stabilisation of the tone, a single dose of 5 µM Yoda1 
or 1 µM ACh was applied. The relaxation response was abolished as showed in Fig. 
3.6a, and as quantified in Fig. 3.6b.   
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Figure 3-5: Effects of Yoda1-induced relaxation mediated by endothelial cells in 
mouse thoracic aorta segments.  
(a) Typical tracing obtained from mouse thoracic aorta responses to Yoda1 (5 μM) 
compared with control acetylcholine (ACh) (1 μM) after endothelial cells (ECs) were 
removed. (b)  Quantification of the degree of relaxation elicited by Yoda1 before and 
after removing the EC (-EC) compared with the control. (c) Quantification of the degree 
of phenylephrine (PE) induced tone before and after removing the EC (n = 5). Data are 
shown as mean ± SEM. NS=not significant.  
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Figure 3-6: Yoda1-induced relaxation mediated by nitric oxide (NO) in mouse 
thoracic aorta segments. 
(a) Typical tracing obtained from mouse thoracic aorta showing responses to Yoda1 (5 
μM) compared with control acetylcholine (ACh) (1 μM) after pre-incubation with 100 µM 
of Nω-nitro-L-arginine methyl ester (L-NAME) with intact ECs. Typical trace also showing 
the responses to Yoda1 (5 μM) before and after the incubation with (100 μM) L-NAME 
in endothelium-intact thoracic aorta isolated from control mice. (b) Quantification of the 
degree of relaxation elicited by Yoda1 or ACh before and after L-NAME treatment. (c) 
Quantification of the degree of phenylephrine (PE) induced tone before and after pre-
incubation with 100 µM L-NAME with intact ECs. (d) Quantification of the L-NAME effects 
on the basal artery tension.  (n = 5). Data are shown as mean ± SEM. NS=not significant.  
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Basal activity of NO generated by the vascular endothelium exerts a tonic vasodilator 
effect that suppresses the actions of vasoconstrictor drugs (Moore et al., 1990, Mian and 
Martin, 1995). Thus, agents that reduce the synthesis or actions of NO produce an 
enhancement of vasoconstrictor-induced tone by removing this endothelium-dependent 
suppression of vasoconstriction. This can be seen by L-NAME’s enhancement of the 
vasoconstriction effect of PE (Fig. 3.6c). L-NAME, however, did not significantly increase 
the basal tone of the aortic segments (Fig. 3.6d). 
3.3.5 Inhibitors of Piezo1 involvement 
Gd3+, an inhibitor of mechanosensitive channels (Ermakov et al., 2010), has been shown 
to potently block Piezo1 channels (Coste, et al 2010). Gd3+ was therefore used to 
examine if Piezo1 is involved in the Yoda1-evoked relaxation of thoracic aorta. This 
nonspecific inhibitor of Piezo1 suppressed the Yoda1 evoked relaxation by 85% (Fig. 
3.7a-c). In contrast, no differences were observed in the resting tone (Fig. 3.7d) or the 
PE-induced vascular tone of mouse thoracic aorta when Gd3+ was used (Fig. 3.7e). The 
data support the contribution of Piezo1 to the Yoda1-induced relaxation. 
3.3.6 Yoda1 inhibition with Dooku1 
Dooku1 is a structural analogue of Yoda-1. It is unable to activate Piezo1 but acts as a 
competitive antagonist of Yoda-1 at this channel. Pre-treatment of thoracic aortic 
segments with Dooku1 completely blocked the Yoda1 evoked relaxation (Fig. 3.8a-c). 
Due to the structural similarity of Dooku1 and Yoda1, Dooku1 likely attaches to the 
Yoda1-binding site on the Piezo1 channel. No differences were observed in the resting 
tone of thoracic aorta when Dooku1 was used (Fig. 3.8d). However, a significant 
reduction (28%) in the level of tone induced by PE was observed (Fig. 3.8e), suggesting 
that Dooku1 has impact on the PE signalling mechanism. 
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Figure 3-7: Effect of gadolinium (Gd3+) on Yoda1-induced relaxation in mouse 
thoracic aorta segments.  
Typical tracing obtained from mouse thoracic aorta (a‒b) showing the Yoda1 (5 μM) 
response before and after pre-incubation for 20 min with gadolinium (Gd3+) (10 μM). The 
aorta was endothelium-intact. (c) Quantification of the degree of relaxation elicited by 
Yoda1 after Gd3+ treatment, compared with the control. (d) Quantification of the Gd3+ 
effects on the basal artery tension. (e) Quantification of the degree of phenylephrine (PE) 
induced tone before and after pre-incubation with 10 μM Gd3+ with intact ECs. (n = 7). 
Data are shown as mean ± SEM. NS=not significant.  
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Figure 3-8: Effect of Dooku1, a Yoda1 analogue, on Yoda1-induced relaxation in 
mouse thoracic aorta segments.  
Typical tracing obtained from mouse thoracic aorta (a) showing the Yoda1 (5 μM) 
response before and after pre-incubation for 30 min with Dooku1 (10 μM) in endothelium-
intact aorta. (b) Quantification of the degree of relaxation elicited by Yoda1 after Dooku1 
treatment, compared with the control. (c) Quantification of the Dooku1 effects on the 
basal artery tension. (d) Quantification of the degree of phenylephrine (PE) induced tone 
before and after pre-incubation with 10 μM Dooku1 with intact ECs (n = 7). Data are 
shown as mean ± SEM . NS=not significant.  
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3.3.7 Yoda1 inhibition by other Yoda1 analogues  
7b, 2g, 11 and 2e are other Yoda1 analogues synthesised at the University of Leeds, 
which have also been tested for inhibition of Yoda1-induced Piezo1 activity and have 
variable effects in vitro on Ca2+ entry (experiments performed by Elizabeth Evans, 
University of Leeds) (Evans et al., 2018). To investigate whether their ability to inhibit 
Yoda-1 induced Piezo1 activity in vitro correlated with their ability to prevent Yoda-1-
evoked relaxation of mouse thoracic aorta, the relaxation to Yoda1 was measured in the 
aortas following pre-treatment with the analogues. Pre-treatment of thoracic aortic 
segments with 7b, 2g and 11 showed variable inhibition of the Yoda1-evoked relaxation, 
but this was not observed with 2e (Figs. 3.9a-b, 3.10a-b, 3.11a-b and 3.12a-b). This 
result correlated well with the in vitro intracellular calcium measurements. No difference 
was observed in the resting tone (Fig. 3.9c, 3.10c, 3.11c and 3.12c) or the PE-induced 
vascular tone of mouse thoracic aorta when these inhibitors were used (Figs. 3.9d, 
3.10d, 3.11d and 3.12d). The data suggest that other Yoda1 analogues, like Dooku1, are 
able to inhibit Yoda1-induced relaxation on mouse thoracic aorta. 
3.3.8 Specificity of Dooku1 
Since Dooku1 had an inhibitory effect on the PE-induced contraction of mouse thoracic 
aorta it was tested for inhibitory activity against another vasoconstrictor which acts 
through a different mechanism. U46619, a thromboxane A2 agonist, contracts VSMCs 
via binding to specific GPCRs (thromboxane receptors) that elevate cytosolic free Ca2+ 
([Ca2+]i) via releasing stored Ca2+ from the SR leading to contraction (Fig. 3.13) 
(McKenzie et al., 2009). Similar to PE, U46619-induced constriction were slightly 
suppressed in the presence of Dooku1 (Fig. 3.14a and c). Dooku1 was also tested for 
an inhibitory effect on other vasodilators, ACh and SIN-1 were applied after pre-
construction with U46619. Incubation with Dooku1 had no effect on ACh or SIN-1-
induced relaxation as quantified in Fig. 14d and e. There was no statistical significance 
between control relaxation and relaxation in the presence of Dooku1. The data indicate 
that Dooku1 may have small off target effects against contractile agents through an 
unknown mechanism, however, it does not seem to block relaxation from other agents.  
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Figure 3-9: Effect of 7b, a Yoda1 analogue, on Yoda1-induced relaxation in mouse 
thoracic aorta segments.  
Typical tracing obtained from mouse thoracic aorta (a) showing Yoda1 (5 μM) response 
before and after pre-incubation for 30 min with 7b (10 μM) in endothelium-intact aorta. 
(b) Quantification of the degree of relaxation elicited by Yoda1 after 7b treatment, 
compared with the control. (c) Quantification of the 7b effects on the basal artery tension. 
(d) Quantification of the degree of phenylephrine (PE) induced tone before and after pre-
incubation with 10 μM 7b with intact ECs (n = 5). Data are shown as mean ± SEM. 
NS=not significant.  
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Figure 3-10: Effect of 2g, a Yoda1 analogue, on Yoda1-induced relaxation in mouse 
thoracic aorta segments. 
Typical tracing obtained from mouse thoracic aorta (a) showing Yoda1 (5 μM) response 
before and after pre-incubation for 30 min with 2g (10 μM) in endothelium-intact aorta. 
(b) Quantification of the degree of relaxation elicited by Yoda1 after 2g treatment, 
compared with the control. (c) Quantification of the 2g effects on the basal artery tension. 
(d) Quantification of the degree of phenylephrine (PE) induced tone before and after pre-
incubation with 10 μM 2g with intact ECs (n = 5). Data are shown as mean ± SEM. 
NS=not significant.  
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Figure 3-11: Effect of 11, a Yoda1 analogue, on Yoda1-induced relaxation in mouse 
thoracic aorta segments.  
Typical tracing obtained from mouse thoracic aorta (a) showing the Yoda1 (5 μM) 
response before and after pre-incubation for 30 min with 11 (10 μM) in endothelium-
intact aorta. (b) Quantification of the degree of relaxation elicited by Yoda1 after 11 
treatments, compared with the control. (c) Quantification of the 11 effects on the basal 
artery tension. (d) Quantification of the degree of phenylephrine (PE) induced tone before 
and after pre-incubation with 10 μM 11 with intact ECs (n = 5). Data are shown as mean 
± SEM. NS=not significant.  
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Figure 3-12: Effect of 2e, a Yoda1 analogue, on Yoda1-induced relaxation in mouse 
thoracic aorta segments. 
Typical tracing obtained from mouse thoracic aorta (a) showing the Yoda1 (5 μM) 
response before and after pre-incubation for 30 min with 2e (10 μM) in endothelium-
intact aorta. (b) Quantification of the degree of relaxation elicited by Yoda1 after 2e 
treatment, compared with the control. (c) Quantification of the 2e effects on the basal 
artery tension. (d) Quantification of the degree of phenylephrine (PE) induced tone before 
and after pre-incubation with 10 μM 2e with intact ECs (n = 5). Data are shown as mean 
± SEM. NS=not significant.  
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Figure 3-13: Mechanisms involved in the thromboxane mimetic U46619-induced 
contraction. 
The diagram illustrates the common signalling mechanisms of U46619 to mediate 
contraction. Thromboxane receptor (TP). Gq protein-coupled receptors (GqPCRs). PIP2, 
phosphatidylinositol bisphosphate. IP3, inositol trisphosphate.  
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Figure 3-14: Dooku1 has minimal effect on thromboxane A2 mediated contraction 
and does not affect other vasodilators 
(a) Isometric tension recording of aorta pre-constricted with 0.1 μM U46619, a 
thromboxane A2 agonist and exposed to 10 μM Dooku1 followed by the addition of 1 μM 
acetylcholine (ACh) and then 10 μM NO-donator, Linsidomine (SIN-1). (b) As for (a) 
except exposed to dimethyl sulfoxide, (DMSO) at concentration of 100%  (c-e) Summary 
data for experiments of the type shown in (a,b) expressed as % of the maximum inhibition 
of U46619 amplitude by Dooku1 (c), relaxation evoked by ACh  (d) or SIN-1 (e) (n=5). 
Data are shown as mean ± SEM. NS=not significant.  
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3.3.9 Yoda1 does not induce relaxation in control and endothelial 
Piezo1∆EC thoracic aorta 
To further investigate the role of Piezo1 in Yoda1 responses of thoracic aortae, 
myography experiments were performed on vessels from mice with endothelial-specific 
deletion of Piezo1 (Piezo1∆EC). Control mice and Piezo1∆EC mice were injected with TAM. 
Mice appeared phenotypically normal and the body weight was normal. There were no 
changes in body weight (gain) and organ weights and serum urea, K+ and Na+; gross 
anatomies and functions of the heart and aorta were also normal (Fig 3.15a–m) (all this 
work was performed by Dr B Rode and Dr M Bailey). Therefore endothelial Piezo1 in the 
adult is without major phenotype. 
As for the previous experiments, traces showing the response to K+, PE, ACh and Yoda1 
before and after incubation with L-NAME were obtained from control and Piezo1∆EC 
thoracic aortae (Fig. 3.16a and b, respectively). In these experiments, addition of high 
K+ (60 mM) induced similar contractions in intact thoracic aorta from control and 
Piezo1∆EC littermates (Fig. 3.17a). Following this, PE was added in increasing 
concentrations (0.01, 0.03, 0.1, 0.3 and 1 μM) to the segments in the wire myograph. 
The magnitude of the PE-induced arterial contractions was similar in intact thoracic aorta 
from control and Piezo1∆EC animals (Fig. 3.17b). Segments of endothelium-intact aorta 
were pre-contracted with 0.3 μM PE. After tone stabilisation, a cumulative concentration-
response curve to ACh (0.01, 0.03, 0.1, 0.3 and 1 μM) was conducted. Both groups of 
control and Piezo1∆EC mice also exhibited similar endothelium-dependent relaxation to 
ACh (Fig. 3.17c). The data suggest that there was no decrease in the viability of tissue 
preparations from these mice.  
Next, a cumulative concentration-response curve to Yoda1 (0.1, 0.3, 1, 3 and 10 μM) 
was constructed. Unexpectedly, vessels from control and Piezo1∆EC mice showed no 
relaxation responses to Yoda1 and actually showed contractile responses (Fig. 3.18a). 
Furthermore, a cumulative concentration-response curve to Yoda1 was obtained before 
and after treatment with L-NAME (100 μM, 20 mins). L-NAME did not significantly inhibit 
the contractile response to Yoda1 in control and Piezo1∆EC aorta (Fig. 3.18b and c, 
respectively). 
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The differences between the ‘control mice’ used here and the ‘wildtype mice’ used earlier 
in this chapter were i) the genotype (Piezo1flox/flox) and ii) being injected with TAM. 
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Figure 3-15: Mice with disruption of the endothelial Piezo1 appeared 
phenotypically normal.  
(a) Physical appearance of control and endothelial Piezo1-deleted (Piezo1∆EC) mice. (b) 
Body weight and percentage change in body weight of control (n=13) and Piezo1∆EC 
(n=14) mice before and 10-14 days after tamoxifen (TAM) treatment. (c) As percentages 
of total body weight, weights of heart, lung, kidney and liver in control (n=13) and 
Piezo1∆EC (n=14) mice. (d) Histological examples of control (top row) and Piezo1∆EC 
(bottom row) sections of aorta, heart, lung, kidney and liver stained with H&E. Scale bars 
100 μm. (e–g) Serum concentrations of urea, K+ and Na+ in control (n = 7) and Piezo1ΔEC 
(n = 7) mice. (h–m) Ultrasound study of the heart (h–j) and aorta (k–m) of control (n = 5) 
and Piezo1ΔEC (n = 5) mice under anaesthesia. (h) Example of left ventricle images of 
control and Piezo1ΔEC at diastole and systole. The left ventricle chamber is circled with a 
white dashed line. Scale bar 1 mm. (i, j) Cardiac parameters measured by ultrasound. 
(k) Example of aorta images of control and Piezo1ΔEC at diastole and systole. The left 
ventricle chamber is circled with a white dashed line. Scale bar 1 mm. (l) Aorta 
anteroposterior diameter at systole. (m) Aortic distensibility. Independent data points are 
displayed with superimposed bars indicating mean ± SEM. Data sets are compared by 
t-test. No significant differences were detected. Experiments were performed by Dr B 
Rode and Dr M Bailey. The figure is from Rode et al, 2017 Nat Comm.  
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Figure 3-16: Typical responses of control and Piezo1∆EC thoracic aorta 
(a) Typical trace showing vasoconstriction in response to high potassium solution that 
shows increased tone in response to phenylephrine (PE) as indicated by the dots (0.01, 
0.03, 0.1, 0.3 and 1 μM), a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM) and concentration-
response curves (contractions) to Yoda1 as indicated by the dots (0.1, 0.3, 1, 3 and 10 
μM) before and after incubation with (100 μM) Nω-nitro-L-arginine methyl ester 
hydrochloride (L-NAME) in endothelium-intact thoracic aorta isolated from control mice. 
(b) As for (a) except in endothelium-intact thoracic aorta isolated from Piezo1∆EC mice.  
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Figure 3-17: Vascular viability in control compared with Piezo1∆EC thoracic aorta 
(a) Comparison of response to high potassium (60 mM K+), (b) concentration response 
curves to phenylephrine (PE) (0.01, 0.03, 0.1, 0.3 and 1 μM), (c) concentration response 
curves to ACh (0.01, 0.03, 0.1, 0.3 and 1 μM) in thoracic aorta of control (n=7) and 
Piezo1∆EC mice (n=5). For high potassium, responses are expressed by the absolute 
value of the K+-induced contraction. For PE and ACh, responses are expressed as 
percent constriction of K+-induced contraction and as percent relaxation of PE-induced 
contraction, respectively. Mean ± SEM values are depicted. NS=not significant.  
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Figure 3-18: Yoda1 responses in control and Piezo1∆EC thoracic aorta  
(a) Concentration-response curves for Yoda1-induced contraction (0.1, 0.3, 1, 3 and 10 
μM) in control (n=7) and Piezo1∆EC (n=5) mice. (b) Concentration-response curves for 
Yoda1-induced contraction before (n=3) and after (n=3) L-NAME treatment in control 
mice. (c) Concentration-response curves for Yoda1-induced contractions before (n=3) 
and after (n=3) L-NAME treatment in Piezo1∆EC mice. Responses are expressed as 
percentages of the contraction in response to PE. Mean ± SEM values are depicted. 
NS=not significant.  
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3.4 Discussion 
The main finding presented in this chapter is that Yoda1 can induce relaxation in isolated 
mouse thoracic aorta pre-constricted by PE. Yoda1 relaxed mouse thoracic aorta via an 
endothelium and NO-dependent mechanism. Furthermore, Dooku1 was a very strong 
inhibitor of this Yoda1 response. 
3.4.1 The Yoda-1 effect depends on endothelial cells 
ECs play a critical role in regulating cardiovascular system function and in mediating 
vasorelaxation by releasing several vasodilating factors, including PGI2, NO, and EDHF 
(Sandoo et al., 2010).  
The data show that Yoda1 is unable to induce relaxation in vessels which were not PE 
pre-constricted (Fig. 3.3b), suggesting that Piezo1 may have a role in vasodilation and 
relaxation only after contraction has been induced by a vasoconstrictor agonist. In mouse 
thoracic aortae pharmacologically pre-contracted with PE, Yoda1 induced relaxation 
(Fig. 3.3c). Interestingly, this ability of Yoda1 to relax mouse thoracic aortae was EC 
dependent as no effect of Yoda1 was observed when the ECs were removed (Fig. 3.5a). 
These findings are consistent with previous reports (e.g. (Furchgott and Zawadzki, 1980) 
that the endothelial lining of blood vessels plays a vital role in facilitating vasodilator 
responses to relaxant agents such as ACh and substance P, due to the production of an 
endothelium-derived relaxing factor, later shown to be nitric oxide (Palmer et al., 1987). 
3.4.2 Yoda-1 depends on NO generation by NOS 
L-NAME almost completely blocks the Yoda-1 effect (Fig. 3.6a) suggesting that Yoda1 
depends upon NO for its downstream effects. This is consistent with a study from Wang 
et al, (2016), which found activation of Piezo1 could lead to eNOS activation. They also 
found that Yoda1 caused relaxation of mouse mesenteric artery in a Piezo1-dependent 
manner  as mice with specific deletion of endothelial-Piezo1 lost the ability to produce 
NO and relax in response to flow (Wang et al., 2016). Furthermore, Li et al observed that 
VEGF stimulated eNOS phosphorylation was reduced in aorta from whole body Piezo1 
knockout (heterozygous) mice (Li et al., 2014).  
105 
 
 
No change was observed in the PE responses before and after removing the EC (Fig. 
3.5c). These results were unexpected as findings from historical study show that removal 
of the endothelium from rat aortic rings results in an increase in contraction induced by 
vasoconstricting agents (Martin et al., 1986). Furthermore, L-NAME had no effect on the 
resting tension of the thoracic aortae (Fig. 3.6d) suggesting only a small basal release of 
NO in these arteries, which is in agreement with previous studies (Dora et al., 2000, 
Inoue et al., 2000). As expected, agents which inhibit NO synthesis produce an 
enhancement of vasoconstrictor-induced tone by removing this endothelium-dependent 
suppression of vasoconstriction (Mian and Martin, 1995, Moore et al., 1990). This was 
observed in the present study, as treatment of endothelial intact thoracic aortae 
segments with the NO synthase inhibitor, L-NAME, resulted in an increase of PE-induced 
tone (Fig. 3.5c). 
There are only a small number of non-specific blockers available for Piezo1, including 
RR and Gd3+ which irreversibly block Piezo1 (Li et al., 2014). Gd3+ is widely used as a 
blocker of mechanosensitive channels and was thus used in this chapter. The effect of 
Yoda1 was largely prevented by pre-incubating the aortae with Gd3+ (Fig. 3.7a and b) 
and also by the Yoda1 competitive antagonist Dooku1 (Fig. 3.8a and b) that was found 
through a screen of Yoda1 analogues synthesised in the School of Chemistry at the 
University of Leeds in an attempt to find better pharmacological tools for Piezo1 study. 
The data suggest a specific effect of Dooku1 for Piezo1 channels. The inhibitory effect 
of Dooku1 against PE and U46619-induced contraction might be related to an unknown 
mechanism of Piezo1, either on EC or SMCs, or an unknown Piezo1 independent effect. 
Piezo1 function is not needed for normal myogenic tone, arguing against Retailleau et 
al, study ((Retailleau et al., 2015).  
Together, the data suggest that the activation of Piezo1 by Yoda1 leads to NO formation 
and to relaxation of vascular tone. As shown in a previous study from our group,, Piezo1 
is critical for endothelial cell alignment in response to shear stress and eNOS 
phosphorylation in the presence of VEGF (Li et al., 2014). Therefore, endothelial Piezo1 
is needed for flow-induced formation of NO via eNOS and flow-induced relaxation. These 
results are novel and add significantly to our understanding of Yoda1-mediated 
vasomotor function by being the first to investigate the endothelium-dependent functional 
responses to Yoda1 and the underlying mechanisms, in thoracic aortae of mice. Dooku1, 
effectively and specifically inhibited Yoda1-induced Piezo1 channel activity. 
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3.4.3  Piezo1 EC knockout mice  
The constrictive effect of Yoda1 was seen in both TAM-treated control and Piezo1∆EC 
mice, but was not observed in wild-type mice not treated with TAM. However, all mice 
exhibited normal responses to both PE and ACh. There is no clear explanation to 
reconcile the discrepancy between the Yoda1 response in wild-type aortae and vessels 
from control and Piezo1∆EC treated with TAM. Finding that Yoda1 could induce 
contraction was surprising and how one mechanism induced by Yoda1 treatment can be 
dominant in the Piezo1flox mice, whereas another mechanism can be dominant in the 
wild-type mice is unclear. The differences could be related to the genotype or to the 
exposure of the mice to TAM. It would seem unlikely that introduction of loxP sites within 
intronic regions of the Piezo1 gene would account for the altered phenotype, however, 
different genetic backgrounds between the wild-type mice and Piezo1flox mice may 
cause, for example, release of an unknown factor(s)/ mechanisms that might mediate 
the contractile effect of Yoda1. 
Importantly, both Cre+ and Cre- mice showed the same phenotype, suggesting that the 
contraction responses were potentially induced by genotype or TAM injection and could 
cause developmental effects or compensatory mechanisms contributing to the 
phenotype of Yoda1-induced contraction, and resulting in failure of Yoda1 to induce 
relaxation. Alternatively, different genetic strains of mice also may have an impact on the 
thoracic aorta’s response to Yoda1. In this study, mice had a different genetic 
background, thus there is a possibility that different genetic strains of mice respond 
differently to Yoda1. Furthermore, the expression of molecules mediating cross-talk 
between Piezo1 activation and NO production may be different between the strains of 
mice.  More research will be necessary to reconcile the disparity in these findings and to 
elucidate the consequences of different Yoda1 responses. It would also be useful to 
determine if this effect is the same in other vascular preparations. 
3.5 Conclusion 
These results demonstrate that Yoda1, a Piezo1 activator, causes vasodilation via an 
endothelium-dependent mechanism, mediated by NO in thoracic aortae of wild-type 
mice which is likely to be Piezo1 dependent. Furthermore, the Yoda1-induced relaxation 
was inhibited by Dooku1 and other Yoda1 analogues (3. 43). These data suggest that 
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Piezo1 may be a useful target for improving vasorelaxation in conduit arteries. Activation 
of Piezo1 by Yoda1 in the vasculature may be a potential strategy for improving the 
vascular dysfunction that exists in cardiovascular disease states, such as hypertension, 
or other disease states exhibiting vasomotor dysfunction due to impaired NO-dependent 
relaxation.  
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Schematic representation of the mechanism of Yoda1-induced relaxation 
proposed in this chapter 
 
 
Figure 3-19: Mechanism of the relaxation effect by Yoda1 
Dooku1 
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Chapter 4 Role of endothelial Piezo1 in second-order 
mesenteric arteries of mice 
4.1 Abstract 
4.1.1 Background 
Resistance arteries, such as mesenteric arteries, provide more than 80% of the 
resistance to blood flow in the body. Consequently their responses are thought to play 
an important role in regulation of BP and blood flow. Additionally, many antihypertensive 
drugs work by reducing peripheral resistance. This study investigates the functional role 
of Piezo1 channels in modulating blood vessel contractility and relaxation, which sheds 
light on understanding the function of Piezo1 from a physiological perspective in these 
arteries.  
4.1.2 Methods 
 Isolated mouse mesenteric arteries were studied using a wire myograph. Endothelial 
deletion of Piezo1 (Piezo1∆EC) in adult mice was achieved using a tamoxifen inducible 
Cre/Lox system. 
4.1.3 Results 
Second-order mesenteric arteries from wild-type and Piezo1∆EC mice responded similarly 
to PE and ACh. Moreover, the inhibition of ACh responses by apamin plus charybdotoxin 
was strong in arteries from Piezo1∆EC mice. Yoda1 caused relaxation in mouse 
mesenteric arteries from control and Piezo1∆EC mice, was endothelial independent. 
Furthermore, NO but not the EDHF was involved in Yoda1-induced relaxation. Although 
Piezo1 blockers inhibited Yoda1-induced relaxation, this relaxation effect of Yoda1 was 
not affected by removing the ECs. 
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4.1.4 Conclusion  
Endothelial Piezo1 promotes resistance to the ACh-induced relaxation mediated by 
EDHF. However, activation of the Piezo1 channel by Yoda1 leads to relaxation. Although 
NO played a role, the relaxation was largely independent of the endothelium. 
4.2 Introduction 
Isolated ECs have been studied but a role for Piezo1 has yet to be studied in the context 
of an intact vessel. Functional experiments to assess the vessel’s responsiveness to 
several agonists were administered using a four chamber wire myograph (Danish 
Myotechnology, Aarhus, Denmark). Wire myography (described in more detail in chapter 
2) is a technique which was introduced to study vascular function in-vitro (Mulvany & 
Halpern, 1977). It represented an improvement on the study of vessels in organ baths 
because the mounting procedure is not compatible with small resistance vessels thus 
the technique is limited to the study of only larger vessels.  Wire myography allowed the 
functional responsiveness of small resistance vessels in-vitro to be measured assessing 
the interaction of ECs with SMCs. Mesenteric arteries were chosen because they 
contribute substantially to the regulation of BP. Mechanisms attributed to local blood flow 
control vary depending on tissue type and can be modulated in vivo by central control 
mechanisms. This is often linked to the cell types involved and the tissue innervation. BP 
can be altered by changing the total peripheral resistance of the vascular system; where 
increasing the resistance increases the pressure of the system. Therefore, the vascular 
tone experienced in large vascular beds, such as mesenteric beds, can easily influence 
systemic BP.  
The mesenteric organs comprise about 5% of body mass, but receive about 30% of 
blood flow distributed from cardiac output. The mesenteric arteries are composed of 
“arcades” or branching arteries from the main mesenteric artery. Primary branches are 
the first branches off of the mesenteric artery. Secondary branches branch off from the 
primary, and so on, with quaternary branches wrapping around the intestine itself to 
supply the intestinal tissues directly. Mesenteric arteries with diameters ~100-300 µm in 
diameter display what is known as a myogenic response which has been well described 
by many researchers (Bayliss, 1902, Christensen and Mulvany, 2001, Mulvany and 
Aalkjaer, 1990, Mulvany, 1994, Khavandi et al., 2008). The myogenic response causes 
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a vessel to constrict in response to an increase in BP. The myogenic response is thought 
to be a mechanosensor because it senses wall tension, which will induce the constriction 
of the vessel (Johnson, 1991, VanBavel and Mulvany, 1994). This response, in what are 
known as small muscular arteries and resistance arterioles, is thought to play an 
important role in regulation of BP and blood flow (Christensen and Mulvany, 2001). 
This study aimed to elucidate the role of Piezo1 channels in modulating blood vessel 
contractility and relaxation. Vascular responses to vasocontracting and vasorelaxing 
factors and Yoda1 were studied in mice with or without endothelial-specific deletion of 
Piezo1. The dependence of vasorelaxation on NO and EDHF was also investigated. 
4.3 Results 
The role of Piezo1 in ACh- and Yoda1-induced relaxation was studied by wire myograph 
on isolated mesenteric arteries of Piezo1∆EC mice and control mice. 
4.3.1 Deletion of endothelial cell Piezo1 affects high potassium-
induced contraction 
To establish artery viability, high K+ is usually used to examine the contractile function of 
the vessel segments. This disrupts the K+ concentration gradient across the cell 
membrane resulting in depolarisation of SMCs, which consequently leads to Ca2+ influx 
through LTCCs, inducing VSMCs contraction.  
Mesenteric arteries from control and Piezo1∆EC mice displayed typical K+-induced 
contraction (Fig. 4.1a and b, respectively). The magnitude of the K+-induced contraction 
was significantly decreased in mesenteric arteries of Piezo1∆EC mice by 40% (Fig. 4.1c). 
These data suggest that in ECs, Piezo1 deletion may reduce K+-induced contraction via 
an unknown mechanism. 
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4.3.2 Deletion of endothelial cell Piezo1 does not affect 
phenylephrine-induced contraction 
PE is a vasoconstrictor that closely mimics the effects of the endogenous hormones 
epinephrine and NE. It is an α1‐adrenergic receptor agonist. α1 receptors are members 
of the GPCRs family and are coupled to Gq, thus their activation results in a rise in [Ca2+]i. 
The overall effect is vasoconstriction (a detailed description of the PE mechanisms are 
provided in Fig. 4.2) (Prewitt et al., 2002, Billington and Penn, 2003). Mesenteric arteries 
from control and Piezo1∆EC mice displayed typical PE-induced contraction (Fig. 4.3a and 
b). PE-induced contraction in control and Piezo1∆EC mice had similar responses (Fig. 
4.3c) (control mice EC50 value: 0.16±0.01 μM, n=10, Piezo1∆EC mice EC50 value: 
0.18±0.07 μM n=10). Fig. 4.3d shows the AUC of the response to PE for each individual 
curve. These data suggest that endothelial cell Piezo1 has no role in PE-induced 
contraction.  
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Figure 4-1: Vascular reactivity to high potassium (60 mM K+) in control compared 
with endothelial Piezo1∆EC mesenteric arteries  
(a) Typical wire myograph trace, demonstrating vasoconstriction in response to high 
potassium solution that validates arterial viability prior to experimentation, in mesenteric 
arteries isolated from control mice. (b) As for (a) except in mesenteric arteries isolated 
from Piezo1∆EC mice. (c) Comparison of response to high potassium (K+)-induced 
contraction in mesenteric arteries of control (n=25) and Piezo1∆EC mice (n=25). 
Responses are expressed by the absolute value of the K+-induced contraction. Mean ± 
SEM values are depicted. Asterisks indicate statistically significant difference (***; 
p<0.001).  
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Figure 4-2: Mechanisms of contraction in a vascular smooth muscle cell 
Phenylephrine (PE) can increase contraction by activating α1 adrenoceptors which are 
coupled to stimulate Gq. The resulting activation of PLC leads to the formation of inositol 
triphosphate (IP3) from PIP2. IP3 activates IP3 receptors on the sarcoplasmic reticulum 
(SR) to cause Ca2+ to be released from the SR, an intracellular Ca2+ store, thus leading 
to Ca2+-calmodulin-dependent stimulation of myosin light-chain kinase (MLCK) and 
subsequent phosphorylation of the myosin regulatory light chain and enhance of actin-
myosin interaction (contraction). This mechanism causes contraction.  
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Figure 4-3: Vascular reactivity to phenylephrine in control compared with 
endothelial Piezo1∆EC mesenteric arteries  
(a) Typical wire myograph tracing, demonstrating increased tone in response to 
phenylephrine (PE) as indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM) in mesenteric 
arteries isolated from control mice. (b) As for (a) except in mesenteric arteries isolated 
from Piezo1∆EC mice. (c) Concentration response curves to PE in control; n=10) and 
Piezo1∆EC (n=10) mice. (d) The area under the curve (AUC) of the response to PE for 
each individual curve of mesenteric arteries isolated from control (n=10) and Piezo1∆EC 
mice (n=10). Responses are expressed as percent constriction and as the area under 
the curve (AUC) of the response to PE. Mean ± SEM values are depicted. NS=not 
significant.  
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4.3.3 Deletion of endothelial cell Piezo1 potentiates ACh-induced 
vasorelaxation 
ACh is a neurotransmitter that activates muscarinic receptors in the resistance vessels 
and is commonly used in vascular research to enhance vasodilation. ACh essentially 
acts through increasing cellular levels of NO, prostacyclin and EDHF. NO increase sGC 
activity (Francis et al., 2010), to mediate the GTP conversion to cGMP. This activates 
PKG (cGMP-dependent protein kinase), the major protein that is responsible for NO 
relaxation (Hofmann et al., 2006). PKG decreases the concentration of [Ca2+]i and 
subsequently reduces Ca2+-dependent activation of MLC kinase, resulting in relaxation 
(Fig. 4.4). Prostacyclin is an eicosanoid of the cyclooxygenase pathway, induce 
relaxation of SMCs in most blood vessels. EDHF functions by the activation of IKCa2+ and 
SKCa2+ thus inducing K+ efflux. Hyperpolarisation is transmitted from ECs to VSMCs via 
gap junctions causing hyperpolarisation. These experiments attempted to assess 
whether deletion of endothelial Piezo1 alters the vasoreactivity in response to ACh.  
Mesenteric arteries from control and Piezo1∆EC mice displayed typical ACh-induced 
relaxation (Fig. 4.5a and b). Vasodilation to ACh was enhanced in Piezo1∆EC compared 
with control arteries at concentrations of 0.01 and 0.1 μM (Fig. 4.5c), however, no 
difference was found in the AUC of the response to ACh for each individual curve in both 
groups (Fig. 4.5d). Overall, this suggests that the response to ACh might have a partial, 
but fairly small, dependence on endothelial Piezo1. 
4.3.4 Deletion of endothelial cell Piezo1 affected EDHF-mediated-
vasorelaxation 
ACh can induce vessel relaxation by the EDHF pathway (Fig. 4.6). A rise in EC [Ca2+]i 
causes stimulation of IKCa2+ and SKCa2+, resulting in endothelial hyperpolarisation 
(Edwards and Weston, 1998). The endothelial hyperpolarisation can then be transferred 
to SMCs through EC-SMCs gap junctions to cause hyperpolarisation of SMCs and 
consequently relaxation (Edwards et al., 1998). The EDHF-mediated response can be 
inhibited by a combination of charybdotoxin, which blocks IKCa2+, and apamin, which 
blocks small SKCa2+ then prevent the hypnotisation (Kang, 2014). IKCa2+ and SKCa2+ are 
critical for EDHF where these channels are arranged in endothelial microdomains, 
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particularly within projections towards the adjacent smooth muscle, which are rich in 
IKCa2+  channels and close to interendothelial gap junctions where SKCa2+  channels, are 
prevalent (Garland and Dora, 2016). 
Mesenteric arteries from control mice displayed typical trace of ACh-induced relaxation 
before and after incubation with apamin plus charybdotoxin (Fig. 4.7a). No difference 
was observed in the resting tone of mouse mesenteric arteries when the combination of 
apamin plus charybdotoxin inhibitors was used (Fig. 4.7b). However, greater contraction 
that did not achieve significance was observed in response to PE (Fig. 4.7c). 
Incubating mesenteric arteries from control mice with apamin plus charybdotoxin 
reduced the ACh induced-relaxation at 0.1 and 0.3 µM concentrations (Fig. 4.7d). 
However, no significant difference was found in the AUC of the response to ACh before 
and after the incubation with apamin plus charybdotoxin (Fig. 4.7e). The results suggest 
that EDHF played a minor role in ACh-induced relaxation. 
As for control mice, no differences were observed in either the resting tone (Fig. 4.8b) or 
the response to PE (Fig. 4.8c) when the combination of the inhibitors apamin and 
charybdotoxin was used on Piezo1∆EC mouse mesenteric arteries. In contrast, however, 
ACh-induced relaxation was reduced by 80% after incubation with apamin plus 
charybdotoxin (Fig. 4.8a,4.8d and 4.8e). The difference in the AUC of the response to 
ACh before and after the incubation with apamin plus charybdotoxin was compared 
between control and Piezo1∆EC mice and it was significantly different (Fig. 4.9). The 
results suggest that Piezo1 has an anti-EDHF effect.  
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Figure 4-4: The nitric oxide (NO) and endothelial derived hyperpolarization factor 
(EDHF) pathway in the vascular smooth muscle cells leading to cell 
relaxation 
 ACh activates muscarinic receptors increasing cellular levels of NO, prostacyclin and 
EDHF. In the NO pathway, the endothelial form of NO synthase (NOS) converts L-
arginine to NO and citrulline. NO is released and diffuses to the vascular smooth muscle 
cells to activate soluble guanylate cyclase (sGC), which converts guanosine triphosphate 
(GTP) to cyclic guanosine monophosphate (cGMP) to activate protein kinase G (PKG) 
and consequently can block myosin light chain kinase (MLCK), leading to relaxation. In 
the EDHF pathway, endothelial-dependent agonists activate endothelial cell receptors 
leading to entry of extracellular and the release of intracellular Ca2+ and synthesis of 
EDHF. Along with the synthesis of EDHF, hyperpolarisation of ECs occurs since the 
increased Ca2+ activates Ca2+-dependent K+-channels (KCa2+), intermediate 
conductance calcium-activated K+ channels (IKCa2+) and small conductance K+-
channels (SKCa2+) thus inducing  K+ efflux. Hyperpolarisation is transmitted from 
endothelial to vascular smooth muscle cells (VSMCs) via gap junctions. Within the 
VSMCs it activates KCa2+ channels, causing endothelial-dependent hyperpolarisation and 
relaxation.                  Inhibition.                      Activation.  
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Figure 4-5: Vascular reactivity to ACh in control compared with endothelial 
Piezo1∆EC mesenteric arteries  
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM) in mesenteric arteries 
isolated from control mice. (b) As for (a) except in mesenteric arteries isolated from 
Piezo1∆EC mice. (c) Concentration response curves to ACh in control (n=25) and 
Piezo1∆EC (n=25) mice. (d) The area under the curve (AUC) of the response to ACh of 
mesenteric arteries isolated from control (n=25) and Piezo1∆EC mice (n=25). Responses 
are expressed as percent relaxation, and as the area under the curve (AUC) of the 
response to ACh. Mean ± SEM values are depicted. Asterisks (*) indicate statistically 
significant difference in ACh response between control and Piezo1∆EC mice (p<0.05). 
NS=not significant.  
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Figure 4-6: Inhibition of endothelial derived hyperpolarisation factor (EDHF)  
 Endothelial-dependent agonists activate endothelial cell receptors leading to entry of 
extracellular and the release of intracellular Ca2+ and synthesis of EDHF. Along with the 
synthesis of EDHF, hyperpolarisation of endothelial cells occurs since Ca2+ activates 
Ca2+-dependent K+-channels (KCa2+), intermediate conductance calcium-activated K+ 
channels (IKCa2+) and small conductance K+-channels (SKCa2+), which all mediate K+ 
efflux. EDHF diffuses to vascular smooth muscle cells (VSMCs), activates KCa2+ 
channels and cause endothelial-dependent hyperpolarisation and relaxation. The 
combination of two toxins, apamin (Apa) that blocks SKCa2+ and charybdotoxin (Ch) that 
inhibits IKCa2+, abolishes EDHF-mediated responses. Inhibitors of EDHF do not entirely 
block the agonist-induced relaxation because the NO pathway remains.                                                               
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Figure 4-7: EDHF-mediated-vasorelaxation in control mice  
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM) before and after the 
incubation with apamin (Apa) (500 nM) plus charybdotoxin (Ch) (100 nM) in mesenteric 
arteries isolated from control mice. (b) Quantification of the Apa+Ch effects on the basal 
mesenteric artery tension (n=8). (c) Quantification of the Apa+Ch effects on 
phenylephrine (PE)-induced constriction in control mesenteric arteries of mice (n=8). (d) 
Concentration response curves to ACh before and after the application of Apa+Ch in 
control mesenteric arteries of mice (n=8). (e) The area under the curve (AUC) of the 
response to ACh before and after the incubation with Apa+Ch of mesenteric arteries, 
isolated from control mice (n=8). Responses are expressed as percent constriction and 
as the area under the curve (AUC) of the response to ACh. Mean ±  SEM values are 
depicted. Asterisks (*) indicate statistically significant difference in ACh response 
(p<0.05). NS=not significant. 
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Figure 4-8: EDHF-mediated-vasorelaxation in endothelial Piezo1∆EC mice  
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM) before and after the 
incubation with apamin (Apa) (500 nM) plus charybdotoxin (Ch) (100 nM) in mesenteric 
arteries isolated from Piezo1∆EC mice. (b) Quantification of the Apa+Ch effects on the 
basal artery tension (n=6). (c) Quantification of the Apa+Ch effects on phenylephrine 
(PE)-induced constriction in Piezo1∆EC mesenteric arteries of mice (n=6). (d) 
Concentration response curves to ACh before and after the application of Apa+Ch in 
Piezo1∆EC mesenteric arteries of mice (n=6). (e) The area under the curve (AUC) of the 
response to ACh before and after the incubation with Apa+Ch of mesenteric arteries 
isolated from Piezo1∆EC mice (n=6). Responses are expressed as percent constriction 
and as the area under the curve (AUC) of the response to ACh. Mean ± SEM values are 
depicted. Asterisks (**) indicate statistically significant difference (p<0.01). NS=not 
significant.  
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Figure 4-9: Comparison of EDHF-mediated-vasorelaxation in control and 
endothelial Piezo1∆EC mice 
The difference in the area under the curve (AUC) of the response to acetylcholine (ACh) 
before and after incubation with apamin (Apa) (500 nM) plus charybdotoxin (Ch) (100 
nM) of mesenteric arteries isolated from control and Piezo1∆EC mice (n=8 and 6, 
respectively). Data are expressed as the area under the curve (AUC) of the response to 
ACh. Mean SEM values are depicted. Asterisks (*) indicate statistically significant 
difference (p<0.05).  
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4.3.5 Deletion of endothelial cell Piezo1 does not affect NO-
mediated-vasorelaxation 
L-NAME is a NOS inhibitor, which tends to be analogue of arginine that features 
substitutions of the guanidino nitrogen (Fig. 4.10) (Huang et al., 1995). L-NAME was 
used to study the contribution of NO to ACh-evoked vasodilatation. 
Mesenteric arteries from control mice displayed typical trace of ACh-induced relaxation 
before and after the incubation with L-NAME (Fig. 4.11a). No difference was observed 
in the resting tone of mice mesenteric arteries in the presence of L-NAME (Fig. 4.11b). 
However, increased contraction was observed in response to PE by 50% (Fig. 4.11c). L-
NAME reduced the ACh-mediated relaxation in mesenteric arteries from control mice by 
62% (Fig.11d). A significant difference was found in the AUC of the response to ACh, 
before and after the incubation with L-NAME (Fig. 4.11e). 
Similar to control mice, no differences were observed in the resting tone of mesenteric 
arteries from Piezo1∆EC mice when L-NAME was present (Fig. 4.12b). However, in the 
contractile response to PE was increased by 42% (Fig. 4.12c). L-NAME also had a 
significant effect on ACh-induced relaxation in mesenteric arteries from Piezo1∆EC mice 
(77% reduction) (Fig. 4.12d). A significant difference was found in the AUC of the 
response to ACh before and after incubation with L-NAME (Fig. 4.12e). 
The difference in the AUC of the response to ACh before and after the incubation with 
L-NAME was compared between control and Piezo1∆EC mice and no significant 
difference was observed (Fig. 4.13). These data indicate that Piezo1 deletion did not 
affect NO mediation of endothelium-dependent relaxation.  
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Figure 4-10: The nitric oxide (NO) inhibation 
The endothelial form of NO synthase (NOS) is expressed which can convert L-arginine 
to NO and citrulline. NO is released and diffuses to the vascular smooth cells to activate 
soluble guanylyl cyclase (sGC), which converts guanosine triphosphate (GTP) to cyclic 
guanosine monophosphate (cGMP) to activate protein kinase G (PKG) leading to 
relaxation.  NOS could be inhibited by Nω-nitro-L-arginine methyl ester hydrochloride (L-
NAME) leads to a reduction in NOS activity and therefore in NO production. However, 
EDHF mediates relaxation still release.        
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Figure 4-11: NO-mediated-vasorelaxation in control mice  
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM) before and after the 
incubation with (100 μM) Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME) in 
endothelium-intact mesenteric arteries isolated from control mice. (b) Quantification of 
the L-NAME effects on the basal mesenteric artery tension (n=7). (c) Quantification of 
the L-NAME effects on phenylephrine (PE)-induced constriction in control mesenteric 
arteries of mice (n=7). (d) Concentration response curves to ACh before and after the 
application of L-NAME in control mesenteric arteries mice (n=7). (e) The area under the 
curve (AUC) of the response to ACh before and after incubation with L-NAME of 
mesenteric arteries isolated from control mice (n=7). Responses are expressed as 
percent constriction and as the area under the curve (AUC) of the response to ACh. 
Mean ± SEM values are depicted Asterisks (**, ***) indicate statistically significant 
difference (p<0.01 and 0.001). NS=not significant.  
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Figure 4-12: NO-mediated-vasorelaxation in endothelial Piezo1∆EC mice  
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM) before and after incubation 
with (100 μM) Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME) in endothelium-
intact mesenteric arteries isolated from Piezo1∆EC mice. (b) Quantification of the L-NAME 
effects on the basal mesenteric artery tension (n=8). (c) Quantification of the L-NAME 
effects on phenylephrine (PE)-induced constriction in Piezo1∆EC mesenteric arteries of 
mice (n=8). (d) Concentration response curves to ACh before and after the application 
of L-NAME in Piezo1∆EC mesenteric arteries of mice (n=8). (e) The area under the curve 
(AUC) of the response to ACh before and after the incubation with L-NAME of mesenteric 
arteries isolated from Piezo1∆EC mice (n=8). Responses are expressed as percent 
constriction and as the area under the curve (AUC) of the response to ACh. Mean ± SEM 
values are depicted. Asterisks (*, **, ***) indicate statistically significant difference 
(p<0.05, 0.01 and 0.001). NS=not significant.  
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Figure 4-13: Comparison of NO-mediated-vasorelaxation in control and 
endothelial Piezo1∆EC mice.  
The difference in the area under the curve (AUC) of the response to acetylcholine (ACh) 
before and after incubation with Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME) 
in mesenteric arteries isolated from control and Piezo1∆EC mice (n=7 and 8, respectively). 
Data are expressed as the area under the curve (AUC) of the response to ACh. Mean ± 
SEM values are depicted. NS=not significant.  
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4.3.6 The effect of removal of endothelial cells on ACh-induced 
relaxation  
To evaluate whether the relaxation caused by ACh was dependent on the endothelium, 
the endothelium was removed by introducing into the lumen a wire and rubbing it back 
and forth various times. Mesenteric arteries from control mice were pre-constricted with 
0.3 μM PE, then ACh (0.01–1 μM) was administered in the presence (Fig. 4.14a) or 
absence of ECs (Fig. 4.14b). PE constriction is dependent on SMCs (as shown in Figs.  
4.2 and 4.3). Accordingly, the data show that mesenteric arteries from control mice 
without functional endothelium are able to produce similar levels of constriction in 
response to PE (Fig. 4.14c). In contrast, both mechanisms of relaxation, NO and EDHF, 
are dependent upon ECs (as shown in Fig. 4.6). Therefore, removal of ECs resulted in 
almost complete elimination of the relaxation response to ACh (94% decrease) (Fig. 
4.14d). A significant difference was found in the AUC of the response to ACh before and 
after removing the ECs (Fig. 4.14e). SIN-1 was used to evaluate an endothelium-
independent vasodilatation response. It decomposes in aqueous solutions generating 
NO without requiring enzymatic bioactivation or other co-factors (Ullrich et al., 1997) (Fig. 
4.15), thus is able elicit vasorelaxation in the absence of endothelial cells (Fig. 4.14b and 
4.17b and c). 
No difference was observed in the nature or magnitude of the effect of removing the 
endothelium from Piezo1∆EC vessels, compared with control mice. Mesenteric arteries 
from Piezo1∆EC mice without functional endothelium are able to produce similar levels of 
constriction in response to PE as intact vessels (Fig. 4.16c). Removal of ECs eliminated 
the relaxation response to ACh by 95% (Fig. 4.16d), a significant difference being found 
in the AUC of the response to ACh before and after removing the ECs (Fig. 4.16e). The 
difference in the AUC of the response to ACh before and after removing the ECs was 
compared between the two groups of mice and no significant difference was observed 
(Fig. 4.17a). These results are in agreement with the L-NAME experiments. SIN-1 (0.01–
1 μM) induced relaxation in both groups was unaffected by the removal of ECs (Fig. 4. 
17b). No differences were found in the AUC of the response to SIN-1 between the two 
groups of mice (Fig. 4.17c). These data indicate that both mechanism of ACh induced 
relaxation are robustly endothelium-dependent and that the SIN-1 response occurs 
independently of Piezo1.  
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Figure 4-14: The effect of removal of endothelial cells on ACh induced-relaxation 
in control mice 
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM) before removing the 
endothelial cells. (b) Typical trace showing a concentration-dependent dilatory response 
to ACh after removing the endothelial cells (-EC) and the application of NO-donator, 
Linsidomine (SIN-1) as indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM)  (c) 
Quantification of the effects of removing the endothelial cells on phenylephrine (PE)-
induced constriction in control mesenteric arteries of mice (n=14). (d) Concentration 
response curves to ACh in mesenteric arteries of control mice before and after removing 
endothelial cells (n=14). (e) The area under the curve (AUC) of the response to ACh 
before and after removing the endothelial cells of mesenteric arteries isolated from 
control mice (n=14). Responses are expressed as percent constriction and as the area 
under the curve (AUC) of the response to ACh. Mean ± SEM values are depicted. 
Asterisks indicate statistically significant difference (***,p< 0.001). NS=not significant.  
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Figure 4-15: NO-donor, Linsidomine (SIN-1) 
SIN-1can be converted into nitric oxide (NO), the common smooth muscle relaxing factor 
and activates of soluble guanylate cyclase (sGC) and generation of the second 
messenger cyclic guanosine monophosphate (cGMP), which mediates vasodilation.  
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Figure 4-16: The effect of removal of endothelial cells on ACh induced-relaxation 
in Piezo1∆EC mice  
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM) before removing the 
endothelial cells. (b) Typical trace showing a concentration-dependent dilatory response 
to ACh after removing the endothelial cells (-EC) and the application of SIN-1 as 
indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM) (c) Quantification of removing the 
endothelial cells effects on phenylephrine (PE)-induced constriction in Piezo1∆EC 
mesenteric arteries of mice (n=10). (d) Concentration response curves to ACh in 
mesenteric arteries of Piezo1∆EC mice before and after the removal of endothelial cells 
(n=10). (e) The area under the curve (AUC) of the response to ACh before and after 
removing the endothelial cells of mesenteric arteries isolated from Piezo1∆EC mice 
(n=10). Responses are expressed as percent constriction and as the area under the 
curve (AUC) of the response to ACh. Mean ± SEM values are depicted. Asterisks indicate 
statistically significant difference (**, p< 0.01; ***, p< 0.001). NS=not significant.  
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Figure 4-17: Comparison of effects of removing the endothelial cells in control and 
endothelial Piezo1∆EC mice 
(a) The difference in the area under the curve (AUC) of the response to acetylcholine 
(ACh) before and after removing the endothelial cells of mesenteric arteries isolated from 
control and Piezo1∆EC mice (n=14 and 10, respectively). (b) Concentration response 
curves to NO-donator, Linsidomine (SIN-1) in mesenteric arteries from control and 
Piezo1∆EC mice (n=14 and 8, respectively). (c) The area under the curve (AUC) of the 
response to SIN-1 in mesenteric arteries isolated from control Piezo1∆EC mice (n=14 and 
10, respectively). Data are expressed as percent constriction and the area under the 
curve (AUC) of the response to ACh. Mean ± SEM values are depicted. NS=not 
significant. 
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Since the data show that Piezo1 has an anti-EDHF effect (i.e. anti-vasodilatation) in 
mesenteric arteries, we considered the physiological circumstances in which this 
regulatory role may be important. Mesenteric arteries contribute substantially to 
peripheral resistance, therefore, regulation of BP represented an obvious parameter for 
examination. Studies have shown that exercise reduces mesenteric blood flow in 
humans, directing it instead to organs/tissues actively required for movement (Qamar 
and Read, 1987). Therefore, we measured BP in both inactive and active states. The 
following experiments were performed by Dr B Rode.   
4.3.7 Measurements of blood pressure  
BP was continuously recorded in mice by implanting telemetry probes. The mice were 
given unrestricted access to a running wheel placed within their cages. BP did not differ 
between groups of control and Piezo1∆EC mice during the periods of physical inactivity 
(Fig. 4.18a); ~ 108 mmHg in control and ~ 102 mmHg in Piezo1∆EC mice, and ~ 87 mmHg 
in control and ~ 83 mmHg in Piezo1∆EC mice systolic and diastolic values respectively. 
During periods of physical activity BP increased in both control and Piezo1∆EC mice, 
however, this increase was significantly smaller in Piezo1∆EC mice; ~ 137 mmHg (29 
mmHG increase) in control and ~ 119 mmHg (17 mmHg increase) in Piezo1∆EC mice and 
~ 113 mmHg (26 mmHg increase) in control and ~ 97 mmHg (14 mmHg increase) in 
Piezo1∆EC mice, systolic and diastolic values respectively. ~ 59% increase in Piezo1∆EC 
mice as a proportion/percentage of control mice (Fig. 4.18). These data demonstrate that 
during whole body physical activity, endothelial Piezo1 plays an important role in 
regulating BP. 
4.3.8 Flow-induced vasoconstriction  
We hypothesised that the reduced exercise-induced increase in BP seen in Piezo1∆EC 
mice was, at least in part, due to a loss of regulation of mesenteric blood flow in response 
to activity; Piezo1 is involved in reducing blood flow through mesenteric vessels during 
exercise (Qamar and Read, 1987). This would suggest the presence of a shear stress 
induced vasoconstriction mechanism linked to Piezo1 within the mesenteric arteries. To 
look for such a mechanism, pressure myography studies were performed together with 
Dr J Shi on isolated intact second-order mesenteric arteries. A pressure myograph can 
more appropriately model the in vivo condition and resistance arteries are more sensitive 
135 
 
 
to stretch in vitro when mounted on a pressure myograph compared with the isometric 
wire myograph (Halpern and Osol, 1985). In order to focus on the potential Piezo1 
vasoconstriction mechanism, the endothelial NOS inhibitor L-NAME was used. Under 
these conditions, a flow-induced vasoconstriction was seen in vessels from control mice. 
In contrast, in Piezo1∆EC mice this vasoconstriction was absent (Fig.4.19d, 4.19e). 
Interestingly, the vasoconstriction produced in vessels from control mice by the flow was 
blocked by the LTCCs inhibitor nicardipine (Fig. 4. 19a-c).  
4.3.9 Constitutive and flow-induced Piezo1 in mesenteric artery 
The presence of functional Piezo1 channels in ECs from second-order mesenteric 
arteries was confirmed by Dr J Shi using cell-detached outside-out membrane patch-
clamp electrophysiology. Piezo1 channels were identified through the size of their unitary 
current and unitary conductance; the channels had a unitary conductance of about 25 
pS, consistent with previous studies (Coste et al., 2010, Coste et al., 2015). Interestingly, 
constitutive activity of Piezo1 channels was observed (Fig. 4.20a, 4.20b), perhaps 
explaining the difference in EDHF-mediated vasorelaxation between the control and 
Piezo1∆EC mice. Channel activity was enhanced approximately two-fold upon application 
of flow (Fig. 4.20c). Sensitivity to Gd3+, a blocker of Piezo1 channels (Coste et al., 2010), 
and the absence of a response to fluid flow in Piezo1∆EC mice (Fig. 4.20d) further 
confirmed the presence of Piezo1 channels in ECs isolated from mesenteric arteries.  
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Figure 4-18: Measurements of blood pressure during whole body physical activity  
Telemetry measurements of mean, systolic and diastolic BPs in conscious freely-moving 
control (n=6) and Piezo1∆EC (n=7) mice. Data were analysed when the mice were inactive 
during the day (a) and voluntarily active on a running wheel during the night (b). Time 
zero is when the mouse was introduced to the running wheel cage. Measurements were 
not made during the first 2 days of acclimatisation. Averaged data are displayed as Mean 
± SEM. Data sets are compared by t-test. Statistical significance is indicated by *p<0.05, 
**p<0.01, ***p<0.001. Experiments were performed by Dr B Rode.  
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Figure 4-19: Flow-induced vasoconstriction in mesenteric artery. Isobaric external 
diameter recordings from second-order mesenteric artery 
(a) Example images of a cannulated artery before and after luminal pressure 
difference (∆P) and then after 10 µM nicardipine was added to the recording 
chamber. Control genotype mouse. Scale bar, 200 µm. (b) Example diameter 
recording for a control genotype mouse during incremental increases in ∆P as 
indicated by the black dots (20, 40, 60, 70, 80, 90 and 100 mmHg). Nicardipine (Nic, 
10 µM), phenylephrine (PE, 1 µM) and acetylcholine (ACh, 10 µM) were applied as 
indicated. The first arrow indicates addition of 100 µM N(ω)-nitro-L-arginine methyl 
ester (L-NAME) to the recording chamber and the second arrow multiple washes of 
the chamber to remove nicardipine and L-NAME. (c) Mean data for the type of 
experiment shown in (b) presented as the constriction to ∆P as a percentage of the 
PE response (9 arteries from n=6 mice). Nicardipine significantly (***) reduced the 
100 mmHg ∆P response to 30.7±3.9% (n=6 mice). (d, e) The same as for (b, c) but 
using Piezo1∆EC genotype mice (8 arteries from n=3 mice). Averaged data are 
displayed as Mean ± SEM. Data sets are compared by t-test. Statistical significance 
is indicated by **p<0.01, ***p<0.001. Experiments were performed in collaboration 
with Dr J Shi.  
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Figure 4-20: Piezo1 channels work as flow sensors in the endothelium of 
mesenteric artery 
Piezo1 channels are flow sensors in endothelium of mesenteric resistance artery. Data 
are for ionic current recordings from outside-out patches excised from freshly isolated 
endothelium of second-order mesenteric arteries. (a) Example recording at −70 mV. Two 
sections are expanded to clarify unitary current events (C: channel closed) (O: 1, 2 or 3 
simultaneous channel openings). The patch was placed at the outlet of a capillary from 
which flowed ionic solution at 20 μl s−1. Gadolinium ion (Gd3+, 10 μM). (b) Mean unitary 
current amplitudes for channels activated by flow as in a (n = 10). (c) Mean channel 
activity (NPo: number × probability of opening) for experiments of the type exemplified in 
a for no flow and flow conditions and the two genotypes (Control and Piezo1ΔEC). 
Individual data points for each independent experiment are shown as symbols, 
superimposed on which are the mean ± s.e.m. values (n = 10 for each group). (d) 
Example original trace for a patch from Piezo1ΔEC endothelium exposed to 20 μl s−1 flow. 
Averaged data are displayed as mean ± SEM. Data sets are compared by t-test. 
Statistical significance is indicated by ***p < 0.001. Experiments were performed by Dr J 
Shi.  
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4.3.10 Yoda1 induced relaxation in the mesenteric arteries of control 
and Piezo1∆EC mice  
Yoda1 is a synthetic small-molecule activator of Piezo1 which was discovered in a 
screen of 3.25 million compounds (Syeda et al., 2015). Previous data within this chapter 
considered a modulatory effect of Piezo1 on vasoconstrictor/vasorelaxant compounds. 
Here the aim was to determine if activation of Piezo1 itself leads to contraction/relaxation 
of a resistance artery. Mesenteric arteries from control and Piezo1∆EC mice were pre-
constricted with 0.3 μM PE, then Yoda1 (0.1–10 μM) was administered as shown in Fig. 
4.21a, and 4.21b respectively. In control segments, Yoda1 caused a concentration-
dependent relaxation (~ 80 % relaxation at 10 µM Yoda1). Unexpectedly, this 
vasorelaxation was not significantly diminished in Piezo1∆EC segments (Fig. 4.21c). No 
significant difference was found in the AUC of the response to Yoda1 for each individual 
curve in both groups (Fig. 4.21d). The data suggest that activation of EC Piezo1 by a 
pharmacological agonist does not influence vessel tension. However, the activation of 
Piezo1 in other cell types (e.g. VSMCs) might promote vasorelaxation. 
4.3.11 The effect of Piezo1 antagonists on Yoda1-induced relaxation 
in mesenteric arteries from control and Piezo1∆EC mice  
Two previously identified non-specific inhibitors of Piezo1 are Gd3+and ruthenium red 
(RR). They were used to determine the contribution of Piezo1 to the relaxation induced 
by Yoda1 on isolated mesenteric arteries from control and Piezo1ΔEC mice. A typical 
relaxation response of Yoda1 before and after inhibition with Gd3+ or RR was obtained 
from control and Piezo1∆EC mesenteric arteries (Fig. 4.21a, 4.22a for Gd3+, 4.23a and 
4.24a for RR, respectively). There was no significant reduction in PE-induced 
constriction observed when these inhibitors were used (Table 4.1). Both of these 
inhibitors significantly reduced Yoda1 induced-relaxation on isolated mesenteric arteries 
from control (45% and 40% reduction respectively) and Piezo1ΔEC mice (31% and 33% 
reduction respectively). (Fig. 4.21b, 4.22b, 4.23b and 4.24b). A significant difference was 
found in the AUC of the response to Yoda1 before and after the incubation with Gd3+ or 
RR (Fig. 4.21c, 4.22c for Gd3+, 4.23c and 4.24c for RR, respectively). These data suggest 
that Piezo1 contributes to Yoda1-induced relaxation.  
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Figure 4-21: Endothelial-dependent relaxation induced by Yoda1 in control 
compared with endothelial Piezo1∆EC mesenteric arteries 
(a) Typical trace showing a concentration-dependent dilatory response to Yoda1 as 
indicated by the dots (0.1, 0.3, 1, 3 and 10 μM) in endothelium-intact mesenteric arteries 
isolated from control mice. (b) As for (a) except in endothelium-intact mesenteric arteries 
isolated from Piezo1∆EC mice. (c) Concentration response curves to Yoda1 in control 
(n=18) and Piezo1∆EC (n=19) mice. (d) The area under the curve (AUC) of the response 
to Yoda1 of mesenteric arteries isolated from control (n=18) and Piezo1∆EC mice (n=19). 
Responses are expressed as percent relaxation, and as the area under the curve (AUC) 
of the response to Yoda1. Mean ± SEM values are depicted. NS=not significant.  
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Treatment 
 
Basal 
tension 
before PE 
(mN)  
Basal 
tension after 
PE 
(mN)  
Maximum 
tension before 
PE 
(mN)  
Maximum 
tension after 
PE 
(mN)  
N 
 Control  
Gd3+ 3.09±0.01 3.06±0.02 5.15±0.04 3.74±0.01 6 
RR 3.02±0.02 3.07±0.01 5.24±0.06 3.19±0.04 3 
 Piezo1∆EC  
Gd3+ 3.04±0.02 3.08±0.03 5.93±0.06 3.24±0.04 6 
RR 3.00±0.01 3.02±0.02 6.35±0.03 3.79±0.03 6 
Table 4-1: Gd3+ and RR inhibitors effects on basal tension and phenylephrine (PE) 
responses in mouse mesenteric arteries.  
The data are presented as mean ± SEM of the mice number (n). There was no significant 
difference in Gd+3 or RR treatments for basal tension (before the application of PE) or for 
maximum tension (after the application of 0.3 µM PE).  
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Figure 4-22: The effect of Piezo1 antagonists on Yoda1-induced relaxation in 
mesenteric arteries from control mice  
(a) Typical trace showing a concentration-dependent response to Yoda1 as indicated by 
the dots (0.1, 0.3, 1, 3 and 10 μM) in the mesenteric arteries isolated from control mice 
before and after (10 μM) gadolinium ions (Gd3+). (b) Concentration response curves to 
Yoda1 in the mesenteric arteries from control mice before and after Gd3+ (n=6). (c) The 
area under the curve (AUC) of the response to Yoda1 before and after Gd3+ in the 
mesenteric arteries isolated from control mice (n=6). Responses are expressed as 
percent constriction and as the area under the curve (AUC) of the response to Yoda1. 
Mean ± SEM values are depicted. Asterisks indicate statistically significant difference 
(*p< 0.05, **p<0.01).  
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Figure 4-23: The effect of Piezo1 antagonists on Yoda1-induced relaxation in 
mesenteric arteries from Piezo1∆EC mice  
(a) Typical trace showing a concentration-dependent response to Yoda1 as indicated by 
the dots (0.1, 0.3, 1, 3 and 10 μM) in the mesenteric arteries isolated from Piezo1∆EC 
mice before and after (10 μM) gadolinium ions (Gd3+). (b) Concentration response curves 
to Yoda1 in the mesenteric arteries from control mice before and after Gd3+ (n=6). (c) The 
area under the curve (AUC) of the response to Yoda1 before and after Gd3+ in the 
mesenteric arteries isolated from Piezo1∆EC mice (n=6). Responses are expressed as 
percent constriction and as the area under the curve (AUC) of the response to Yoda1. 
Mean ± SEM values are depicted.  Asterisks indicate statistically significant difference 
(*p< 0.05, **p<0.01).  
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Figure 4-24: The effect of Piezo1 antagonists on Yoda1-induced relaxation in 
mesenteric arteries from control mice  
(a) Typical trace showing a concentration-dependent response to Yoda1 as indicated by 
the dots (0.1, 0.3, 1, 3 and 10 μM) in the mesenteric arteries isolated from control mice 
before and after  (30 μM)  ruthenium red (RR). (b) Concentration response curves to 
Yoda1 in the mesenteric arteries from control mice before and after RR (n=3). (c) The 
area under the curve (AUC) of the response to Yoda1 before and after RR in the 
mesenteric arteries isolated from control mice (n=3). Responses are expressed as 
percent constriction and as the area under the curve (AUC) of the response to Yoda1. 
Mean ± SEM values are depicted. Asterisks indicate statistically significant difference 
(*p< 0.05,**p< 0.01,***p< 0.001).  
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Figure 4-25: The effect of Piezo1 antagonists on Yoda1-induced relaxation in 
mesenteric arteries from Piezo1∆EC mice  
(a) Typical trace showing a concentration-dependent response to Yoda1 as indicated by 
the dots (0.1, 0.3, 1, 3 and 10 μM)  in the mesenteric arteries isolated from Piezo1∆EC 
mice before and after  (30 μM)  ruthenium red (RR). (b) Concentration response curves 
to Yoda1 in the mesenteric arteries from control mice before and after RR (n=3). (c) The 
area under the curve (AUC) of the response to Yoda1 before and after RR in the 
mesenteric arteries isolated from Piezo1∆EC mice (n=3). Responses are expressed as 
percent constriction and as the area under the curve (AUC) of the response to Yoda1. 
Mean ± SEM values are depicted. Asterisks indicate statistically significant difference 
(*p< 0.05).  
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4.3.12 The effect of removal of endothelial cells on Yoda1-induced 
relaxation 
Yoda1 was used in the mesenteric arteries from control and Piezo1∆EC mice after pre-
constriction with PE, with and without functional endothelium. Endothelium was removed 
by gently rubbing the lumen of the arteries with a wire to test whether removing the ECs 
would affect Yoda1-induced relaxation. Endothelial denudation was confirmed via the 
failure of the arteries to relax in response to ACh.  
A typical relaxation response of Yoda1 before and after removing EC was obtained from 
control and Piezo1∆EC mesenteric arteries (Fig. 4.26a, 4.27a, respectively). Thus, the 
vasorelaxant effect of Yoda1 is largely EC-independent which agrees with the Piezo1∆EC 
data. Furthermore, neither the maximal relaxation nor concentration-dependent 
relationship of Yoda1 was significantly altered by removal of the ECs (30% relaxation). 
Yoda1 caused a concentration-dependent vasorelaxation, and was not significantly 
influenced by removing the endothelium, although there was a trend towards a rightward 
shift in the concentration-relaxation curve to Yoda1. (Fig. 4.26b). In Piezo1∆EC mice (Fig. 
4.27b), likewise, no significant difference was found in the AUC of the response to Yoda1 
before and after removing the ECs (Fig. 4.26c and 4.27c) 
As introduced previously, the NO donor SIN-1 was used as a control to test the ability of 
the smooth muscle to relax. SIN-1 (0.01–1 μM) elicited concentration-dependent 
relaxation in endothelium-denuded arteries pre-stimulated with PE (0.3 μM) (Fig. 4.28a). 
No differences were observed between the relaxant actions in both groups. No significant 
difference was observed in the AUC of the response to SIN-1 in both groups (Fig. 4.28b). 
Together with the previous results, this suggests that Piezo1 might be involved in the 
portion of vasorelaxation mediated by VSMCs.  
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Figure 4-26: The effect of the endothelium removal on Yoda1-induced relaxation 
in mesenteric arteries from control mice  
(a) Typical trace showing a concentration-dependent response to Yoda1 as indicated by 
the dots (0.1, 0.3, 1, 3 and 10 μM) in the mesenteric arteries isolated from control mice 
before and after EC removing (-EC). (b) (c) Concentration response curves to Yoda1 in 
the mesenteric arteries from control mice before and after -EC (n=9). (d) The area under 
the curve (AUC) of the response to Yoda1 before and after --EC in the mesenteric 
arteries isolated from control mice (n=9). Responses are expressed as percent 
constriction and as the area under the curve (AUC) of the response to Yoda1. Mean ± 
SEM values are depicted. NS=not significant.  
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Figure 4-27: The effect of the endothelium removal on Yoda1-induced relaxation 
in mesenteric arteries from Piezo1∆EC mice  
(a) Typical trace showing a concentration-dependent response to Yoda1 as indicated by 
the dots (0.1, 0.3, 1, 3 and 10 μM) in the mesenteric arteries isolated from Piezo1∆EC 
mice before and (b) after EC removing (-EC). (c) Concentration response curves to 
Yoda1 in the mesenteric arteries from Piezo1∆EC mice before and after -EC (n=6). (d) The 
area under the curve (AUC) of the response to Yoda1 before and after -EC in the 
mesenteric arteries isolated from Piezo1∆EC mice (n=6). Responses are expressed as 
percent constriction and as the area under the curve (AUC) of the response to Yoda1. 
Mean ± SEM values are depicted. NS=not significant.  
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Figure 4-28: NO-donor, Linsidomine (SIN-1)-induced relaxation in mesenteric arteries from 
control and Piezo1∆EC mice  
(a) Concentration response curves to (0.01, 0.03, 0.1, 0.3 and 1 μM) SIN-1 in the 
mesenteric arteries from control and Piezo1∆EC mice after EC removing (n=14, 6 
respectively). (b) The area under the curve (AUC) of the response to SIN-1 after EC 
removing in the mesenteric arteries isolated from control and Piezo1∆EC mice (n=14, 6 
respectively). Responses are expressed as percent constriction and as the area under 
the curve (AUC) of the response to SIN-1. Mean ± SEM values are depicted. NS=not 
significant.  
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4.3.13 The contribution of EDHF to Yoda1-induced relaxation  
To test if the trend towards a rightward shift in the concentration-relaxation curve to 
Yoda1 in -EC vessels was associated with the action of EDHF, a combination of apamin 
plus charybdotoxin against Yoda1 was used.  
Relaxation responses of Yoda1 before and after inhibition with apamin plus 
charybdotoxin were obtained from control and Piezo1∆EC mesenteric arteries (Fig. 4.29a 
and 4.30a, respectively). In control mice, the degree of relaxation by Yoda1 was 
unaffected by the combination of apamin plus charybdotoxin, although there was a trend 
towards reduced relaxation (Fig. 4.29b). No significant difference was found in the AUC 
of the response to Yoda-1 before and after the incubation with apamin plus 
charybdotoxin (Fig. 4.29c). In mesenteric arteries from Piezo1∆EC mice, the combination 
of apamin plus charybdotoxin has no significant effect on Yoda1-induced relaxation (Fig. 
4.30b). No differences were found in the AUC of the response to Yoda1 before and after 
the incubation with apamin plus charybdotoxin (Fig. 4.30c). This indicates that EDHF is 
unlikely to contribute to Yoda1-induced relaxation. 
4.3.14 The contribution of NO to Yoda1-induced relaxation  
To test if the trend of a rightward shift in the concentration-relaxation curve to Yoda1 was 
associated with the action of endothelium derived NO, L-NAME against Yoda1 was used.  
Relaxation responses to Yoda1 before and after inhibition with L-NAME were obtained 
from control and Piezo1∆EC mesenteric arteries (Fig. 4.31a and 32a, respectively). In 
control mice, incubation with L-NAME resulted in a significant reduction in relaxation 
induced by Yoda1. (Fig. 4.31b). Also, a significant difference was found in the AUC of 
the response to Yoda-1 before and after the incubation with L-NAME (Fig. 4.31c). This 
indicates the involvement of NO in Yoda1 induced relaxation.  
Conversely, in mesenteric arteries from Piezo1∆EC mice, the incubation with L-NAME 
(Fig. 4.32b) had no significant effect on Yoda1-induced relaxation. No differences were 
found in the AUC of the response to Yoda1 before and after the incubation with L-NAME 
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(Fig. 4.32c). These data suggest that NO-mediated vasorelaxation has no role in Yoda1 
induced relaxation in Piezo1∆EC mice. 
4.3.15 The contribution of NO to Yoda1-induced relaxation in 
denuded ECs. 
L-NAME was found to be a potent inhibitor of Yoda1-induced relaxation, despite the fact 
that the activity of Yoda-1 was essentially endothelium-independent.  
Therefore, to investigate the role of NO in Yoda1-induced relaxation further mesenteric 
arteries were incubated with L-NAME following removal of the endothelium. Curiously, 
incubation with L-NAME did not affect the Yoda1-induced relaxation of mouse 
mesenteric arteries in the absence of endothelial cells. A similar response was observed 
before and after 20 min incubation with L-NAME (Fig. 4.33). This potentially suggests a 
role for the endothelium in modulating the relaxation induced by Yoda1 in mouse 
mesenteric artery.  
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Figure 4-29: The contribution of EDHF to Yoda1-induced relaxation in control 
mesenteric arteries  
(a) Typical tracing showing a concentration-dependent relaxation response to Yoda1 as 
indicated by the dots (0.1, 0.3, 1, 3 and 10 μM) before and after  incubation with apamin 
(Apa) (500 nM) plus charybdotoxin (Ch) (100 nM) in endothelium-intact mesenteric 
arteries isolated from control mice. (b) Concentration response curves to Yoda1 before 
and after the application of Apa+Ch in control mesenteric arteries mice (n=6). (c) The 
area under the curve (AUC) of the response to Yoda1 before and after the incubation 
with Apa+Ch of mesenteric arteries isolated from control mice (n=6). Responses are 
expressed as percent constriction and as the area under the curve (AUC) of the response 
to Yoda1. Mean ± SEM values are depicted. NS=not significant.  
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Figure 4-30: The contribution of EDHF to Yoda1-induced relaxation in Piezo1∆EC 
mesenteric arteries  
(a) Typical trace showing a concentration-dependent relaxation response to Yoda1 as 
indicated by the dots (0.1, 0.3, 1, 3 and 10 μM) before and after the incubation with 
apamin (Apa) (500 nM) plus charybdotoxin (Ch) (100 nM) in endothelium-intact 
mesenteric arteries isolated from Piezo1∆EC mice. (b) Concentration response curves to 
Yoda1 before and after the application of Apa+Ch in Piezo1∆EC mesenteric arteries mice 
(n=8). (c) The area under the curve (AUC) of the response to Yoda1 before and after the 
incubation with Apa+Ch of mesenteric arteries isolated from Piezo1∆EC mice (n=8). 
Responses are expressed as percent constriction and as the area under the curve (AUC) 
of the response to Yoda1. Mean ± SEM values are depicted. NS=not significant.  
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Figure 4-31: The contribution of NO to Yoda1-induced relaxation in endothelium-
intact control mesenteric arteries  
(a) Typical trace illustrating a concentration-dependent relaxation response to Yoda1 as 
indicated by the dots (0.1, 0.3, 1, 3 and 10 μM) before and after 20 min of incubation with 
(100 µM) Nω-nitro-l-arginine methyl ester hydrochloride (L-NAME) in endothelium-intact 
mesenteric arteries isolated from control mice. (b) Concentration response curves to 
Yoda1 before (n=7) and after (n=7) L-NAME treatment. (c) The area under the curve 
(AUC) of the response to Yoda1 before and after the incubation with L-NAME of 
mesenteric arteries isolated from control mice (n=7). Responses are expressed as 
percent constriction and as the area under the curve (AUC) of the response to Yoda1. 
Mean ± standard error of the mean (SEM) values are depicted. Asterisks indicate 
statistically significant difference (*p<0.05 and **p<0.01).  
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Figure 4-32: The contribution of NO to Yoda1-induced relaxation in endothelium-
intact Piezo1∆EC mesenteric arteries  
(a) Typical trace illustrating a concentration-dependent relaxation response to Yoda1 as 
indicated by the dots (0.1, 0.3, 1, 3 and 10 μM) before and after 20 min of incubation with 
(100 µM) Nω-nitro-l-arginine methyl ester hydrochloride (L-NAME) in endothelium-intact 
mesenteric arteries isolated from Piezo1∆EC mice. (b) Concentration response curves to 
Yoda1 before (n=3) and after (n=3) L-NAME treatment. (c) The area under the curve 
(AUC) of the response to Yoda1 before and after the incubation with L-NAME of 
mesenteric arteries isolated from Piezo1∆EC mice (n=3). Responses are expressed as 
percent constriction and as the area under the curve (AUC) of the response to Yoda1. 
Mean ± SEM values are depicted.  
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Figure 4-33: The contribution of NO to Yoda1-induced relaxation in endothelium-
denuded mesenteric arteries isolated from wild type mice  
(a) Typical trace illustrating a concentration-dependent relaxation response to Yoda1 as 
indicated by the dots (0.1, 0.3, 1, 3 and 10 μM) before and after 20 min of incubation with 
(100 µM) Nω-nitro-l-arginine methyl ester hydrochloride (L-NAME) in endothelium-
denuded mesenteric arteries isolated from wild type mice. (b) Concentration response 
curves to Yoda1 before (n=4) and after (n=4) L-NAME treatment. Responses are 
expressed as percent constriction of the response to Yoda1. Mean ± SEM values are 
depicted. NS=not significant.  
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4.4 Discussion  
This study used endothelial-specific deletion of Piezo1 to determine the contribution of 
Piezo1 in endothelium-dependent and -independent relaxation, as well as the effects of 
Piezo1 on arterial tone and BP. It was found that vasodilation in response to ACh was 
enhanced in Piezo1∆EC mice and that Piezo1 activity opposes EDHF. All ACh responses 
were endothelium-mediated. However, the relaxation due to Yoda1 was not significantly 
reduced in Piezo1∆EC mice. Furthermore, Yoda1 vasodilator responses were impaired 
with L-NAME treatment but not with a combination of apamin plus charybdotoxin. This 
illustrates an opposing influence of Piezo1 on endothelial function with ACh- and Yoda1-
induced relaxation in mouse mesenteric arteries.  
4.4.1 Deletion of endothelial cell Piezo1 affects high potassium-
induced contraction 
High K+ solution was used to confirm vessel viability. However, the addition of high 
potassium solution did not contract the vessels from both control and Piezo1 ∆EC mice to 
a similar level. Without further study it is not possible to know whether the reason for this 
decrease in contraction in Piezo1∆EC vessels results directly from loss of Piezo1 activity 
or some other unknown indirectimpact of Piezo1 deletion. Comparing the contractile 
potential of endothelium-denuded arteries from control and Piezo1∆EC mice in response 
to 60mM K+ might offer some insight. 
4.4.2 Deletion of endothelial cell Piezo1 potentiates ACh-induced 
vasorelaxation 
In addition to their activation by shear stress Piezo1 seems to also function in ECs in the 
absence of mechanical stimulation (Li et al., 2014, Rode et al., 2017). ACh-induced 
relaxation was enhanced in Piezo1∆EC segments, compared to control segments. One 
possible explanation is that constitutive Piezo1 activity causes depolarisation, which 
counteracts the hyperpolarisation induced by the activation of muscarinic receptors by 
ACh. The next experiments investigated the relative importance of NO and EDHF 
mechanisms in ACh responses of Piezo1∆EC compared with control mice.  
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4.4.3 Deletion of endothelial cell Piezo1 affected EDHF-mediated 
vasorelaxation but does not affect NO-mediated-
vasorelaxation 
ACh has been reported to promote the release of EDHF and NO from vascular 
endothelium via the M2 muscarinic receptor. Additional research has shown that EDHF 
induces hyperpolarisation of the VSMC membrane through the activation of a K+ 
channel, resulting in VSMC relaxation (Endo et al., 1995). In contrast, NO is synthesized 
in the endothelium from L-arginine, by the enzyme NO synthase, and causes 
vasodilation by an increase in cGMP by the activation of guanylate cyclase in VSMCs 
(Endo et al., 1995). Therefore, a combination of apamin plus charybdotoxin was used to 
inhibit EDHF while L-NAME was used to inhibit NO synthesis with and without the 
presence of endothelial Piezo1. 
Under basal conditions, the tension in mesenteric arteries from control and Piezo1∆EC 
mice was unaffected after the incubation with L-NAME or combination of apamin plus 
charybdotoxin. This is consistent with the study of Dora, et al (2000) because at this time 
there was no stimulus for contraction, so simply recording resting tension would not allow 
an assessment of either NO or EDHF release (Dora, et al, 2000). Further contraction 
was observed in response to the pre-constriction with PE after incubation with L-NAME 
or the combination of apamin and charybdotoxin. This is again consistent with Dora, et 
al (2000) who suggests that EDHF is released together with NO during smooth muscle 
contraction to PE, as blockade of NO synthesis, or EDHF-release, greatly augmented 
the contraction to PE. These observations demonstrate that even before the onset of 
contraction there are already signalling processes occurring between the ECs and SMCs 
which can significantly modulate the contraction (Dora et al., 2000).  
Pre-incubation of the mesenteric arteries from both groups with apamin plus 
charybdotoxin decreased the level of ACh-induced vasodilation mediated by EDHF. This 
is consistent with previous findings which illustrate that blocking the Ca2+-activated K+ 
channels via apamin and charybdotoxin abolishes the EDHF-mediated relaxation in rat 
mesenteric arteries (Yang et al., 2010). these results are also consistent with previous 
studies that showed EDHF-mediated relaxation in small mesenteric arteries (Yang et al., 
2010, Yap et al., 2014). In arteries from control mice the toxins caused a slight inhibition 
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of the ACh response (Fig. 4.7), but they strongly inhibited the ACh response in arteries 
from Piezo1∆EC mice (Fig. 4.8). This confirms that the depolarisation induced by Piezo1 
channels (a contractile function) was opposing the hyperpolarisation-induced by EDHF 
(a relaxation mechanism), meaning active Piezo1 channels act as an anti-EDHF 
modulators. Previous studies suggested that endothelial Piezo1 channels-induce NOS 
and the NO formation and thus enhance relaxation in response to flow (Li et al. 2014; 
Wang et al. 2016). These differences indicate a dichotomy for Piezo1 channel activity in 
endothelial biology. While Ca2+ entry leads to activation of the prorelaxant endothelial 
nitric oxide synthase, entry of cations as a whole (Ca2+ and Na+) cause membrane 
potential depolarisation and thus enhance contraction. 
Previous research has shown that in rat mesenteric arteries, NO-mediated 
hyperpolarisation has only a minor role in ACh-induced relaxation (Garland and 
McPherson, 1992). Within this study, pre-treatment of the mesenteric arteries from both 
control and Piezo1∆EC mice with L-NAME resulted in a more major decrease in ACh-
induced relaxation (Fig. 4.11 and 4.12). These results suggest that NO is important in 
ACh-induced vasodilation and that Piezo1 depletion does not affect NO-induced 
relaxation. Figure 4.12 showed that incubation with L-NAME suppressed ACh induced 
relaxation. L-NAME itself can significantly increase the PE-induced vasoconstriction. 
Therefore, NO signal seems involved in the vasoconstraction induced by PE. Then after 
L-NAME and ACh were added simultaneously to the chamber, it is expected that L-
NAME itself can still evoke more contraction by inhibiting No signal in the presence of 
ACh. ACh-mediated relaxation will be compromised significantly even NO signal plays 
very limited role in ACh-mediated relaxation. It is not suprising that ACh and L-NAME 
added together would significantly reduced the PE-induced vasoconstriction.  
4.4.4 The effect of removal of endothelial cells on ACh-induced 
relaxation   
ECs play an essential role in maintaining local vascular tone (Lüscher et al., 1990). 
Removal of the endothelium entirely abolished ACh-induced relaxation (Fig. 4.14 and 
4.16), which is consistent with previous studies (Raffetto et al., 2012, Kwon et al., 1999).   
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SIN-1, a NO donor, causes relaxation by the direct activation of guanylate cyclase, 
resulting in a rise in cGMP levels in SMCs (Plane, Sampson et al. 2001). Here, data 
showed that there was no difference in the levels of SIN-1-induced relaxation of the 
mesenteric arteries among the two groups (Fig. 4.17), suggesting that functional 
changes in the SMCs due to endothelial Piezo1 deletion are unlikely. 
4.4.5 Piezo1 channels role in whole body physical activity 
In addition to determining that loss of endothelial Piezo1 channels affects the activity of 
isolated mesenteric arteries, we observed that endothelial Piezo1 channels have a 
significant role in controlling BP in vivo in mice. The depolarising, anti-EDHF and so pro-
contractile effects of Piezo1 observed in mesenteric arteries might be expected to cause 
depressed BP levels in the Piezo1∆EC mice, these mice possessing more dilated blood 
vessels. Under resting conditions, however, no change in BP was observed. This finding 
was in contrast to a recent study which reported that deletion of endothelial Piezo1 in 
mice results in an increase in systolic BP (Wang et al., 2016). They demonstrated in 
HUAEC, HUVEC and BAECs that Piezo1 was important for shear stress induced eNOS 
activity, thus proposing that Piezo1 is involved in flow-induced NO-dependent 
vasodilatation. They did not, however, observe any an increase in diastolic BP (personal 
communication), which would be expected to accompany any loss of vasodilatation. 
Intriguingly, while a flow-induced vasodilatation mechanism is present in mesenteric 
arteries (Wang et al., 2016, Ahn et al., 2017) we have demonstrated that pressure can 
also activate a vasoconstrictive mechanism, which is also dependent on Piezo1. Under 
active conditions we propose that the latter is pre-dominant since elevations seen in BP, 
both systolic and diastolic, during physical activity were reduced in Piezo1∆EC mice. It has 
been shown that exercise reduces mesenteric blood flow in humans (Qamar and Read, 
1987), with our study suggesting that Piezo1 channels are the dominant source of the 
vasoconstrictor mechanism responsible.  
4.4.6 Relaxation induced by Yoda1 in control, compared with 
Piezo1∆EC mice mesenteric arteries 
Yoda1, a chemical activator of Piezo1, evoked calcium responses dependent largely on 
Ca2+ influx (Syeda et al., 2015, Cahalan et al., 2015). Yoda1 induced relaxation in mouse 
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mesenteric artery segments. These data are consistent with other data showing that 
Yoda1 caused relaxation in mouse mesenteric arteries (Wang et al., 2016). However, 
Yoda1-induced relaxation was not significantly reduced in Piezo1∆EC. It was therefore 
concluded that the ability of Yoda1 to induce relaxation is not influenced by the deletion 
of Piezo1 in the endothelium and thus that Piezo1 in the endothelium is not essential to 
the relaxation response mediated by Yoda1. Previously, Wang and colleagues, using 
equivalent  concentrations of Yoda1 as tested here, reported that Yoda1 responses were 
lost in a knockout of endothelial Piezo1 in mouse mesenteric arteries (Wang et al., 2016). 
This inconsistency with the results presented here may arise from different strategies to 
knockout endothelial Piezo1 in mice. Additionally in conflict with their data, results from 
our lab found that at rest, BP was the same in control and Piezo1∆EC mice, suggesting 
endothelial Piezo1 does not affect basal vascular tone. Another previous study suggests 
that endothelial inwardly rectifying K+ channels regulate flow-induced vasodilatation 
rather than Piezo1 in ECs (Ahn et al., 2016).  
The following experiments aim to explore Yoda1-mediated vasorelaxation in the absence 
or the presence of non-specific Piezo1 inhibitors, EC, EDHF and NO. 
4.4.7 Contribution of Piezo1 in Yoda1-induced relaxation 
The data show that control and Piezo1∆EC mesenteric arteries of mice treated with Piezo1 
inhibitors, Gd3+ and RR (Cinar et al., 2015), have significantly reduced the vasorelaxation 
response to Yoda1 (Fig. 4.21). These antagonists were able to reduce Yoda1-induced 
relaxation, indicating that Piezo1 channels are involved in Yoda1-induced relaxation.  
4.4.8 The effect of removal of endothelial cells on Yoda1-induced 
relaxation 
The findings reported here show only a small role for the ECs in mediating Yoda1-
induced relaxation. Removal of ECs did not alter Yoda1-induced relaxation in either 
control or Piezo1∆EC mice. Mesenteric arteries from both groups were still able to respond 
to Yoda1. It can be concluded that the ability of Yoda1 to provide relaxation is not 
influenced by removing ECs and is largely endothelial independent, and that Piezo1 
present in SMCs might be involved in this relaxation ((Retailleau et al., 2015). These 
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results are inconsistent with a recent study showing that Yoda1 responses were strongly 
reduced in a knockout of Piezo1 in mouse mesenteric arteries (Wang et al., 2016). 
However, the level of SIN-1-induced relaxation was similar in both groups. It appears 
that SMCs function is protected in both groups. 
4.4.9 The contribution of EDHF and NO to Yoda1-induced relaxation 
It is well known that EDHF is a mechanism for endothelium-dependent vasodilatation. 
However, Yoda1-induced vasodilation does not seem to be different from that of 
mesenteric arteries incubated with apamin plus charybdotoxin, indicating that EDHF 
does not contribute to Yoda1 responses.  
Piezo1 is important for alignment of ECs in response to shear stress and for the 
phosphorylation of endothelial NOS in the presence of VEGF (Li et al., 2014) and also 
Yoda1 induced NOS phosphorylation (Wang et al., 2016). Relaxation induced by in 
control segments treated with the endothelial NOS inhibitor L-NAME was impaired. 
Yoda1 relaxation appears to act through NO pathways. These results showed the effect 
of L-NAME on the Yoda1 response which does not match a previous observation that in 
vessels with denuded endothelium, the relaxation response of Yoda1 can still be 
observed, suggesting that the endothelium may play a minor role in endothelium-
dependent relaxations and a dominant role of endothelial NOS activity. In contrast, 
mesenteric artery segments from Piezo1∆EC mice were insensitive to the endothelial NOS 
inhibitor L-NAME. Furthermore, after denuding the ECs the incubation with L-NAME did 
not reduce the Yoda1-induced relaxation and the independent relaxation effect of Yoda1 
is clear in mesenteric arteries from wild-type mic.  
Overall, the Yoda1 response has both endothelium-dependent and independent 
vasodilation. However, the endothelium-dependent effect did not reach statistical 
significance, thus without increasing the numbers of these experiments this effect is still 
difficult to show. This could be related to the fact that Yoda1 has both endothelium 
dependent vasodilator and vasoconstrictor effects of Yoda1, which makes it difficult to 
ensure that an endothelium-dependent vasodilator effect of Yoda1 is seen. Moreover, 
the presence of endothelium and vascular smooth muscle is necessary for endothelial 
NOS and Yoda1 activation of Piezo1, because the loss of the endothelium means the 
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loss of the vascular smooth muscle Piezo1 channel dependency on endothelial NOS. 
However, the reason why they lose this dependence is unknown, but it might relate to a 
signalling system between ECs and VSMCs, whereby the VSMCs adapt to achieve 
different properties when the endothelium is damaged. Hence, endothelial damage can 
lead to change in the mechanisms or the properties of the vascular SMCs. 
4.5 Conclusion 
The data presented here suggest that constitutive Piezo1 channel activity in the 
endothelium normally opposes ACh-induced vasorelaxation of mouse mesenteric 
arteries with Piezo1 deletion and EDHF contributing to this relaxation. A possible 
mechanism is that Piezo1 channel activity depolarises the membrane, therefore 
counteracting the effect of ACh (Fig. 4.34). The consequence is that Piezo1 in the 
endothelium may increase BP. However, activation of Piezo1 channels by Yoda1 leads 
to relaxation, suggesting the potential to lower BP by enhancing Piezo1 channel activity 
over and above the constitutive level. Furthermore, endothelial Piezo1 may be a 
molecular mechanism for sensing whole body physical activity. The channels could 
sense and transduce fluid-flow into constriction of mesenteric arteries leading to 
increased BP at the time of physical activity where these arteries contribute to total 
peripheral resistance.  
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Figure 4-34: Ischaemic diagram presenting the effects of Piezo1 channel activity 
in the endothelial cells    
Relaxation 
 
VSMC 
Anti-EDHF 
Ca
2
+
NO 
NOS 
EC 
Depolarization 
Contraction  
 
Piezo1  
Na
2
+
165 
 
 
Chapter 5 Lack of role of endothelial Piezo1 in 
saphenous and carotid arteries of mice 
5.1 Introduction  
The arterial system is the network of blood vessels which carries oxygenated blood from 
the heart to organs. Beginning with the ascending aorta the arterial system undergoes 
repeated branching, both as asymmetrical bifurcations and also higher order branching.  
Fig. 5.1 demonstrates the arteries’ anatomical layout. It also reveals the reduction in the 
diameter of the arteries as they advance to the periphery. Diameter variations also 
happen at the branches, with the daughter branches having smaller diameters than the 
parent. The descending aorta is also noticeably tapered, narrowing as it spreads away 
from the heart. It is evident that functional and morphological properties of elastic and 
muscular arteries vary considerably. Elastic arteries, such as the aorta and the carotid 
artery, include more elastin per unit area and have significant pulse-smoothing properties 
of the pressure wave starting in the left ventricle. On the other hand, the muscular 
arteries, such as femoral or mesenteric arteries, have relatively more smooth muscle 
and less elastin. They distribute the blood according to moment-to-moment demands 
and are more able of vasoconstriction and dilation. The structure of the arterial system 
in humans and in several other mammals is comparable. Several mammalian species 
illustrate similar pressure and flow waveforms at several sites along the arterial tree 
(Leloup et al., 2015).  
Having established that the functional role of endothelial Piezo1 differs between the aorta 
(Chapter 3) and mesenteric arteries (Chapter 4), in this chapter two further arteries are 
studied in order to further our understanding of this channel’s involvement in the 
mammalian arterial system. The saphenous artery, a skeletal muscle vessel that 
supplies the leg, and the carotid artery, a main blood vessel that supplies the brain, were 
chosen for comparison. As in the previous chapters, the functional responses of 
saphenous and carotid arteries from control and Piezo1∆EC mice were assessed by wire 
myography. There are currently no reports in the literature relating to Piezo1 function or 
expression in ECs in these vessels. 
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Figure 5-1: Schematic representation of arterial vessels topography and preparation of mouse arteries. 
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5.2 Results 
5.2.1 Deletion of endothelial cell Piezo1 does not affect high 
potassium-induced contraction  
Incubation of saphenous and carotid arteries from control and Piezo1∆EC mice in high K+ 
(60 mM) over a 10 minute period induced constriction, confirming their viability.  
Saphenous and carotid arteries from control and Piezo1∆EC mice displayed typical K+-
induced contraction as shown in Fig. 5.2a and 5.2b respectively (saphenous artery) and 
Fig. 5.3a and 5.3b respectively (carotid artery). Similar to previous findings 
(Golubinskaya et al., 2014), the active tone of saphenous arteries was around ~ 5 mN, 
and in carotid arteries was about ~1.3 mN. Of the four vessels tested in this thesis carotid 
arteries were the least contractile in response to high K+, this difference possibly relating 
to size, composition and role of the vessel. K+-induced contractions were similar in 
magnitude for control and Piezo1∆EC mice in both saphenous and carotid arteries (Fig. 
5.2c and 5.3c). These data suggest that in EC Piezo1 deletion does not affect K+-induced 
contraction in either saphenous or carotid arteries. 
5.2.2 Deletion of endothelial cell Piezo1 does not affect 
phenylephrine-induced contraction  
After the standard high K+ start procedure, contractions to increasing concentrations of 
PE were measured to further assess the contractile responses of the vessels (similar 
dose range for PE that used with mouse mesenteric artery). Representative traces of 
PE-induced tone are provided of saphenous and carotid arteries from control and 
Piezo1∆EC mice (Fig. 5.4a and 5.4b, respectively of saphenous artery and Fig. 5.5a and 
5.5b, respectively of carotid artery). The two vessels displayed distinct sensitivities and 
responsiveness.  
At 1 μM PE saphenous arteries were ~50% contracted, while carotid arteries were 
~130% contracted, the greater than 100% value arising because PE responses are 
expressed as percentage of the 60 mM of high K+-induced contraction. Furthermore, 
contraction to PE was seen at a slightly lower concentration for carotid than saphenous 
arteries, 0.1 μM compared with 0.03 μM. For both vessels, however, there was no 
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difference in the PE-induced tone between control and Piezo1∆EC mice (Fig. 5.4c, 5.4d 
and 5.5c, 5.5d). These data suggest that the sensitivity to PE in the saphenous and 
carotid arteries is not influenced by endothelial Piezo1. 
5.2.3 Deletion of endothelial cell Piezo1 does not affect ACh-
induced vasorelaxation 
Saphenous and carotid arteries were pre-contracted with 0.3 µM PE in order to establish 
a maintained constriction of the vessel upon which concentration dependent relaxations 
to ACh could be assessed. When a stable plateau in tension was achieved, each ring 
was exposed to increasing concentrations of ACh to generate concentration-dependent 
relaxation responses.  
In saphenous arteries relaxation was observed at concentrations equal to or above 0.01 
μM ACh (the dose range for ACh was based on prior experiments examining mouse 
mesenteric arteries). However, in carotid arteries, since transient contraction (rather than 
relaxation) was observed in response to ACh concentrations above 0.03 μM, the 
concentration range tested had to be extended down to 1 nM to assess ACh-induced 
relaxation. The maximal magnitude of relaxation was very similar (~90%) in both arteries, 
although this occurred at different concentrations  Particular sensitivity of the carotid 
artery to ACh has been reported previously, as compared with the femoral artery 
(Crauwels et al., 2000).  
In carotid arteries at concentrations of ACh above 0.03 µM, contractions, rather than 
relaxations were observed. These contractions likely correspond to the EDCF that has 
been demonstrated in mouse carotid arteries and other blood vessels (Furchgott and 
Vanhoutte, 1989, Tang et al., 2005). The fundamentals of the EDCF cell-signalling 
pathway seem to be as follows. In response to receptor activation, an increase in 
endothelial [Ca2+]i stimulates Ca2+-dependent phospholipase A2, releasing arachidonic 
acid that is subsequently metabolised via cyclooxygenases resulting in the synthesis and 
liberation of endoperoxides and/or prostaglandins. These then travel to the VSMCs, 
stimulating thromboxane prostanoid receptors and leading to calcium influx into the 
SMCs and so activation of contractile signalling. (Fig. 5.6) (Katusic et al., 1988, Miller 
and Vanhoutte, 1985, Tang et al., 2005). This phenomenon was not observed in 
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saphenous arteries, which could be related to differential sensitivity of different types of 
artery or that the EDCF is not created in saphenous arteries. 
Representative traces of ACh concentration response curves in control and Piezo1∆EC 
mice saphenous and carotid arteries are provided in Fig 5.7 and 5.8. The control and 
Piezo1∆EC mice saphenous arteries showed a steady decrease in tension until a maximal 
relaxation of near 80% was achieved, thus almost fully reversing the PE induced 
contraction (Fig. 5.7a and 5.7b, respectively of saphenous artery and Fig. 5.8a and 5.8b, 
respectively of carotid artery). The response to cumulative concentrations of ACh, for 
both control and Piezo1∆EC mice saphenous and carotid arteries, was not different (Fig. 
5.7c for saphenous artery and Fig. 5.8c for carotid artery). Furthermore, no difference 
was found in the AUC of the response to ACh for each individual curve as indicated in 
Fig. 5.7d and 5.8d of saphenous and carotid arteries from control and Piezo1∆EC mice 
respectively. Overall, this suggests that the response to ACh was not modified by 
deletion of endothelial Piezo1 in saphenous or carotid arteries.  
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Figure 5-2: Vascular reactivity to high potassium (60 mM K+) in control compared 
with endothelial Piezo1∆EC saphenous arteries  
(a) Typical wire myograph trace, demonstrating vasoconstriction in response to high 
potassium solution that validates arterial viability prior to experimentation, in saphenous 
arteries isolated from control mice. (b) As for (a) except in saphenous arteries isolated 
from Piezo1∆EC mice. (c) Comparison of response to high potassium (K+)-induced 
contraction in saphenous arteries of control (n=10) and Piezo1∆EC mice (n=7). 
Responses are expressed by the absolute value of the K+-induced contraction. Mean ± 
SEM values are depicted. NS=not significant.  
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Figure 5-3: Vascular reactivity to high potassium (60 mM K+) in control compared 
with endothelial Piezo1∆EC carotid arteries  
(a) Typical wire myograph trace, demonstrating vasoconstriction in response to high 
potassium solution that validates arterial viability prior to experimentation, in carotid 
arteries isolated from control mice. (b) As for (a) except in carotid arteries isolated from 
Piezo1∆EC mice. (c) Comparison of response to high potassium (K+)-induced contraction 
in carotid arteries of control (n=10) and Piezo1∆EC mice (n=9). Responses are expressed 
by the absolute value of the K+-induced contraction. Mean ± SEM values are depicted. 
NS=not significant.  
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Figure 5-4: Vascular reactivity to phenylephrine in control compared with 
endothelial Piezo1∆EC saphenous arteries  
(a) Typical wire myograph tracing, demonstrating increased tone in response to 
phenylephrine (PE) as indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM) in saphenous 
arteries isolated from control mice. (b) As for (a) except in saphenous arteries isolated 
from Piezo1∆EC mice. (c) Concentration response curves to PE in control; n=11) and 
Piezo1∆EC (n=9) mice. (d) The area under the curve (AUC) of the response to PE for each 
individual curve of saphenous arteries isolated from control (n=11) and Piezo1∆EC mice 
(n=9). Responses are expressed as percent constriction and as the area under the curve 
(AUC) of the response to PE. Mean ± SEM values are depicted. NS=not significant.  
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Figure 5-5: Vascular reactivity to phenylephrine in control compared with 
endothelial Piezo1∆EC carotid arteries  
(a) Typical wire myograph tracing, demonstrating increased tone in response to 
phenylephrine (PE) as indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM) in carotid 
arteries isolated from control mice. (b) As for (a) except in carotid arteries isolated from 
Piezo1∆EC mice. (c) Concentration response curves to PE in control; n=15) and Piezo1∆EC 
(n=11) mice. (d) The area under the curve (AUC) of the response to PE for each 
individual curve of carotid arteries isolated from control (n=11) and Piezo1∆EC mice (n=9). 
Responses are expressed as percent constriction and as the area under the curve (AUC) 
of the response to PE. Mean ± SEM values are depicted. NS=not significant.  
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Figure 5-6: EDCF cell-signalling activity  
Arachidonic acid (AA) can be metabolised into endoperoxides by cyclooxygenases, 
which can be additionally broken down through enzymes producing prostaglandin E2, 
prostaglandin D2, prostaglandin F2, prostacyclin, and also thromboxane A2. One or 
several of these prostanoids can diffuse across to the smooth muscle cell (SMC) and 
activate thromboxane prostanoid (TP) receptors, which leads to calcium (Ca2+) influx into 
the SMC and induces its contraction.  
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Figure 5-7: Vascular reactivity to ACh in control compared with endothelial 
Piezo1∆EC saphenous arteries  
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM) in saphenous arteries 
isolated from control mice. (b) As for (a) except in saphenous arteries isolated from 
Piezo1∆EC mice. (c) Concentration response curves to ACh in control (n=10) and 
Piezo1∆EC (n=7) mice. (d) The area under the curve (AUC) of the response to ACh of 
saphenous arteries isolated from control (n=10) and Piezo1∆EC mice (n=7). Responses 
are expressed as percent relaxation, and as the area under the curve (AUC) of the 
response to ACh. Mean ± SEM values are depicted. NS=not significant. 
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Figure 5-8: Vascular reactivity to ACh in control, compared with endothelial 
Piezo1∆EC carotid arteries  
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.001, 0.003, 0.01, 0.03 and 0.1 μM) in carotid arteries 
isolated from control mice. (b) As for (a) except in carotid arteries isolated from Piezo1∆EC 
mice. (c) Concentration response curves to ACh in control (n=10) and Piezo1∆EC (n=9) 
mice. (d) The area under the curve (AUC) of the response to ACh of carotid arteries 
isolated from control (n=10) and Piezo1∆EC mice (n=8). Responses are expressed as 
percent relaxation, and as the area under the curve (AUC) of the response to ACh. Mean 
± SEM values are depicted. NS=not significant.  
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5.2.4 Deletion of endothelial cell Piezo1 does not affect EDHF-
mediated-vasorelaxation 
As in the previous chapter, the ACh response was analysed in more detail, assessing 
the contributions of both the EDHF and NO derived mechanisms underlying the 
relaxation induced. Again apamin and charybdotoxin, blockers of SKCa2+ and IKCa2+ 
channels respectively located on the endothelium, were employed to prevent 
hyperpolarisation of the endothelial cell but leave the NO component of relaxation intact. 
Apamin and charybdotoxin had no effect on either the basal or PE-induced tension in 
either vessel nor on the ACh-induced relaxation of the carotid artery (Fig. 5.11 and 5.12). 
The blockers did, however, significantly reduce the magnitude of the ACh-induced 
relaxation of the saphenous artery (Fig. 5.9 and 5.10).  
Saphenous and carotid arteries from control and Piezo1∆EC mice displayed a typical trace 
of ACh-induced relaxation before and after incubation with apamin plus charybdotoxin 
(Fig. 5.9a and 5.10a, respectively for the saphenous artery and Fig. 5.11a and 5.12a, 
respectively for the carotid artery). Comparing control with Piezo1∆EC mice vessels, no 
differences were observed in the resting tone (Fig. 5.9b and 5.10b, respectively of the 
saphenous artery and Fig. 5.11b and 5.12b, respectively of the carotid artery) or PE-
induced contraction (Fig. 5.9c to 5.12c). Similar significant differences were observed in 
ACh-induced relaxation of mouse saphenous arteries from both strains of mice when the 
combination of the apamin plus charybdotoxin inhibitors was used (44% decrease for 
control and 39% decrease for Piezo1∆EC) (Fig. 5.9d-5.10d). As for control mice, apamin 
plus charybdotoxin had no effect on the ACh-induced relaxation of carotid arteries of 
Piezo1∆EC mice (Fig. 5.11d-5.12d). The data suggest that endothelial Piezo1 is of no 
consequence to the EDHF-derived component of the ACh response.  
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Figure 5-9: EDHF-mediated-vasorelaxation in control mice saphenous arteries  
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM) before and after the 
incubation with apamin (Apa) (500 nM) plus charybdotoxin (Ch) (100 nM) in saphenous 
arteries isolated from control mice. (b) Quantification of the Apa+Ch effects on the basal 
saphenous artery tension (n=5). (c) Quantification of the Apa+Ch effects on 
phenylephrine (PE)-induced constriction in control saphenous arteries of mice (n=5). (d) 
Concentration response curves to ACh before and after the application of Apa+Ch in 
control saphenous arteries of mice (n=5). (e) The area under the curve (AUC) of the 
response to ACh before and after the incubation with Apa+Ch of saphenous arteries, 
isolated from control mice (n=5). Responses are expressed as percent constriction and 
as the area under the curve (AUC) of the response to ACh. Mean ± SEM values are 
depicted. Asterisks indicate statistically significant difference (*p<0.05 and **p<0.1). 
NS=not significant.  
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Figure 5-10: EDHF-mediated-vasorelaxation in endothelial Piezo1∆EC mice 
saphenous arteries  
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM) before and after the 
incubation with apamin (Apa) (500 nM) plus charybdotoxin (Ch) (100 nM) in saphenous 
arteries isolated from Piezo1∆EC mice. (b) Quantification of the Apa+Ch effects on the 
basal artery tension (n=5). (c) Quantification of the Apa+Ch effects on phenylephrine 
(PE)-induced constriction in Piezo1∆EC saphenous arteries of mice (n=5). (d) 
Concentration response curves to ACh before and after the application of Apa+Ch in 
Piezo1∆EC saphenous arteries of mice (n=5). (e) The area under the curve (AUC) of the 
response to ACh before and after the incubation with Apa+Ch of saphenous arteries 
isolated from Piezo1∆EC mice (n=5). Responses are expressed as percent constriction 
and as the area under the curve (AUC) of the response to ACh. Mean ± SEM values are 
depicted. Asterisks indicate statistically significant difference (*p<0.05 and **p<0.01). 
NS=not significant.  
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Figure 5-11: EDHF-mediated-vasorelaxation in control mice carotid arteries  
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.001, 0.003, 0.01, 0.03 and 0.1 μM) before and after the 
incubation with apamin (Apa) (500 nM) plus charybdotoxin (Ch) (100 nM) in carotid 
arteries isolated from control mice. (b) Quantification of the Apa+Ch effects on the basal 
carotid artery tension (n=5). (c) Quantification of the Apa+Ch effects on phenylephrine 
(PE)-induced constriction in control carotid arteries of mice (n=5). (d) Concentration 
response curves to ACh before and after the application of Apa+Ch in control carotid 
arteries of mice (n=5). (e) The area under the curve (AUC) of the response to ACh before 
and after the incubation with Apa+Ch of carotid arteries, isolated from control mice (n=4). 
Responses are expressed as percent constriction and as the area under the curve (AUC) 
of the response to ACh. Mean ± SEM values are depicted. NS=not significant.  
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Figure 5-12: EDHF-mediated-vasorelaxation in endothelial Piezo1∆EC mice carotid 
arteries  
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.001, 0.003, 0.01, 0.03 and 0.1 μM) before and after the 
incubation with apamin (Apa) (500 nM) plus charybdotoxin (Ch) (100 nM) in carotid 
arteries isolated from Piezo1∆EC mice. (b) Quantification of the Apa+Ch effects on the 
basal artery tension (n=5). (c) Quantification of the Apa+Ch effects on phenylephrine 
(PE)-induced constriction in Piezo1∆EC carotid arteries of mice (n=5). (d) Concentration 
response curves to ACh before and after the application of Apa+Ch in Piezo1∆EC carotid 
arteries of mice (n=5). (e) The area under the curve (AUC) of the response to ACh before 
and after the incubation with Apa+Ch of carotid arteries isolated from Piezo1∆EC mice 
(n=5). Responses are expressed as percent constriction and as the area under the curve 
(AUC) of the response to ACh. Mean ± SEM values are depicted. NS=not significant.  
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5.2.5 Deletion of endothelial cell Piezo1 does not affect NO-
mediated-vasorelaxation 
L-NAME, a NOS inhibitor, was used to study the NO contribution to this ACh-induced 
relaxation. Saphenous and carotid arteries from control and Piezo1∆EC mice showed a 
typical trace of ACh-induced relaxation before and after the incubation with L-NAME (Fig. 
5.13a and 5.14a, respectively of saphenous arteries and Fig. 5.15a and 5.16a, 
respectively of the carotid artery). After the first concentration-response curves to ACh, 
the saphenous and carotid arteries from control mice were washed with Krebs solution 
and the procedure was repeated following incubation with L-NAME to block the 
production of NO. No difference in resting tone was observed in control saphenous 
arteries (Fig. 5.13b), but a significant increase was apparent for control carotid arteries 
(Fig. 5.15b), indicating that the basal NO release is not important for saphenous arteries 
but is essential for carotid arteries. The magnitude of the PE response increased in both 
arteries in the presence of L-NAME (30% for the saphenous artery and 51% for the 
carotid artery) (Fig. 5.13c and 5.15c, respectively). Furthermore, in the saphenous artery 
L-NAME decreased the ACh-induced relaxation by 77%, the magnitude of this decrease 
fitting reasonably well with the apamin plus charybdotoxin data (44% reduction).  In 
control carotid arteries, which displayed a minimal EDHF component to the ACh 
response (Fig. 5.11d), L-NAME almost completely abolished relaxation (95% decrease) 
(Fig. 5.15d). The contraction element of the ACh response in carotid arteries remained 
evident over a similar concentration range in the presence of L-NAME (Fig. 5.15d). This 
suggests, as expected, that the EDCF mechanism is NO-independent.  
Similar to saphenous arteries from control, no differences were observed in the resting 
tone of saphenous arteries from Piezo1∆EC mice when L-NAME was used (Fig. 5.13b 
and 5.14b respectively). Moreover, further significant contraction was observed in 
response to the pre-constriction with PE (30% increase for control and 25% increase for 
Piezo1∆EC) (Fig. 5.13c and 14c respectively). As for saphenous arteries from control 
mice, incubation with L-NAME significantly reduced the ACh-induced relaxation in 
saphenous arteries from Piezo1∆EC mice (77% decrease for control and 71% decrease 
for Piezo1∆EC) (Fig. 5.13d and 5.14d respectively), and also a significant difference was 
observed in the AUC of the response to ACh, before and after the incubation with L-
NAME in control and Piezo1∆EC mice saphenous arteries (Fig. 5.13e and 5.14e 
respectively). 
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Similar to carotid arteries from control mice, in carotid arteries from Piezo1∆EC mice, 
significant differences were found in the resting tone and in response to the pre-
constriction with PE (51% increase for control and 42% increase for Piezo1∆EC) when L-
NAME was used (Fig. 5.15b, 5.15c and 5.16b, 5.16c respectively). Furthermore, ACh-
mediated relaxation was totally abolished by the NOS inhibitor in both mouse strains 
(95% decrease for control and 100% decrease for Piezo1∆EC). However, contraction 
remained over a similar concentration range in both control and Piezo1∆EC mice (Fig. 
5.15d and 5.16d, respectively). A significant difference was also found in the AUC of the 
response to ACh before and after incubation with L-NAME in carotid arteries from control 
and Piezo1∆EC mice (Fig. 5.15e and 5.16e, respectively). This indicates that the 
relaxation in these arteries is mediated by NO. Overall, the data suggest that endothelial 
Piezo1 is of no consequence to the NO-derived ACh response. 
5.2.6 The effect of removal of endothelial cells on ACh-induced 
relaxation  
After undergoing the same set-up protocol used prior to the ACh concentration-response 
curve experiments of saphenous and carotid arteries were also performed on 
endothelium-denuded arteries. This was used to confirm that the relaxation-induced by 
ACh was endothelium-dependent and to further investigate the ACh response (Fig. 5.17a 
and 5.18a, respectively of saphenous arteries and Fig. 5.19a and 5.20a, respectively of 
the carotid artery). After removal of the endothelium by rubbing the endothelial surface 
of the artery with a wire, arteries were pre-contracted with PE (0.3 µM), and then exposed 
to increasing concentrations of ACh (0.1 µM to 1 µM for saphenous arteries and (0.001 
µM to 0.1 µM) to generate concentration-response curves (Fig. 5.17b and 5.18b, 
respectively of saphenous arteries and Fig. 5.19b and 5.20b, respectively of carotid 
artery). In endothelium-denuded saphenous arteries from control mouse, there was no 
change in PE response and no response to ACh. However, in endothelium-denuded 
carotid arteries from control mouse, an increase in PE contraction was seen where 
removing the ECs prevented NO release, which linked to the L-NAME data. Furthermore, 
contraction in response to ACh was observed which fits with the L-NAME data. SIN-1-
induced relaxation was unaffected by the removal of ECs in saphenous and carotid 
arteries from both control groups of mice. Further experiments are needed to show if this 
contractile effect without PE pre-stimulation can be seen. 
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Similar to control saphenous arteries, the data showed that removing the endothelium 
did not modify PE-induced contraction in Piezo1∆EC mice saphenous arteries (2% 
increase for control and % 10 increase for Piezo1∆EC) (Fig. 5.17c and 5.18c). In both 
control carotid arteries and Piezo1∆EC carotid arteries, removing the endothelium 
potentiated PE-induced contraction (20% increase for control and 23% increase for 
Piezo1∆EC) (Fig. 5.19c and 5.20c) indicating the presence of endothelium-derived 
relaxing factors. Furthermore, ACh-induced relaxation was abolished in Piezo1∆EC 
saphenous arteries and carotid arteries of mice, and compared to endothelium intact 
arteries, the difference was significant (100% decrease for control and 95% decrease for 
Piezo1∆EC, 96% decrease for control and 99% decrease for Piezo1∆EC, respectively) (Fig. 
5.17d and 18d, respectively of saphenous arteries and Fig. 5. 19d and 20d, respectively 
of carotid artery). A significant difference was found in the AUC of the response to ACh 
before and after removing the ECs (Fig. 5.17e and 18e, respectively of saphenous 
arteries and Fig. 5.19e and 20e, respectively of carotid artery). These results are 
opposite to those obtained with the L-NAME experiments. The endothelial-independent 
relaxation responses to the NO donor, SIN-1 were also obtained in Piezo1∆EC mice 
saphenous and carotid arteries to assess the endothelium-independent relaxation 
responses and if Piezo1 has a role in SIN-1 response. 
SIN-1 (0.01–1 μM) induced relaxation was unaffected by the removal of EC in both 
groups of Piezo1∆EC mice saphenous and carotid arteries (Fig. 5.21a for saphenous 
arteries and Fig. 5. 22a for carotid artery). No differences were found in the AUC of the 
response to SIN-1 between control and Piezo1∆EC mice saphenous and carotid arteries 
(Fig. 5.21b for saphenous arteries and Fig. 5.22b for carotid artery). These data suggest 
that each of these effects is due to endothelium-dependent effects of ACh in control and 
Piezo1∆EC mice saphenous and carotid arteries and that the SIN-1 response is Piezo1 
independent.   
185 
 
 
 
Figure 5-13: NO-mediated-vasorelaxation in control mice saphenous arteries  
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM) before and after the 
incubation with (100 μM) Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME) in 
saphenous arteries isolated from control mice. (b) Quantification of the L-NAME effects 
on the basal saphenous artery tension (n=5). (c) Quantification of the L-NAME effects 
on phenylephrine (PE)-induced constriction in control saphenous arteries of mice (n=5). 
(d) Concentration response curves to ACh before and after the application of L-NAME in 
control saphenous arteries mice (n=5). (e) The area under the curve (AUC) of the 
response to ACh before and after incubation with L-NAME of saphenous arteries isolated 
from control mice (n=5). Responses are expressed as percent constriction and as the 
area under the curve (AUC) of the response to ACh. Mean ± SEM values are depicted. 
Asterisks indicate statistically significant difference (*p<0.05, **p<0.01 and ***P<0.001). 
NS=not significant.  
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Figure 5-14: NO-mediated-vasorelaxation in Piezo1∆EC mice saphenous arteries  
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM) before and after the 
incubation with (100 μM) Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME) in 
saphenous arteries isolated from control mice. (b) Quantification of the L-NAME effects 
on the basal saphenous artery tension (n=3). (c) Quantification of the L-NAME effects 
on phenylephrine (PE)-induced constriction in control saphenous arteries of mice (n=3). 
(d) Concentration response curves to ACh before and after the application of L-NAME in 
control saphenous arteries mice (n=3). (e) The area under the curve (AUC) of the 
response to ACh before and after incubation with L-NAME of saphenous arteries isolated 
from control mice (n=3). Responses are expressed as percent constriction and as the 
area under the curve (AUC) of the response to ACh. Mean ± SEM values are 
depicted.*p<0.05, for ACh in control mice. Asterisks indicate statistically significant 
difference (*p<0.05). NS=not significant.  
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Figure 5-15: NO-mediated-vasorelaxation in control mice carotid arteries 
 (a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.001, 0.003, 0.01, 0.03 and 0.1 μM) before and after the 
incubation with (100 μM) Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME) in 
carotid arteries isolated from control mice. (b) Quantification of the L-NAME effects on 
the basal carotid artery tension (n=5). (c) Quantification of the L-NAME effects on 
phenylephrine (PE)-induced constriction in control carotid arteries of mice (n=5). (d) 
Concentration response curves to ACh before and after the carotid of L-NAME in control 
carotid arteries mice (n=5). (e) The area under the curve (AUC) of the response to ACh 
before and after incubation with L-NAME of carotid arteries isolated from control mice 
(n=5). Responses are expressed as percent constriction and as the area under the curve 
(AUC) of the response to ACh. Mean ± SEM values are depicted.*p<0.05 and 0.001 for 
ACh in control mice. Asterisks indicate statistically significant difference (*p<0.05 and 
**p<0.001).  
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Figure 5-16: NO-mediated-vasorelaxation in Piezo1∆EC mice carotid arteries 
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.001, 0.003, 0.01, 0.03 and 0.1 μM) before and after the 
incubation with (100 μM) Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME) in 
carotid arteries isolated from control mice. (b) Quantification of the L-NAME effects on 
the basal carotid artery tension (n=3). (c) Quantification of the L-NAME effects on 
phenylephrine (PE)-induced constriction in control carotid arteries of mice (n=3). (d) 
Concentration response curves to ACh before and after the carotid of L-NAME in control 
carotid arteries mice (n=3). (e) The area under the curve (AUC) of the response to ACh 
before and after incubation with L-NAME of carotid arteries isolated from control mice 
(n=3). Responses are expressed as percent constriction and as the area under the curve 
(AUC) of the response to ACh. Mean ± SEM values are depicted. Asterisks indicate 
statistically significant difference (*p<0.05 and **p<0.01).  
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Figure 5-17: The effect of removal of endothelial cells on ACh induced-relaxation 
in control mice saphenous arteries  
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM) before removing the 
endothelial cells. (b) Typical trace showing a concentration-dependent dilatory response 
to ACh after removing the endothelial cells (-EC) and the application of (concentration) 
amino-3-morpholinyl-1,2,3-oxadiazolium (SIN-1) as indicated by the dots (0.01, 0.03, 
0.1, 0.3 and 1 μM)  (c) Quantification of the effects of removing the endothelial cells on 
phenylephrine (PE)-induced constriction in control saphenous arteries of mice (n=7). (d) 
Concentration response curves to ACh in saphenous arteries of control mice before and 
after endothelial cells removing (n=7). (e) The area under the curve (AUC) of the 
response to ACh before and after removing the endothelial cells of saphenous arteries 
isolated from control mice (n=7). Responses are expressed as percent constriction and 
as the area under the curve (AUC) of the response to ACh. Mean ± SEM values are 
depicted. Asterisks indicate statistically significant difference (*p< 0.05, **p<0.01 and 
***p<0.001). NS=not significant. 
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Figure 5-18: The effect of removal of endothelial cells on ACh induced-relaxation 
in Piezo1∆EC mice saphenous arteries  
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.01, 0.03, 0.1, 0.3 and 1 μM) before removing the 
endothelial cells. (b) Typical trace showing a concentration-dependent dilatory response 
to ACh after removing the endothelial cells (-EC) and the application of (concentration) 
amino-3-morpholinyl-1,2,3-oxadiazolium (SIN-1) as indicated by the dots (0.01, 0.03, 
0.1, 0.3 and 1 μM)  (c) Quantification of the effects of removing the endothelial cells on 
phenylephrine (PE)-induced constriction in Piezo1∆EC saphenous arteries of mice (n=5). 
(d) Concentration response curves to ACh in Piezo1∆EC arteries of control mice before 
and after endothelial cells removing (n=5). (e) The area under the curve (AUC) of the 
response to ACh before and after removing the endothelial cells of saphenous arteries 
isolated from Piezo1∆EC mice (n=5). Responses are expressed as percent constriction 
and as the area under the curve (AUC) of the response to ACh. Mean ± SEM values are 
depicted. Asterisks indicate statistically significant difference (**p< 0.01 and ***p<0.001). 
NS=not significant.  
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Figure 5-19: The effect of removal of endothelial cells on ACh induced-relaxation 
in control mice carotid arteries.  
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.001, 0.003, 0.01, 0.03 and 0.1 μM) before removing 
the endothelial cells. (b) Typical trace showing a concentration-dependent dilatory 
response to ACh after removing the endothelial cells (-EC) and the application of 
(concentration) amino-3-morpholinyl-1,2,3-oxadiazolium (SIN-1) as indicated by the dots 
(0.001, 0.003, 0.01, 0.03 and 0.1 μM) (c) Quantification of the effects of removing the 
endothelial cells on phenylephrine (PE)-induced constriction in control carotid arteries of 
mice (n=8). (d) Concentration response curves to ACh in carotid arteries of control mice 
before and after endothelial cells removing (n=8). (e) The area under the curve (AUC) of 
the response to ACh before and after removing the endothelial cells of carotid arteries 
isolated from control mice (n=8). Responses are expressed as percent constriction and 
as the area under the curve (AUC) of the response to ACh. Mean ± SEM values are 
depicted. Asterisks indicate statistically significant difference (*p< 0.05, **p<0.01 and 
***p<0.001).  
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Figure 5-20: The effect of removal of endothelial cells on ACh induced-relaxation 
in Piezo1∆EC mice carotid arteries  
(a) Typical trace showing a concentration-dependent dilatory response to acetylcholine 
(ACh) as indicated by the dots (0.001, 0.003, 0.01, 0.03 and 0.1 μM) before removing 
the endothelial cells. (b) Typical trace showing a concentration-dependent dilatory 
response to ACh after removing the endothelial cells (-EC) and the application of 
(concentration) amino-3-morpholinyl-1,2,3-oxadiazolium (SIN-1) as indicated by the dots 
(0.001, 0.003, 0.01, 0.03 and 0.1 μM) (c) Quantification of the effects of removing the 
endothelial cells on phenylephrine (PE)-induced constriction in Piezo1∆EC carotid arteries 
of mice (n=8). (d) Concentration response curves to ACh in carotid arteries of Piezo1∆EC 
mice before and after endothelial cells removing (n=8). (e) The area under the curve 
(AUC) of the response to ACh before and after removing the endothelial cells of carotid 
arteries isolated from Piezo1∆EC mice (n=8). Responses are expressed as percent 
constriction and as the area under the curve (AUC) of the response to ACh. Mean ± SEM 
values are depicted. Asterisks indicate statistically significant difference (*p< 0.05 and 
***p<0.001).  
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Figure 5-21: Comparison of effects of removing the endothelial cells in control and 
endothelial Piezo1∆EC mice saphenous arteries.  
(a) Concentration response curves to NO-donator, Linsidomine (SIN-1) in saphenous 
arteries from control and Piezo1∆EC mice (n=7 and 5, respectively). (b) The area under 
the curve (AUC) of the response to SIN-1 in saphenous arteries isolated from control 
Piezo1∆EC mice (n=7 and 5, respectively). Data are expressed as percent constriction 
and the AUC of the response to ACh. Mean ± SEM values are depicted. NS=not 
significant.  
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Figure 5-22: Comparison of effects of removing the endothelial cells in control and 
endothelial Piezo1∆EC mice carotid arteries.  
(a) Concentration response curves to NO-donator, Linsidomine (SIN-1) in carotid arteries 
from control and Piezo1∆EC mice (n=8 and 5, respectively). (b) The area under the curve 
(AUC) of the response to SIN-1 in carotid arteries isolated from control Piezo1∆EC mice 
(n=8 and 5, respectively). Data are expressed as percent constriction and the AUC of 
the response to ACh. Mean ± SEM values are depicted. NS=not significant.  
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5.2.7 Yoda1 induced relaxation in the saphenous and carotid 
arteries of control and Piezo1∆EC mice  
The aim was to determine if activation of Piezo1 by Yoda1,a synthetic small-molecule 
activator of Piezo1 (Syeda et al., 2015), results in contraction/relaxation of arteries.  
Endothelium-intact saphenous arteries from control and Piezo1∆EC mice were pre-
contracted with PE (0.3 µM) then Yoda1 (0.1–10 μM) was applied as shown in Fig. 5.23a, 
and 5.23b respectively. Only a small concentration-dependent relaxation response of 
Yoda1 was seen in saphenous arteries from control and Piezo1∆EC mice. The 
concentration range (0.01 - 10 μM) of activation of Piezo1 channels by Yoda-1 and the 
concentration-response curve in control and Piezo1∆EC mice matched the concentration-
response curve for Yoda1 in HUVECs and HEK-Piezo1 cells (performed by Dr. Melanie 
Ludlow) confirming that the responses are mediated by Piezo1. Furthermore, the 
relaxation was not different between both saphenous arteries from control and Piezo1∆EC 
mice (Fig. 5.23c). No significant difference was found in the AUC of the response to 
Yoda1 for each individual curve in both groups (Fig. 5.23d). These data suggest that 
relaxation induced by Yoda1 might be promoted through other cell types such as 
VSMCs.  
Interestingly Yoda1 caused contraction in carotid arteries with intact endothelium from 
control and Piezo1∆EC mice which were pre-contracted with PE (0.3 µM). When stable 
pre-constrictions were obtained the Yoda1 (0.1–10 μM) response was assessed as 
shown in Fig. 5.24a, and 5.24b respectively, no evidence was found for such an effect 
of Yoda1 in these arteries, where Yoda1 does not have any relaxation effect and caused 
a small contraction in control and Piezo1∆EC mice carotid arteries (Fig. 5.24c). 
Furthermore, no significant difference was observed in the AUC of the response to 
Yoda1 for each individual curve in control and Piezo1∆EC mice carotid arteries (Fig. 
5.24d). Overall, this suggests a lack of role of endothelial Piezo1 in mouse saphenous 
and carotid arteries of mice. Further experiments are needed with Yoda1 in the absence 
of PE pre-constriction.  
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Figure 5-23: Endothelial-dependent relaxation induced by Yoda1 in control 
compared with endothelial Piezo1∆EC saphenous arteries  
(a) Typical trace showing a concentration-dependent dilatory response to Yoda1 as 
indicated by the dots (0.1, 0.3, 1, 3 and 10 μM) in saphenous arteries isolated from 
control mice. (b) As for (a) except in saphenous arteries isolated from Piezo1∆EC mice. 
(c) Concentration response curves to Yoda1 in control (n=5) and Piezo1∆EC (n=5) mice. 
(d) The area under the curve (AUC) of the response to Yoda1 of saphenous arteries 
isolated from control (n=5) and Piezo1∆EC mice (n=5). Responses are expressed as 
percent relaxation, and as the AUC of the response to Yoda1. Mean ± SEM values are 
depicted. NS=not significant.  
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Figure 5-24: Endothelial-dependent relaxation induced by Yoda1 in control 
compared with endothelial Piezo1∆EC carotid arteries  
(a) Typical trace showing a concentration-dependent dilatory response to Yoda1 as 
indicated by the dots (0.1, 0.3, 1, 3 and 10 μM) in carotid arteries isolated from control 
mice. (b) As for (a) except in carotid arteries isolated from Piezo1∆EC mice. (c) 
Concentration response curves to Yoda1 in control (n=6) and Piezo1∆EC (n=7) mice. (d) 
The area under the curve (AUC) of the response to Yoda1 of carotid arteries isolated 
from control (n=6) and Piezo1∆EC mice (n=7). Responses are expressed as percent 
relaxation, and as the AUC of the response to Yoda1. Mean ± SEM values are depicted. 
NS=not significant.  
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5.2.8 The effect of removal of endothelial cells on Yoda1-induced 
relaxation in saphenous and carotid arteries from control and 
Piezo1∆EC mice  
Given that the deletion of Piezo1 in ECs had no effect on the responses to Yoda-1 in 
these vessels, it would suggest that the Yoda-1 induced effects were endothelial-
independent. To confirm this, Yoda-1 was applied to vessels from which the endothelium 
had been removed by gently rubbing the lumen of the arteries with a wire and the failure 
of 1 μM ACh to relax saphenous and carotid arteries was considered as endothelium-
denuded. 
A typical trace for relaxation to Yoda1 was obtained in a concentration dependent 
manner with and without ECs in both control and Piezo1∆EC mice saphenous and carotid 
arteries (Fig. 5.25a and 5.26a for saphenous arteries and 5.27a and 5.28a for carotid 
arteries, respectively). No difference in either vessel confirms endothelial-independence, 
where after removal of the endothelium, Yoda1-induced relaxation remained in control 
and Piezo1∆EC mice saphenous arteries and did not alter this small relaxation response 
in either control or Piezo1∆EC mice saphenous arteries (Fig. 5.25b and 5.26b). The control 
and Piezo1∆EC mice carotid arteries had no difference in their responses to Yoda1 and 
the effect of Yoda1 was not noticeably altered following removal of the ECs in control or 
Piezo1∆EC mice carotid arteries (Fig. 5.27b and 5.28b). Similarly, saphenous arteries from 
Piezo1∆EC mice without functional endothelium have been shown to produce a 
constriction of similar magnitude to PE (Fig. 5.25c and 5.26c, respectively). However, in 
carotid arteries, a significant increase in contraction to PE was seen when endothelium 
was removed (Fig. 5.27c and 5.28c, respectively). Furthermore, no significant difference 
was found in the AUC of the response to Yoda1 before and after removing the ECs in 
control and Piezo1∆EC mice saphenous and carotid arteries (Fig. 5.25d and 5.26d for 
saphenous arteries and 5.27d and 5.28d for carotid arteries, respectively). Therefore, 
these results suggest that Piezo1 might be involved in the small relaxation mediated by 
vascular SMCs in saphenous arteries and without consequence with removing the 
endothelium in carotid arteries.  
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Figure 5-25: The effect of the endothelium removal on Yoda1-induced relaxation 
in saphenous arteries from control mice  
(a) Typical trace showing a concentration-dependent response to Yoda1 as indicated by 
the dots (0.1, 0.3, 1, 3 and 10 μM) in the saphenous arteries isolated from control mice 
before and (b) after EC removing (-EC). (c) Concentration response curves to Yoda1 in 
the saphenous arteries from control mice before and after -EC (n=5). (d) The area under 
the curve (AUC) of the response to Yoda1 before and after EC removal in the saphenous 
arteries isolated from control mice (n=5). Responses are expressed as percent 
constriction and as the AUC of the response to Yoda1. Mean ± SEM values are depicted. 
NS=not significant.  
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Figure 5-26 The effect of the endothelium removal on Yoda1-induced relaxation in 
saphenous arteries from Piezo1∆EC mice  
(a) Typical trace showing a concentration-dependent response to Yoda1 as indicated by 
the dots (0.1, 0.3, 1, 3 and 10 μM) in the saphenous arteries isolated from Piezo1∆EC 
mice before and (b) after EC removing (-EC). (c) Concentration response curves to 
Yoda1 in the saphenous arteries from Piezo1∆EC mice before and after -EC (n=3). (d) The 
area under the curve (AUC) of the response to Yoda1 before and after -EC in the 
saphenous arteries isolated from Piezo1∆EC mice (n=3). Responses are expressed as 
percent constriction and as the AUC of the response to Yoda1. Mean ± SEM values are 
depicted. NS=not significant.  
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Figure 5-27: The effect of the endothelium removal on Yoda1-induced relaxation 
in carotid arteries from control mice  
(a) Typical trace showing a concentration-dependent response to Yoda1 as indicated by 
the dots (0.1, 0.3, 1, 3 and 10 μM) in the carotid arteries isolated from control mice before 
and (b) after EC removing (-EC). (c) Concentration response curves to Yoda1 in the 
carotid arteries from control mice before and after -EC (n=4). (d) The area under the 
curve (AUC) of the response to Yoda1 before and after -EC in the carotid arteries isolated 
from control mice (n=4). Responses are expressed as percent constriction and as the 
AUC of the response to Yoda1. Mean ± SEM values are depicted.  NS=not significant.  
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Figure 5-28: The effect of the endothelium removal on Yoda1-induced relaxation 
in carotid arteries from Piezo1∆EC mice  
(a) Typical trace showing a concentration-dependent response to Yoda1 as indicated by 
the dots (0.1, 0.3, 1, 3 and 10 μM) in the carotid arteries isolated from Piezo1∆EC mice 
before and (b) after EC removing (-EC). (c) Concentration response curves to Yoda1 in 
the carotid arteries from Piezo1∆EC mice before and after -EC (n=3). (d) The area under 
the curve (AUC) of the response to Yoda1 before and after -EC in the carotid arteries 
isolated from Piezo1∆EC mice (n=5). Responses are expressed as percent constriction 
and as the AUC of the response to Yoda1. Mean ± SEM values are depicted.  NS=not 
significant.  
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5.3 Discussion  
Surprisingly, these data provide no evidence for the presence of functional Piezo1 
channels and no anti-EDH effect of Piezo1 in the endothelium of saphenous or carotid 
arteries. Furthermore, the data do show endothelial-independent responses to Yoda-1. 
5.3.1 Deletion of endothelial cell Piezo1 does not affect high 
potassium or phenylephrine-induced contraction in 
saphenous or carotid arteries from control and Piezo1∆EC 
mice. 
Contractile responses induced by either K+ or PE, were initially studied. The saphenous 
artery developed more force in response to high K+ as compared to the carotid artery. 
The same phenomenon was observed with PE at high concentrations, indicating that it 
is indeed a difference in contractile machinery. The smaller response in the carotid artery 
can be explained via a bigger influence of spontaneously released NO. Furthermore, the 
carotid artery is an elastic artery, and the saphenous artery is a muscular artery, where 
the muscular arteries ability to contract is promoted by the formation of the structural 
elements of the arterial wall and the lower volume of elastic tissue. This phenotypic 
heterogeneity may have outcomes for the vessel contractile capacity (Levický and 
Dolezel, 1979). 
Moreover, there was no difference in the sensitivity to K+ or PE between any of the groups 
of saphenous and carotid arteries from control and Piezo1∆EC mice. These contractile 
responses were not influenced by endothelial Piezo1 deletion in either type of arteries.  
5.3.2 Deletion of endothelial cell Piezo1 does not affect ACh-
induced vasorelaxation in saphenous or carotid arteries from 
control and Piezo1∆EC mice. 
ACh-induced relaxation was similar in both groups of saphenous and carotid arteries 
from control and Piezo1∆EC mice. Piezo1 deletion does not alter the responses to ACh, 
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implying that endothelial Piezo1 played no role in the relaxation response to ACh in these 
arteries. 
Endothelium-dependent contractions, found in various types of mouse arteries (aorta, 
carotid, and femoral arteries) (Liu et al., 2012, Golubinskaya et al., 2014, Zhou et al., 
2005), were also observed in carotid but not in saphenous arteries from control and 
Piezo1∆EC mice. These contractions are a secondary contraction to ACh that was 
observed after a high concentration had been applied. It was presumed to be an 
endothelium-derived contraction and not a direct effect of ACh on the SMCs since this 
secondary contractile response to ACh was abolished by removing the ECs. Therefore, 
this latter contraction at higher concentrations of ACh appears to be due to the release 
of EDCF in particular the cyclooxygenase enzyme that is involved in the production of 
EDCF (Vanhoutte and Tang, 2008). In contrast to carotid arteries, in saphenous arteries 
from control and Piezo1∆EC mice, ACh-induced relaxations were not affected and 
cyclooxygenase products do not contribute to endothelium-dependent relaxation at the 
concentrations of ACh used in this study.  
5.3.3 Deletion of endothelial cell Piezo1 does not affect EDHF or 
NO-mediated vasorelaxation in saphenous or carotid arteries 
from control and Piezo1∆EC mice. 
In the elastic arteries, the basal NO formation inhibition through endothelial NOS with L-
NAME constantly raised the tension but not in the muscular arteries (Leloup et al., 2015). 
The tension in saphenous artery from control and Piezo1∆EC mice was unaffected after 
the incubation with L-NAME or combination of apamin plus charybdotoxin. However, the 
tension in carotid artery from control and Piezo1∆EC mice significantly increased after the 
incubation with L-NAME but not with the combination of apamin plus charybdotoxin. This 
indicates that the basal NO release is not essential in saphenous arteries isolated from 
control and Piezo1∆EC mice, but basal NO secretion is greater in carotid arteries from 
control and Piezo1∆EC mice. Interestingly, in saphenous or carotid arteries isolated from 
control and Piezo1∆EC mice the contractile response of PE was significantly affected by 
the presence of L-NAME but not with the presence of both apamin and charybdotoxin.  
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The important contribution of NO and EDHF to endothelium-dependent relaxation 
presents a significant heterogeneity between species and types of vessels (Triggle et al., 
1999). Treatment of saphenous arteries from control and Piezo1∆EC mice with L-NAME 
resulted in a significant shift of about 80-fold of the endothelium-dependent 
concentration-relaxation curve to ACh, showing that under conditions where NOS activity 
is absent, an endothelium-dependent relaxation can still be produced by ACh and this 
relaxation has the properties of being mediated by an EDHF. Furthermore, the relaxation 
to ACh following incubation with the combination of apamin and charybdotoxin produced 
a significant rightward shift of about 20-fold of ACh-induced relaxation in any of the 
groups tested. However, the relaxation to ACh was not completely abolished. This raised 
the possibility of the remaining relaxation being due to NO.  
In small muscular resistance arteries, marked endothelium-dependent vasodilatation can 
continue during pharmacological NOS inhibition or NOS deficiency (Huang et al., 2000). 
This has been attributed to EDHF (Feletou and Vanhoutte, 1999, Busse et al., 2002). 
This mechanism involves SKca2+ and IK ca2+ channels which are located in the 
plasmalemma of the ECs (Edwards et al., 1998, Stankevičius et al., 2006, Grgic et al., 
2009). Activation of these channels can cause endothelium-dependent vasodilatation by 
conduction of the ECs hyperpolarisation to the underlying SMCs by gap junctions 
(Félétou and Vanhoutte, 2009). 
These results are consistent with previous findings in which the EDHF was the dominant 
mechanism in rat mesenteric artery but not in femoral artery due to the presence of 
efficient gap junction communication between ECs and SMs in mesenteric artery but not 
femoral artery. Furthermore, EDHF contributes to ACh-induced relaxation and the 
endothelium-dependent vasodilator EDHF changes during development in the 
saphenous artery of the rat (Sandow et al., 2004, Sandow et al., 2002). Chennupati et al 
2013 also showed that EDHF contributed to endothelium-dependent relaxations but it 
decreased with age and the contribution of endothelium-derived NO increased in adult 
male mouse saphenous arteries (Chennupati et al., 2013).   
In carotid arteries from control and Piezo1∆EC mice, ACh elicited almost no response 
following incubation with L-NAME and the ACh response seemed completely dependent 
on NO (fully blocked by L-NAME), indicating that EDHF was not the prevalent relaxing 
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factor in these arteries. This was in contrast to the EDHF, in response to ACh following 
apamin plus charybdotoxin incubation which showed that the arteries were still capable 
of a full relaxation in the presence of these agents which block EDHF. Therefore, it can 
be concluded that there is no contribution of non-NO factors to ACh-induced relaxation 
in the carotid artery and that if any relaxation by hyperpolarisation, could be mediated 
through NO. These data do not necessarily mean that the full relaxation to ACh is 
mediated by NO rather than EDHF in the carotid arteries, but they do show that when 
EDHF production was blocked NO was capable of fully compensating. This is in 
agreement with previous findings in mouse and rabbit carotid vessels (Golubinskaya et 
al., 2014, Cohen et al., 1997). Furthermore, the contribution of EDHF factor to the 
relaxation of the saphenous, but not the carotid artery, this is again in agreement with 
previous study that showed the relevant role of EDHF reduced as the size of the vessel 
increased (Shimokawa et al., 1996). 
Furthermore, it was shown that no anti-EDHF effect of Piezo1 occurred in saphenous 
(similar in diameter to second-order mesenteric artery) or carotid artery and that Piezo1 
activity did not interfere with the relaxation as ACh responses were similar in saphenous 
and carotid arteries from control and Piezo1∆EC mice. No anti-EDH effect of Piezo1 in 
these arteries as seen in the mesenteric artery confirmed that there is vascular bed 
specificity of the Piezo1 vasoconstrictor mechanism. Vascular bed specificity was also 
found in response to exercise to promote blood flow redistribution, vasoconstriction in 
intestines and vasodilatation in skeletal muscle (Joyner and Casey, 2015). Thus, Piezo1 
plays an essential role in redistribution of blood flow during the periods of physical activity 
by restriction blood flow. 
5.3.4 The effect of removal of endothelial cells on ACh-induced 
relaxation in saphenous or carotid arteries from control and 
Piezo1∆EC mice. 
Removing the endothelium totally abolished ACh-induced relaxation, indicating that the 
ability of ACh to induce relaxation was lost in endothelium-denuded saphenous and 
carotid arteries isolated from control and Piezo1∆EC mice, which is consistent with 
previous studies.  Removal of the endothelium significantly increased the response to 
PE in carotid arteries from control and Piezo1∆EC mice but not in saphenous arteries from 
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control and Piezo1∆EC mice, suggesting that PE caused the contraction through direct 
activation of SMCs. SIN-1, a NO donor, causes relaxation by direct activation of sGC, 
resulting in a rise in cGMP levels in SMC (Plane, Sampson et al. 2001). Here, data 
showed that there was no difference in the levels of SIN-1-induced relaxation in 
saphenous or carotid arteries isolated from control and Piezo1∆EC mice, suggesting that 
the responses mediated by SIN-1 were not affected by Piezo1 deletion in saphenous or 
carotid arteries isolated from control and Piezo1∆EC mice. 
5.3.5 Endothelial-dependent relaxation induced by Yoda1 in 
saphenous or carotid arteries from control and Piezo1∆EC 
mice. 
Yoda1, a chemical activator of Piezo1 (Syeda et al., 2015) induced a small relaxation in 
saphenous arteries from control and Piezo1∆EC mice compared to mesenteric artery. 
However, the relaxation induced by Yoda1 was not significantly reduced in Piezo1∆EC 
mice. Therefore, the ability of Yoda1 to induce relaxation is not affected by the 
endothelial Piezo1 deletion showing that an endothelium-independent pathway is also 
involved in the vasorelaxain similar to the mesenteric artery. In contrast to the saphenous 
artery, Yoda1 in carotid arteries from control and Piezo1∆EC mice induced contraction 
rather than relaxation which might reflect a Piezo1 role or some other unidentified 
mechanism associated with Piezo1. 
5.3.6 The effect of removal of endothelial cells on Yoda1-induced 
relaxation in saphenous or carotid arteries from control and 
Piezo1∆EC mice. 
Removal of ECs did not alter the effects of Yoda1 in either group. In saphenous artery, 
as mentioned before, it can be concluded that the ability of Yoda1 to provide relaxation 
is largely endothelial independent, and that Piezo1 present in SMC ((Retailleau et al., 
2015) might be involved in this relaxation. Furthermore, in carotid arteries, the 
contraction seen with Yoda1 did not change by removing the ECs. This can be related 
to the different expression or function of Piezo1 in difference types of arteries. 
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5.4 Conclusion  
Studies with mouse saphenous arteries and carotid arteries indicate that the function of 
endothelial Piezo1 may not be the same from vessel to vessel. 
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Chapter 6 Final summary and Future Directions 
This study was focussed on investigating and understanding the role of the 
mechanosensitive cation channel Piezo1 in arteries. Disruption of the Piezo1 gene in 
mice has demonstrated that this channel has a critical role in vascular development in 
embryogenesis (Li et al., 2014) and in adult vascular regulation (Wang et al., 2016(Wang 
et al., 2016), however, the mechanism(s) by which Piezo1 contributes to these processes 
largely remains to be determined. Therefore, within this work the function of Piezo1 has 
been examined using wire myography, assessing its contribution to the contractility of 
intact blood vessels.   
Four structurally and functionally distinct arteries, the thoracic aorta, mesenteric, 
saphenous and carotid arteries, were selected. Their physiological differences are 
evident just by comparing their responses to PE and ACh.  The lowest concentration of 
PE to constrict mesenteric, saphenous and carotid arteries was fairly similar, between 
0.03 and 0.1 µM, however, the EC50 concentrations and the magnitude of the constrictive 
effect varied considerably (Table 6. 1). Carotid arteries showed greater sensitivity to ACh 
than mesenteric or saphenous arteries, although the extent of relaxation at a 1 µM 
concentration was relatively similar (Table 6. 1). It is well known that elastic and muscular 
arteries differ in function and in the magnitude of their response to vasoconstrictor effects 
(Bevan et al., 1972). Carotid and renal arteries, which are pathways to BP sensors, have 
a higher ratio of collagen to elastin than the femoral and mesenteric arteries, which are 
pathways to regulated beds (Fischer and Llaurado, 1966). Thus the various patterns of 
structure and content in collagen to elastin ratio through these four types of arteries 
would result in various vessel wall mechanical properties. Therefore, it was unlikely that 
the contribution, if any, of Piezo1 to these arteries would be equivalent and a comparison 
of the four vessels types should provide a more rounded understanding of the role(s) 
and importance of this channel. This proved to be the case, Piezo1 having a prominent 
role in mesenteric arteries that was not mirrored in the thoracic aorta, saphenous or 
carotid arteries.   
Mice in which the Piezo1 gene had been disrupted in EC displayed no obvious 
phenotype. Their resting BP was normal (Fig 3. 18) and isolated mesenteric, saphenous 
and carotid arteries constricted and relaxed in response to the PE and ACh respectively 
in the same manner as control vessels (Figs 4. 3 and 5, 5. 4, 5, 7 and 8). However, 
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multiple pieces of data point to a functional role of Piezo1 in blood vessels.  Yoda-1, a 
Piezo1 agonist, had effects on all tested arteries, though the nature of these effects was 
not consistent. Mesenteric and saphenous arteries from control mice both respond with 
vasorelaxation, though the magnitude of this response was almost two fold greater in the 
former (Table 6. 2). In contrast carotid arteries from control mice respond with 
vasoconstriction. For the thoracic aorta relaxation was seen in vessels from wild mice, 
however, constriction was seen in vessels from control mice, the reason for this 
difference most probably relating to mouse genotype, as discussed in chapter 3. Overall 
this suggests that the role for Piezo1 is multifaceted and non-uniform between vessels. 
Slightly unexpectedly, only in thoracic aorta was the Yoda-1 response (relaxation) 
dependent upon ECs. It was also sensitive to L-NAME, fitting with the finding the Yoda-
1 leads to phosphorylation and so activation of eNOS (Fig 3. 9) (Wang et al., 2016). For 
the other vessels the response to Yoda-1 is most likely explained by the presence of 
Piezo1 in VSMC ((Retailleau et al., 2015). It is obvious that influx of Ca2+ into these cells 
could lead to contraction, however, how Piezo1 activation could result in contraction, as 
in the case in thoracic aorta and carotid arteries from control mice, is less clear and 
requires further exploration. It would be interesting to repeat these experiments on 
arteries isolated from mice globally heterozygous for Piezo1 (Li et al., 2014). 
Consistent with the absence of an endothelial based effect of Yoda-1 essentially no 
difference was found between control and Piezo1EC mice in carotid or saphenous 
arteries. However, a significant difference was identified in mesenteric arteries. There 
was no effect on the sensitivity or magnitude of the response to ACh alone, but when 
production of EDHF was inhibited by the combination of apamin and charybdotoxin, 
inhibitors of two K+ channels which are important for EDHF, the relaxation to ACh was 
clearly impaired. Thus, deletion of endothelial Piezo1 enhances the EDHF response in 
mesenteric arteries. The fact that the EDHF effect was not amplified by Piezo1 disruption 
in saphenous or carotid arteries indicates that nature of the EDHF component may not 
be the same from artery to artery, thus is in agreement with the theory that EDHF is more 
critical in small resistance arteries compared with conduit arteries (Berman et al., 2002), 
and also that Piezo1 might not be expressed in endothelium of all vessels. 
While wire myography allows the Piezo1 channel to be assessed in the context of an 
intact vessel, it does have limitations. Vascular contractility is evaluated in the absence 
of circulating factors, sympathetic activity and importantly blood flow, when compared 
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with in vivo. The solution bathing the vessels is static, thus the experiments primarily 
consider the contribution of the constitutive activity of Piezo1, not its activation by shear 
stress. Therefore, a functional role for endothelial Piezo1 in saphenous and carotid 
arteries cannot be discounted. Equally, the possible impact of the absence of continuous 
exposure to pulsatile shear stress on Piezo1 stability and trafficking cannot be 
overlooked. Wang and colleagues, using pressure myography, reported Yoda-1 
stimulated relaxation in mesenteric arteries that is reduced in their Piezo1EC mouse. 
Given that within the work presented here Yoda-1 induced relaxation was equivalent in 
mesenteric vessels from control and Piezo1EC mice it would be interesting to study 
saphenous and carotid arteries using the pressure myograph.  
Regardless of these limitations, an important anti-EDHF role for Piezo1 activity was 
identified in mesenteric arteries, providing insight into our finding that BP in active 
Piezo1EC mice was increased to a lesser extent than control mice. Mesenteric arteries 
are crucial to BP control, consequently require the additional EDHF mechanism to back 
up the NO. The saphenous and the carotid arteries, in contrast, are capable of relaxation 
via the release of NO, but its relaxation effect does not impact upon BP. Thus, the lack 
of a role for endothelial Piezo1 in saphenous and carotid arteries is consistent with prior 
knowledge that whole body physical activity involves reduced blood flow to the 
gastrointestinal tract but increased or sustained blood flow to skeletal muscle and the 
brain (Qamar and Read, 1987, Perko et al., 1998, Joyner and Casey, 2015).  
Exercise can protect against or reduce the risk of high BP, but the hypertension 
experienced during exercise has been shown to be an essential predecessor of 
continuous hypertension (Sabbahi et al., 2016, Miyai et al., 2002). Given that 
hypertension remains one of the major health issues of the 21st century, promoting new 
methodologies and tools for studying Piezo1 channels are involved in the regulation of 
BP in a manner which allows it to enhance physical performance. 
In summary, this study has demonstrated a functional role for Piezo1 in arterial vessels. 
In ECs there a dichotomy exists, Piezo1 channels being linked to both NO-dependent 
vasorelaxant and anti-EDHF based vasoconstrictant effects. Add to this the further 
endothelial-independent vasoactive effects of Yoda-1 and it appears that Piezo1 has a 
complex role in the cardiovascular system. An influence of endothelial Piezo1 on EDHF 
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function in second order mesenteric arteries was revealed by comparing Piezo1∆EC mice 
with control mice. This effect was vascular bed-specific, not being observed in either 
saphenous or carotid arteries, which, unlike mesenteric vessels, do not undergo 
vasoconstriction during exercise. Thus, implying that in mouse vasculature, Piezo1 
channels are involved in the regulation of BP in a way which allows it to enhance physical 
performance. 
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  Mesenteric arteries Saphenous arteries Carotid arteries 
  Control  Piezo1∆EC Control  Piezo1∆EC Control  Piezo1∆EC 
high K+  effect contraction 
34.4% decrease 
in contraction vs 
control 
contraction 
no difference to 
control 
contraction  
no difference to 
control 
        
PE 
effect contraction  
no difference to 
control 
contraction 
no difference to 
control 
contraction 
no difference to 
control 
EC50 ~0.2 μM 
(plateau not 
reached by 1 μM) 
(plateau not 
reached by 1 μM) 
+ L-
NAME 
50% increase  35% increase  30% increase  36% increase  65% increase  35% increase 
        
ACh 
effect relaxation Decrease only at 
one ACh 
concentration 
relaxation 
no difference to 
control 
relaxation 
no difference to 
control 
EC50 ~0.1 μM 
(plateau not 
reached by 1 μM) 
~0.01 μM 
+ Apa + 
Ch 
Decrease only at 
some ACh 
concentrations               
90% decrease 
(AUC) 
33% decrease 
(AUC) 
25% decrease 
(AUC) 
no effect 
no difference to 
control 
+ L-
NAME 
72% decrease 
(AUC) 
no difference to 
control 
60% decrease 
(AUC) 
64% decrease 
(AUC) 
96% decrease 
(AUC) 
90% decrease 
(AUC) 
        
SIN-1 
effect relaxation  
no difference to 
control 
relaxation 
no difference to 
control 
relaxation 
no difference to 
control EC50 ~0.1 μM 
(plateau not 
reached by 1 μM) 
(plateau not 
reached by 1 μM) 
 
Table 6-1: Summarised data for effects of vasoconstriction and vasodilation agonists on mouse mesenteric, saphenous and carotid arteries
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   Aorta        
(WT mice) 
Aorta              
(Cre- mice) 
Mesenteric 
arteries          
(Cre- mice) 
Saphenous 
arteries          
(Cre- mice) 
Carotid 
arteries          
(Cre- mice) 
Yoda-1 
basal arteries   no effect         
PE pre-constricted 
arteries 
effect relaxation contraction relaxation  relaxation contraction 
EC50 2.3 μM 
plateau not 
reached by      
10 μM 
1.8 μM 
plateau not 
reached by      
10 μM 
plateau not 
reached by      
10 μM 
10 μM Yoda-1                  
response magnitude vs PE 
    ~60% ~38%   
endothelial cell 
dependent? 
yes   no no no 
+ L-NAME 
relaxation 
inhibited by 
99% 
  
relaxation 
inhibited by 
30% 
contraction 
unaffected 
contraction 
unaffected 
Piezo1∆EC (Cre+) - 
no 
difference to 
control          
(cre-) 
no 
difference to 
control          
(cre-) 
no 
difference to 
control          
(cre-) 
no 
difference to 
control          
(cre-) 
 
Table 6-2: Summarised data for effects induced by Yoda1 on mouse aorta, mesenteric, saphenous and carotid arteries from control and 
Piezo1EC mouse
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